Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3046279	p-pct	ug/l (ug/l)	9981	19918	1.18%
3046279	s-pct	ug/l (ug/l)	2586	4303	0.00%
3046279	p-pct	— (—)	1710	2552	100.00%	Distribution not available
3046279	p-pct	ng/ml (ug/l)	839	1493	0.00%
3046279	s-pct	— (—)	581	1373	100.00%	Distribution not available
3046279	p-pctpika	ug/l (ug/l)	108	141	0.00%
3046279	p-pctpika	— (—)	36	37	100.00%	Distribution not available
3046279	p-pct-o	— (—)	13	15	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Cardiovascular diseases

1442

2365

3.40

321.27

2.2

1.8

1.95

ug/l

0.00

1305

2098

Care involving dialysis

543

913

7.01

318.93

2.8

1.8

3.55

2.45

ug/l

0.56

516

807

Hypertensive diseases

2402

5612

2.49

313.89

2.2

1.9

2.49

2.12

ug/l

0.41

2160

4953

Hypertension

2401

5608

2.49

313.79

2.2

1.9

2.49

2.13

ug/l

0.41

2159

4949

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1230

2252

3.58

309.10

2.4

1.7

1.77

1.85

ug/l

0.10

1117

2013

Viral pneumonia (unknown virus, not influenza)

473

715

7.82

307.89

2.7

2.0

1.23

2.08

ug/l

0.68

441

632

Streptococcal septicaemia

514

763

7.77

307.65

2.3

1.7

3.78

1.57

ug/l

3.11

467

636

Viral pneumonia

836

1150

8.41

307.65

2.6

1.8

1.26

2.78

ug/l

1.60

751

983

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

2407

5138

4.55

307.65

2.1

1.9

2.60

2.10

ug/l

0.36

2222

4478

Complications of medical and surgical care

2718

10745

2.51

307.65

2.3

1.9

2.40

2.24

ug/l

0.21

2388

9449

Oral corticosteroids

4438

9253

3.04

307.65

2.1

1.9

1.95

2.27

ug/l

0.84

3966

8091

Parasetamol

2454

4637

2.77

307.65

2.1

1.9

2.38

1.95

ug/l

0.67

2180

4123

Implicit bacterial Sepsis

2783

4877

5.97

307.65

2.7

1.7

3.75

1.45

ug/l

3.81

2501

4212

Cerebrovascular diseases (FINNGEN)

1075

1808

4.46

307.65

2.3

1.7

2.33

2.03

ug/l

0.25

927

1620

Non-ischemic cardiomyopathy

1345

3499

3.39

307.65

2.2

1.8

3.45

2.40

ug/l

0.45

1175

2992

Excluding asthma or asthma-COPD overlap

2556

4199

3.15

307.65

2.1

1.8

1.96

2.54

ug/l

1.12

2289

3678

Heart failure and bmi 25plus

1699

3993

3.17

307.65

2.2

1.8

2.42

2.12

ug/l

0.39

1505

3409

COPD/asthma related infections

3880

6140

3.29

307.65

2.1

1.8

1.95

2.41

ug/l

1.19

3471

5357

Asthma, hospital admissions 3, pneumonia

1612

5529

3.10

307.65

2.4

1.9

2.26

2.46

ug/l

0.22

1455

4778

Asthma (mode)

2160

4195

2.91

307.65

2.1

1.7

2.05

2.54

ug/l

0.83

1938

3671

Bleeding

3006

10087

2.25

307.65

2.3

1.9

2.52

2.03

ug/l

0.93

2624

8908

Aplastic and other anaemias

2248

6975

3.30

307.65

2.3

1.9

3.27

2.17

ug/l

0.91

2023

6026

Insulin medication

2329

8026

2.59

307.65

2.2

2.0

2.25

2.17

ug/l

0.14

2125

6996

Any reimbursement code in KELA

1422

1783

4.10

307.65

2.2

1.8

2.20

1.69

ug/l

0.82

1284

1500

Asthma-related pneumonia or sepsis

1612

5529

3.10

307.65

2.4

1.9

2.26

2.46

ug/l

0.22

1455

4778

Covid-19 confirmed case

2039

3638

6.45

307.65

2.3

1.9

1.34

2.38

ug/l

3.26

1797

3174

Non-invasive ventilation

1301

1604

8.48

307.65

2.9

1.8

2.48

2.11

ug/l

0.32

1031

1427

Codes for special purposes

2448

5441

4.92

307.65

2.2

1.9

1.36

2.25

ug/l

3.84

2172

4786

General symptoms and signs

4131

6808

3.16

307.65

2.2

1.8

1.89

2.46

ug/l

1.14

3707

5957

Dialysis, with operation codes

844

1652

5.92

307.65

3.1

1.8

3.82

2.12

ug/l

1.70

800

1449

Inflammatory bowel disease treatment related agents

4412

9365

2.78

307.65

2.1

1.9

2.00

2.27

ug/l

0.65

3947

8190

Complications of procedures, not elsewhere classified

2895

10469

2.48

307.65

2.3

1.9

2.32

2.29

ug/l

0.03

2566

9209

ILD medications: prednisolone, methylprednisolone, prednisone

4339

8606

2.97

307.65

2.2

1.9

2.16

2.28

ug/l

0.20

3883

7529

ILD medications

4351

8667

2.86

307.65

2.2

1.9

2.13

2.27

ug/l

0.27

3897

7582

Complications of surgical and medical care, not elsewhere classified

3745

10791

2.59

307.65

2.3

1.9

2.26

2.28

ug/l

0.04

3297

9482

Bacterial infection, other or unspecified

4435

5260

8.94

307.65

2.3

1.7

2.38

1.60

ug/l

1.38

4043

4449

All-cause Heart Failure

2851

6897

3.21

307.65

2.2

1.9

2.86

2.21

ug/l

0.61

2553

5990

Asthma, unspecified (mode), excluding more controls

1717

3378

4.17

307.65

2.1

1.7

1.91

2.53

ug/l

1.22

1520

2954

Heart failure,strict

2707

5442

3.90

307.65

2.2

1.9

2.92

2.11

ug/l

0.76

2429

4775

Bacterial pneumonia, not elsewhere classified

1708

4086

3.95

307.65

2.7

1.7

2.21

2.42

ug/l

0.23

1526

3513

Infections, IBD-co-morbidities

895

926

7.69

307.65

2.8

1.8

2.28

2.44

ug/l

0.08

815

830

Other bacterial diseases

6393

7080

6.93

307.65

2.3

1.7

3.00

1.50

ug/l

6.35

5826

6054

Hypertension, essential

2473

5511

2.65

307.65

2.3

1.9

2.41

2.14

ug/l

0.27

2226

4864

Malignant neoplasm

2985

7590

2.41

307.65

2.2

1.9

2.53

2.03

ug/l

0.90

2709

6650

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

641

727

7.22

307.65

2.5

1.8

2.43

2.60

ug/l

0.06

580

649

Transplanted organ and tissue status

595

1049

6.52

307.65

2.7

1.9

2.63

ug/l

0.00

569

946

Atrial fibrillation and flutter with reimbursement

1013

1470

4.68

307.65

2.2

1.7

2.45

2.04

ug/l

0.34

914

1326

Provisional assignment of new diseases of uncertain etiology

2445

5430

4.92

307.65

2.2

1.9

1.36

2.25

ug/l

3.84

2169

4780

Acute renal failure

1392

3082

5.19

307.65

2.9

1.8

5.38

2.02

ug/l

2.46

1274

2649

Malignant neoplasm, wide definition for exclusion

2913

7239

2.46

307.65

2.2

2.0

2.52

2.10

ug/l

0.69

2645

6329

Erysipelas

2555

5715

4.38

307.65

2.2

1.7

2.26

1.56

ug/l

2.37

2288

4871

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3366

9439

2.51

307.65

2.2

1.9

2.41

2.26

ug/l

0.21

2981

8350

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2517

9793

2.50

307.65

2.2

1.9

1.75

2.26

ug/l

1.33

2240

8572

Chronic kidney disease

1679

4742

3.89

307.65

2.5

1.8

3.82

1.91

ug/l

3.79

1530

4053

Asthma-related pneumonia

1609

5518

3.10

307.65

2.4

1.9

2.23

2.46

ug/l

0.27

1452

4767

Hypertensive diseases (excluding secondary)

1562

2406

3.91

307.65

2.3

1.8

2.06

1.88

ug/l

0.24

1424

2151

Metabolic disorders

3420

8909

2.47

307.65

2.2

1.9

2.27

2.29

ug/l

0.02

3063

7829

Primary_lymphoid and hematopoietic malignant neoplasms

1168

3186

4.00

307.65

2.5

1.9

2.40

1.90

ug/l

0.47

1072

2764

Cardiac arrhythmias

1723

3901

3.01

307.65

2.3

1.8

2.13

ug/l

0.00

1553

3442

All influenza

1007

2507

4.29

307.65

2.2

1.7

1.62

2.53

ug/l

1.72

880

2154

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

4984

6139

5.48

307.65

2.3

1.8

2.28

2.41

ug/l

0.15

4490

5356

Implicit Sepsis

3701

7468

4.14

307.65

2.5

1.7

3.23

1.41

ug/l

4.01

3277

6506

Other medical care

2177

5716

4.05

307.65

2.2

1.8

2.85

2.20

ug/l

0.43

1964

4963

Heart failure, strict

2897

6967

3.22

307.65

2.2

1.9

2.83

2.20

ug/l

0.60

2595

6053

Renal failure

2678

6638

4.09

307.65

2.6

1.8

4.39

1.81

ug/l

4.29

2440

5703

Pneumonias (Asthma/COPD co-morbidities)

5428

7953

5.09

307.65

2.3

1.8

2.29

2.27

ug/l

0.02

4883

6927

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4414

9864

3.39

307.65

2.3

1.9

2.76

1.99

ug/l

1.31

3997

8590

Other heart diseases

1666

2387

4.82

307.65

2.5

1.8

2.09

1.91

ug/l

0.25

1511

2130

COPD differential diagnosis

2547

4196

3.14

307.65

2.1

1.7

1.98

2.54

ug/l

1.05

2280

3672

Tramadol

2570

6783

2.52

307.65

2.2

1.9

2.61

2.18

ug/l

0.73

2285

5979

ILD, hospital admission 2, with pulmonary infections

587

960

7.06

307.65

2.6

1.7

2.38

3.01

ug/l

0.26

533

809

Type 2 diabetes, wide definition

3099

8147

2.59

307.65

2.1

1.9

2.34

2.23

ug/l

0.16

2771

7113

Malaise and fatigue

1948

4925

3.47

307.65

2.1

1.8

1.98

2.42

ug/l

0.90

1669

4270

COPD/asthma/ILD related infections

3880

6140

3.29

307.65

2.1

1.8

1.95

2.41

ug/l

1.19

3471

5357

ILD, hospital admissions 3, with pneumonia sepsis

545

897

7.14

307.65

2.6

1.7

2.35

2.63

ug/l

0.11

496

753

GASTRO-related operations

2596

3758

3.58

307.65

2.1

1.7

2.52

2.08

ug/l

0.62

2306

3275

Persons encountering health services for specific procedures and health care

4200

9326

2.91

307.65

2.3

1.9

2.68

2.10

ug/l

0.79

3732

8178

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

1055

2257

5.32

307.65

2.0

1.8

2.00

1.69

ug/l

0.35

981

1959

Other septicaemia

2932

3968

8.49

307.65

2.7

1.7

4.87

1.58

ug/l

15.23

2679

3330

COPD (mode)

1247

2635

4.00

307.65

2.1

1.7

1.81

2.52

ug/l

1.21

1096

2303

Renal tubulo-interstitial diseases

4458

8926

4.11

307.65

2.4

1.8

3.48

1.65

ug/l

5.37

4002

7794

Pneumonia, organism unspecified

4949

7445

5.20

307.65

2.3

1.8

2.34

2.28

ug/l

0.06

4457

6499

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1301

3094

4.72

307.65

2.0

1.9

3.15

1.82

ug/l

0.63

1216

2696

Acute tubulo-interstitial nephritis

2778

7290

3.59

307.65

2.2

1.8

3.05

1.66

ug/l

5.20

2444

6310

Asthma (only as main-diagnosis)

1980

4158

2.96

307.65

2.1

1.7

1.98

2.55

ug/l

0.97

1755

3640

Asthma, excluding more controls

2218

3603

3.38

307.65

2.2

1.7

2.10

2.61

ug/l

0.80

1993

3149

4984

6139

5.48

307.65

2.3

1.8

2.28

2.41

ug/l

0.15

4490

5356

Non-rheumatic valve diseases

1825

4654

3.01

307.65

2.2

1.9

1.80

2.29

ug/l

1.15

1596

4101

Other heart diseases, wide

2974

7115

2.68

307.65

2.3

1.9

2.12

2.17

ug/l

0.06

2670

6299

Oxycodone

2316

4828

5.20

307.65

2.3

1.8

2.58

2.23

ug/l

0.22

2063

4260

Other anaemias

2034

6599

3.20

307.65

2.3

1.8

3.32

2.16

ug/l

0.85

1821

5691

Diseases of arteries, arterioles and capillaries (FINNGEN)

1056

1426

5.55

307.65

2.3

1.7

2.24

2.05

ug/l

0.17

969

1286

Valvular heart disease excluding rheumatic fever

1837

4672

3.02

307.65

2.2

1.9

1.80

2.29

ug/l

1.18

1607

4115

Viral Sepsis

1120

2183

5.76

307.65

2.8

1.7

3.50

1.44

ug/l

0.87

986

1865

Explicit Sepsis

3246

5206

6.87

307.65

2.6

1.7

4.69

1.42

ug/l

18.82

2966

4506

Heart failure and antihypertensive medication

1405

1743

5.85

307.65

2.4

1.8

2.60

1.68

ug/l

1.62

1292

1550

Asthma, unspecified (mode)

1779

3892

3.78

307.65

2.1

1.7

1.86

2.49

ug/l

1.42

1569

3408

Other and unspecified anaemias

2018

6544

3.21

307.65

2.3

1.8

3.33

2.16

ug/l

0.85

1806

5642

Other diseases of pleura

2226

6893

3.08

307.65

2.4

1.9

2.46

2.24

ug/l

0.12

1980

6012

Opioids

3099

7087

2.36

307.65

2.1

1.9

1.99

2.18

ug/l

0.32

2737

6240

Other pulmonary diagnosis

2582

4199

3.18

307.65

2.1

1.8

1.96

2.54

ug/l

1.12

2312

3678

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5239

8215

4.82

307.65

2.4

1.8

2.37

2.20

ug/l

0.21

4715

7165

Bacterial pneumonia (organism specified)

2024

6342

3.09

307.65

2.7

1.8

2.14

2.30

ug/l

0.21

1816

5467

Asthma

2298

4158

3.05

307.65

2.2

1.7

2.07

2.55

ug/l

0.83

2055

3640

Anaemias

1059

521

14.51

307.65

2.5

1.5

3.34

1.75

ug/l

1.75

997

453

Bacterial Sepsis

3127

5309

5.94

307.65

2.6

1.7

3.68

1.43

ug/l

4.40

2811

4599

ILD medications: immunosuppressive drugs

2408

7087

3.43

307.65

2.2

1.9

2.47

2.13

ug/l

0.22

2181

6253

Nephropathy related operations

828

1709

5.64

307.65

3.1

1.9

3.49

2.58

ug/l

0.67

787

1515

Heart failure, not strict

3841

7209

3.96

307.65

2.3

1.9

2.88

2.09

ug/l

1.11

3448

6376

Dyspnoea

3390

10526

2.57

307.65

2.2

1.9

2.55

2.14

ug/l

0.40

3025

9218

Asthma (only as main-diagnosis), excluding more controls

1919

3603

3.27

307.65

2.1

1.7

2.02

2.61

ug/l

0.92

1705

3149

Any gastric operation

2596

3758

3.58

307.65

2.1

1.7

2.52

2.08

ug/l

0.62

2306

3275

First line medication for Crohn's disease

4444

7845

3.22

307.65

2.2

1.9

2.02

2.28

ug/l

0.63

4001

6816

Oedema, not elsewhere classified

1192

3461

3.63

307.65

2.2

1.7

1.81

2.44

ug/l

1.03

1023

3017

Abnormalities of breathing

3094

7293

2.60

307.65

2.1

1.9

2.00

2.40

ug/l

0.98

2754

6426

Cardiovascular diseases (excluding rheumatic etc)

1715

2747

3.71

307.65

2.3

1.8

2.00

1.81

ug/l

0.27

1555

2435

Septicaemia

3189

4332

8.23

307.65

2.7

1.7

4.73

1.56

ug/l

16.18

2910

3649

Condition for Implicit Sepsis (Organ dysfunction codes)

3630

7973

3.49

307.65

2.5

1.7

3.19

1.36

ug/l

4.09

3226

6974

Implicit viral Sepsis

1118

2175

5.77

307.65

2.8

1.7

3.50

1.45

ug/l

0.86

984

1858

Fever of other and unknown origin

3704

5779

6.61

307.65

2.3

1.8

1.82

2.33

ug/l

1.45

3374

5042

All pneumoniae

5441

7968

5.07

307.65

2.3

1.8

2.28

2.27

ug/l

0.01

4894

6946

ILD differential diagnosis

2540

4195

3.13

307.65

2.1

1.7

1.98

2.54

ug/l

1.05

2273

3671

Atrial fibrillation and flutter

1173

1754

4.60

307.65

2.4

1.7

2.29

2.13

ug/l

0.17

1067

1576

Other disorders of fluid, electrolyte and acid-base balance

1553

4201

3.89

307.65

2.4

1.9

2.50

2.35

ug/l

0.14

1361

3656

Bacterial pneumoniae

1829

4283

4.04

307.65

2.7

1.7

2.29

2.43

ug/l

0.16

1635

3689

Polyarthropathies

2753

6752

2.84

307.65

2.2

1.9

1.93

2.33

ug/l

0.67

2469

5978

Influenza and pneumonia

5494

7771

4.98

307.65

2.3

1.8

2.26

2.29

ug/l

0.03

4938

6779

Certain infectious and parasitic diseases

3797

5060

3.92

307.65

2.2

1.7

2.16

1.60

ug/l

1.62

3446

4283

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

2913

7239

2.46

307.65

2.2

2.0

2.52

2.10

ug/l

0.69

2645

6329

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

2914

7238

2.46

307.65

2.2

2.0

2.52

2.10

ug/l

0.68

2645

6328

Codeine

2848

7024

2.29

306.51

2.1

1.9

1.91

2.16

ug/l

0.53

2498

6188

Autoimmune diseases excluding thyroid diseases

3397

9132

2.12

304.80

2.1

2.0

2.68

2.21

ug/l

0.48

3045

8000

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

780

1866

4.65

302.09

2.1

1.9

2.31

1.60

ug/l

0.66

716

1620

Insulin, combination of fast acting with intermediate-acting or long-acting

2336

9493

2.36

300.49

2.2

1.9

2.24

2.23

ug/l

0.02

2132

8283

Abnormal findings on diagnostic imaging of lung

1958

7841

2.57

300.08

2.2

1.9

1.80

2.29

ug/l

0.96

1754

6877

Autoimmune diseases excluding thyroid diseases, strict definition

3309

8929

2.12

297.33

2.1

2.0

2.23

2.24

ug/l

0.02

2963

7819

Asthma, hospital admission 2, infections

2057

8518

2.47

296.83

2.2

1.9

2.02

2.29

ug/l

0.43

1835

7433

Asthma-related infections

2057

8518

2.47

296.83

2.2

1.9

2.02

2.29

ug/l

0.43

1835

7433

Primary_lymphoid and hematopoietic malignant neoplasms

1168

3757

3.38

290.56

2.5

1.9

2.40

2.04

ug/l

0.31

1072

3277

Any event in cancer register

2851

7889

2.20

286.45

2.1

2.0

2.44

1.99

ug/l

0.83

2557

6951

Diseases of the respiratory system

1899

3585

2.72

284.75

2.0

1.7

2.03

2.57

ug/l

0.83

1694

3125

Insulin, intermediate and long-acting

2084

8855

2.41

283.06

2.2

1.9

2.27

2.25

ug/l

0.04

1899

7747

Agranulocytosis

628

1337

5.32

282.51

2.6

1.9

1.57

2.30

ug/l

0.78

595

1189

3556

9487

2.03

281.24

2.1

1.9

2.26

2.31

ug/l

0.04

3128

8296

Gout

1304

4126

3.10

277.06

2.3

1.9

2.21

2.19

ug/l

0.02

1177

3636

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2138

9414

2.35

277.03

2.3

1.9

2.46

2.12

ug/l

0.54

1878

8269

Intestinal infectious diseases

2968

11370

2.09

276.81

2.3

1.9

2.73

2.15

ug/l

0.56

2652

9950

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

3034

9009

2.11

276.75

2.1

1.9

2.41

2.20

ug/l

0.33

2751

7850

Diseases of arteries, arterioles and capillaries

2536

8810

2.24

274.33

2.2

1.9

2.30

2.17

ug/l

0.20

2271

7691

Explicit bacterial Sepsis

559

1100

5.69

274.27

2.3

1.7

3.62

1.81

ug/l

2.12

509

950

Diabetes mellitus

3129

9231

2.07

271.12

2.2

1.9

2.35

2.19

ug/l

0.23

2838

8043

Diabetes, varying definitions

3116

9227

2.07

268.32

2.2

1.9

2.36

2.19

ug/l

0.24

2825

8040

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1659

5071

2.68

266.92

2.1

1.9

2.11

2.13

ug/l

0.03

1502

4410

L04AA Selective immunosuppressants

906

2617

3.72

265.90

2.4

2.0

2.04

2.15

ug/l

0.11

831

2346

Iron deficiency anaemia

1600

6277

2.66

265.59

2.2

1.9

3.71

2.20

ug/l

0.92

1416

5445

Diabetes, insulin treatment (Kela reimbursement)

3209

9900

2.04

265.49

2.1

2.0

2.51

2.16

ug/l

0.64

2899

8624

Bronchitis

3314

11192

1.99

262.35

2.1

1.9

2.20

2.30

ug/l

0.08

2917

9821

Early onset COPD, excluding more controls

745

1891

4.18

261.79

2.3

1.7

1.89

2.53

ug/l

0.70

682

1670

Nutritional anaemias

1823

7518

2.47

259.98

2.2

1.9

3.60

2.10

ug/l

1.09

1614

6512

Type 2 diabetes

3044

9030

2.05

256.35

2.2

1.9

2.32

2.18

ug/l

0.18

2749

7864

Nausea and vomiting

1044

3323

3.26

252.49

2.2

1.8

2.55

2.63

ug/l

0.06

914

2857

Dentinal caries

961

2964

3.44

251.28

2.3

1.9

2.04

2.14

ug/l

0.09

860

2627

Autoimmune diseases related-to ILD

2627

11403

2.08

249.32

2.1

2.0

2.56

2.19

ug/l

0.27

2344

10003

L04AD Calcineurin inhibitors

553

1181

5.23

246.93

2.6

2.1

2.70

2.32

ug/l

0.25

522

1066

Diarrhoea and gastroenteritis of presumed infectious origin

2194

9283

2.21

244.20

2.3

1.9

2.88

2.15

ug/l

0.53

1958

8130

Glucagon-like peptide-1 (GLP-1) analogues

2080

7784

2.30

243.73

2.1

2.0

2.30

2.26

ug/l

0.05

1851

6811

Second line medication for Crohn's disease

1825

7958

2.38

243.63

2.1

2.0

2.46

2.18

ug/l

0.14

1634

7054

L04AX Other immunosuppressants

1793

7776

2.39

242.52

2.1

2.0

2.46

2.16

ug/l

0.14

1608

6890

Gout, FINNGEN

1304

4916

2.84

242.42

2.3

1.9

2.21

2.19

ug/l

0.02

1177

4271

Dental caries

1028

3353

3.21

242.07

2.3

2.0

2.06

2.15

ug/l

0.09

919

2967

Drug-induced neutropenia

456

864

6.18

236.41

2.6

1.9

1.76

1.84

ug/l

0.05

439

775

Other diseases of blood and blood-forming organs, wide

951

3053

3.35

236.38

2.6

1.9

1.73

2.31

ug/l

0.88

883

2691

Diabetes medication

3080

9687

1.98

236.20

2.1

1.9

2.11

2.29

ug/l

0.31

2770

8455

Other bacterial intestinal infections

837

2487

3.64

236.13

2.6

1.8

2.16

2.33

ug/l

0.12

762

2143

Secondary hypertension

360

524

7.47

235.59

2.4

1.7

2.95

2.26

ug/l

0.24

330

468

Extracorporeal dialysis

441

824

6.45

233.86

2.9

1.9

3.62

2.30

ug/l

0.64

419

733

Medical observation and evaluation for suspected diseases and conditions

2206

5074

2.29

232.74

2.1

1.8

1.56

2.46

ug/l

3.21

1905

4520

Diseases of pulp and periapical tissues

1298

4958

2.74

231.94

2.3

2.0

3.01

2.24

ug/l

0.30

1169

4411

Other acute lower respiratory infections

1829

7757

2.33

231.62

2.3

1.9

2.56

2.26

ug/l

0.14

1616

6761

Presence of cardiac and vascular implants and grafts

1803

5936

2.41

230.93

2.1

1.9

1.77

2.21

ug/l

1.20

1551

5197

Chronic periapical parodontitis

910

2882

3.39

230.91

2.3

2.0

3.21

2.17

ug/l

0.29

821

2573

Pulmonary heart disease, diseases of pulmonary circulation

1307

5090

2.72

226.36

2.3

1.9

2.89

2.32

ug/l

0.21

1159

4429

Other CVD (FINNGEN)

481

710

5.79

226.00

2.2

1.7

1.78

2.02

ug/l

0.16

421

630

Enterocolitis due to Clostridium difficile

606

1500

4.53

225.21

2.8

1.9

2.33

2.18

ug/l

0.08

556

1280

Hypo-osmolality and hyponatraemia

801

2381

3.64

225.05

2.2

1.8

2.08

2.61

ug/l

0.54

702

2050

Insulin, fast-acting

1327

5202

2.67

224.87

2.3

1.9

2.52

2.20

ug/l

0.49

1223

4542

Systemic connective tissue disorders

1298

5045

2.71

224.61

2.1

1.9

1.25

2.40

ug/l

4.93

1135

4416

Venous thromboembolism

1954

8845

2.23

221.77

2.3

1.9

2.66

2.25

ug/l

0.22

1723

7723

DVT of lower extremities and pulmonary embolism

1598

6867

2.43

221.12

2.3

1.9

2.88

2.24

ug/l

0.30

1411

5993

Osteopathies and chondropathies

1824

7840

2.29

220.44

2.1

1.9

2.19

2.27

ug/l

0.09

1588

6883

Lung cancer and mesothelioma

737

1746

3.85

219.85

2.0

1.7

1.77

2.67

ug/l

0.89

667

1514

Hernia of abdominal wall, postoperative

602

1487

4.28

219.60

2.4

1.7

2.06

2.15

ug/l

0.06

545

1314

General examination and investigation of persons without complaint and reported diagnosis

2096

5063

2.26

218.32

2.3

1.8

1.93

2.47

ug/l

1.25

1873

4511

Depression medications

598

585

5.25

217.21

2.1

1.5

1.96

1.61

ug/l

0.34

543

506

Hypothyroidism (congenital or acquired)

527

554

5.60

216.81

2.3

1.6

1.83

1.69

ug/l

0.13

474

479

Other diseases of intestines

3059

9415

1.93

216.58

2.1

1.9

2.06

2.25

ug/l

0.31

2699

8280

Disorders of lipoprotein metabolism and other lipidaemias

2605

8295

2.03

215.02

2.0

1.9

2.04

2.36

ug/l

0.57

2310

7298

Pain in throat and chest

2398

7168

2.09

214.75

2.0

1.9

1.46

2.41

ug/l

5.06

2120

6320

Enlarged lymph nodes

603

1521

4.23

214.44

2.3

1.8

1.53

2.44

ug/l

1.16

538

1333

Glomerular diseases

834

2629

3.44

214.39

2.6

1.9

3.75

2.18

ug/l

1.39

766

2306

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1923

9041

2.21

213.89

2.3

1.9

2.41

2.18

ug/l

0.30

1689

7948

Infections of the skin and subcutaneous tissue

1797

8190

2.26

213.09

2.4

2.0

2.40

2.06

ug/l

0.42

1626

7237

Pulmonary embolism

1196

4601

2.76

212.46

2.4

1.9

2.85

2.35

ug/l

0.17

1055

3995

Other respiratory disorders and diseases

964

3331

3.13

211.75

2.8

1.9

2.08

2.50

ug/l

0.36

833

2885

Other diseases of the respiratory system

964

3331

3.13

211.75

2.8

1.9

2.08

2.50

ug/l

0.36

833

2885

Bacterial intestinal infections, IBD co-morbidities

823

2593

3.42

211.31

2.6

1.8

2.17

2.24

ug/l

0.05

750

2253

Pulmonary heart disease

1196

4626

2.74

210.16

2.4

1.9

2.85

2.41

ug/l

0.14

1055

4021

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

940

1388

3.47

209.64

2.1

1.8

1.70

2.74

ug/l

1.25

850

1213

STROKE

1756

5415

2.32

207.08

2.2

1.9

2.13

2.43

ug/l

0.28

1517

4791

Autoimmune diseases

3290

9152

1.87

206.81

2.1

2.0

2.12

2.22

ug/l

0.18

2928

8017

Other and unspecified iron deficiency

1205

4708

2.69

206.33

2.2

1.9

3.94

2.10

ug/l

0.85

1073

4066

Hypothyroidism, levothyroxine purchases

513

554

5.45

205.99

2.2

1.6

1.78

1.69

ug/l

0.08

461

479

Hypothyroidism and >3 levothyroxin purchases

513

554

5.45

205.99

2.2

1.6

1.78

1.69

ug/l

0.08

461

479

Neoplasms

2008

4923

2.23

204.68

2.2

2.0

2.42

1.98

ug/l

0.56

1802

4324

Endocrine, nutritional and metabolic diseases

2160

5151

2.18

204.49

2.1

1.9

2.02

2.13

ug/l

0.15

1943

4473

Fentanyl

530

1272

4.59

203.77

2.5

1.8

2.62

2.30

ug/l

0.14

465

1103

Other disorders of urethra and urinary system

2148

7864

2.10

203.25

2.2

1.9

2.96

2.10

ug/l

0.62

1884

6909

Symptoms and signs involving the circulatory and respiratory systems

2806

7307

1.96

201.74

2.1

1.9

1.81

2.40

ug/l

1.87

2474

6436

Other nutritional deficiencies

1840

8471

2.19

201.74

2.3

2.0

2.13

2.05

ug/l

0.11

1637

7498

Pleural effusion

763

2382

3.51

200.33

2.3

1.8

3.75

2.65

ug/l

0.25

706

2073

Other respiratory diseases principally affecting the interstitium

858

2872

3.25

200.14

2.6

1.9

2.27

2.49

ug/l

0.14

786

2484

Hard cardiovascular diseases

2542

8442

1.99

199.11

2.2

2.0

2.08

2.32

ug/l

0.33

2231

7468

Fungal Sepsis

274

370

9.05

198.71

3.2

1.6

1.70

2.12

ug/l

0.19

250

322

Codeine or tramadol medication

3408

10611

1.82

198.05

2.1

2.0

2.02

2.22

ug/l

0.45

2984

9352

Glomerular disorders in diseases classified elsewhere

602

1627

4.10

197.70

2.6

1.9

3.24

2.09

ug/l

0.82

551

1429

Diseases of oesophagus, stomach and duodenum

3164

10642

1.85

197.58

2.1

2.0

2.47

2.19

ug/l

0.41

2800

9361

Later onset COPD, excluding more controls

788

1888

3.47

196.08

2.0

1.7

1.67

2.78

ug/l

1.61

682

1607

Finngen Rheumatological endpoints

2737

8227

1.94

195.26

2.1

2.0

2.06

2.37

ug/l

0.44

2396

7275

Insulin, fast-acting or short human

1330

5579

2.49

194.96

2.3

1.9

2.54

2.15

ug/l

0.66

1226

4874

Headache

1553

5703

2.33

194.60

2.0

1.8

2.19

2.54

ug/l

0.38

1356

5007

Obesity due to excess calories

1367

5802

2.44

194.22

2.3

2.0

1.92

2.15

ug/l

0.37

1214

5169

Respiratory insufficiency

388

754

5.67

191.99

2.5

1.7

1.85

3.07

ug/l

0.86

339

634

Syncope and collapse

1328

4906

2.48

191.19

2.0

1.8

1.68

2.34

ug/l

1.75

1138

4266

Type 2 diabetes, definitions combined

2766

8840

1.91

191.02

2.1

1.9

2.36

2.21

ug/l

0.19

2473

7703

Pure hypercholesterolaemia

2313

7908

2.02

190.93

2.0

1.9

1.92

2.36

ug/l

0.91

2030

6956

Intracranial trauma

1609

5368

2.30

189.90

2.2

1.9

1.78

2.47

ug/l

1.07

1382

4820

Disorders of gallbladder, biliary tract and pancreas

3001

10724

1.85

189.39

2.2

1.9

2.50

2.16

ug/l

0.54

2693

9400

Obesity

1737

8162

2.17

187.49

2.3

2.0

1.92

2.09

ug/l

0.30

1541

7233

Pneumonia due to other infectious organisms, not elsewhere classified

230

269

10.36

187.18

3.0

1.7

0.79

2.54

ug/l

0.92

211

234

Obesity and other hyperalimentation

1745

8215

2.16

187.06

2.3

2.0

1.92

2.10

ug/l

0.34

1546

7280

Symptoms and signs involving the urinary system

2454

10064

1.94

185.46

2.0

2.57

2.08

ug/l

0.82

2086

8917

Type 2 diabetes, strict (exclude DM1)

2770

8950

1.89

185.27

2.1

1.9

2.35

2.19

ug/l

0.22

2477

7803

Ischemic heart diseases

2481

8178

1.96

183.81

2.2

2.0

1.80

2.44

ug/l

1.57

2242

7175

Care involving use of rehabilitation procedures

1813

8336

2.12

183.81

2.4

1.9

1.85

2.09

ug/l

0.58

1613

7308

Hypertensive heart and/or renal disease

988

2789

2.89

183.28

2.1

1.8

2.13

2.01

ug/l

0.10

884

2429

Implicit fungal Sepsis

247

326

9.25

182.62

3.3

1.7

1.71

2.34

ug/l

0.28

226

286

Type 2 diabetes, definitions combined, including avohilmo

2745

8811

1.89

182.09

2.1

1.9

2.29

2.19

ug/l

0.11

2464

7679

Ischaemic heart disease, wide definition

2460

8117

1.95

181.42

2.2

2.0

1.83

2.45

ug/l

1.47

2222

7121

Volume depletion

474

1146

4.58

181.02

2.3

1.8

2.92

2.35

ug/l

0.34

435

975

Other systemic involvement of connective tissue (FG)

898

3206

2.92

180.53

2.1

1.8

1.21

2.27

ug/l

3.19

774

2806

Gout, idiopatic and unspecified

1064

4209

2.71

180.10

2.2

1.9

2.21

2.19

ug/l

0.02

951

3689

Other disorders of skin and subcutaneous tissue

2175

10367

1.98

180.08

2.2

1.9

2.29

2.26

ug/l

0.04

1921

9080

1329

5721

2.38

179.03

2.3

2.0

1.84

2.23

ug/l

0.64

1172

5001

Antihypertensive medication - note that there are other indications

1336

2962

2.51

178.50

2.2

1.8

2.22

2.11

ug/l

0.07

1198

2608

Peripheral artery disease

1701

6508

2.20

178.49

2.2

1.9

2.24

2.27

ug/l

0.03

1524

5623

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

593

1693

3.81

178.45

2.6

1.8

2.31

1.74

ug/l

0.48

549

1457

Other (not insulin) diabetes medications

2822

9387

1.85

178.09

2.1

2.0

2.03

2.29

ug/l

0.50

2529

8192

Chronic lower respiratory diseases

3420

10724

1.76

177.77

2.1

2.0

2.08

2.34

ug/l

0.50

3056

9418

Symptoms and signs involving the digestive system and abdomen

2992

8317

1.84

176.74

2.1

1.9

1.87

2.36

ug/l

1.10

2661

7271

Used for control exclusion in common control thyroid runs

3041

8612

1.82

176.08

2.1

2.0

2.21

2.26

ug/l

0.07

2710

7539

Hydronephrosis

515

1351

4.16

175.31

2.1

1.8

2.78

1.87

ug/l

0.75

470

1166

ILD medications: azathioprine

524

1386

4.01

174.22

2.3

1.9

4.46

2.63

ug/l

0.31

482

1235

COPD

1663

6532

2.19

174.06

2.2

1.9

1.65

2.27

ug/l

2.02

1473

5713

Other functional intestinal disorders

1438

6238

2.27

171.58

2.1

1.9

1.89

2.18

ug/l

0.45

1253

5448

Heart failure and coronary heart disease

1398

4634

2.38

171.27

2.2

1.9

2.53

2.27

ug/l

0.24

1258

3943

Other soft tissue disorders, not elsewhere classified

2637

8919

1.87

171.24

2.1

2.0

2.04

2.47

ug/l

0.80

2294

7852

Coronary atherosclerosis

2224

7490

1.98

170.25

2.1

2.0

2.06

2.31

ug/l

0.41

1999

6566

Pain, not elsewhere classified

759

2572

3.07

169.03

2.1

1.8

1.80

2.33

ug/l

0.75

681

2246

Rheumatoid arthritis

1120

4185

2.54

168.34

2.1

1.9

1.59

2.44

ug/l

1.09

999

3689

Acute bronchitis

1370

6075

2.29

167.33

2.2

1.9

3.01

2.17

ug/l

0.35

1196

5264

Other chronic obstructive pulmonary disease

1600

6368

2.18

165.58

2.2

1.9

1.70

2.28

ug/l

1.77

1415

5561

Other interstitial pulmonary diseases

710

2381

3.25

165.39

2.5

1.8

2.33

2.70

ug/l

0.21

646

2054

ILD, hospital admissions

703

2346

3.27

165.24

2.4

1.9

2.31

2.73

ug/l

0.24

639

2029

Other disorders of teeth and supporting structures

821

2962

2.93

164.98

2.3

1.9

2.46

2.12

ug/l

0.32

715

2624

Benign neoplasm of colon, rectum, anus and anal canal

1584

5313

2.20

164.93

2.1

1.9

2.08

2.13

ug/l

0.06

1404

4637

Kidney transplant status

313

584

6.20

164.68

2.5

2.1

3.41

1.80

ug/l

1.14

302

535

Interstitial lung disease

710

2393

3.23

163.95

2.5

1.9

2.33

2.69

ug/l

0.20

646

2065

Interstitial lung disease endpoints

710

2393

3.23

163.95

2.5

1.9

2.33

2.69

ug/l

0.20

646

2065

Paralytic ileus and intestinal obstruction

968

3811

2.67

163.40

2.3

1.9

2.77

2.37

ug/l

0.42

864

3326

Other special examinations and investigations of persons without complaint or reported diagnosis

2012

5077

2.05

162.94

2.1

1.8

2.09

2.46

ug/l

0.60

1755

4521

Azathioprine

524

1455

3.81

162.41

2.3

1.9

4.46

2.69

ug/l

0.29

482

1296

Pain in limb

2249

8706

1.91

162.41

2.0

2.01

2.49

ug/l

0.87

1943

7669

Substance abuse, excluding more controls

1694

7302

2.09

161.95

2.2

2.0

2.28

2.09

ug/l

0.32

1502

6527

Reimbursement for rheumatic diseases

1725

8624

2.06

161.28

2.1

1.9

1.80

2.22

ug/l

0.69

1539

7567

COPD, hospital admission 2, with asthma infections

1295

4935

2.36

160.96

2.2

1.9

1.65

2.27

ug/l

1.67

1151

4291

Gout, unspecified

888

3401

2.81

160.91

2.2

1.9

2.43

2.26

ug/l

0.15

796

2961

Conduction disorders

984

3220

2.65

158.97

2.1

1.8

1.89

2.25

ug/l

0.53

845

2806

Sequelae of external causes of morbidity and mortality

944

3735

2.67

158.34

2.5

1.9

2.27

2.24

ug/l

0.03

867

3275

Asthma (diagnoses ohter than nonallergic)

2456

11769

1.82

157.99

2.1

2.0

1.94

2.31

ug/l

0.85

2174

10314

Haemorrhage from respiratory passages

1191

4823

2.38

157.36

2.3

1.9

2.35

2.45

ug/l

0.09

1034

4222

Other diseases of urinary system

2935

9527

1.77

156.93

2.1

1.9

2.08

2.13

ug/l

0.08

2565

8422

COPD, hospital admissions 3, with asthma pneumonia sepsis

1153

4222

2.46

156.47

2.3

1.9

1.67

2.41

ug/l

1.83

1025

3655

Myocardial infarction

1764

6351

2.07

155.92

2.1

1.9

2.00

2.33

ug/l

0.47

1573

5532

Abdominal and pelvic pain

2896

8316

1.78

155.51

2.1

1.9

1.88

2.36

ug/l

1.04

2587

7270

Diseases of the digestive system

1547

7560

2.12

155.00

2.3

1.9

2.40

2.22

ug/l

0.20

1365

6607

Osteoporosis

944

3591

2.65

154.30

2.1

1.8

1.94

2.41

ug/l

0.51

800

3098

Dialysis

261

437

7.03

154.21

3.0

1.8

3.90

2.07

ug/l

0.62

250

391

Hypertensive Heart Disease

861

2634

2.81

153.96

2.1

1.8

2.02

2.04

ug/l

0.01

762

2292

Diagnoses used for exclusion with ILD

977

3993

2.58

152.85

2.4

1.9

2.48

2.23

ug/l

0.21

870

3485

Hypokalaemia

493

1384

3.86

151.90

2.4

1.9

2.15

2.51

ug/l

0.24

435

1210

Constipation

2600

10656

1.79

151.22

2.2

1.9

2.57

2.19

ug/l

0.28

2265

9401

Anaemia in chronic diseases classified elsewhere

209

287

9.37

151.01

2.7

1.8

2.44

1.51

ug/l

0.70

202

248

Low back pain

2072

8576

1.90

149.60

2.1

2.0

1.70

2.25

ug/l

2.14

1816

7576

Biguanides

2728

9702

1.77

149.03

2.0

1.94

2.33

ug/l

0.94

2440

8498

Non-follicular lymphoma, hilmo, excluding all cancers

439

1160

4.17

148.65

2.7

1.7

2.70

1.58

ug/l

0.82

409

992

Other disorders of skin and subcutaneous tissue, not elsewhere classified

605

1961

3.32

148.28

2.3

1.9

2.32

2.29

ug/l

0.02

511

1714

Presence of other functional implants

1845

6760

1.99

148.20

2.0

1.9

2.27

2.23

ug/l

0.05

1595

5937

Gout, strict definition

794

3024

2.84

145.89

2.3

1.9

2.34

2.28

ug/l

0.04

710

2643

Disorders of lens

2107

7162

1.91

145.68

2.1

2.0

3.14

2.06

ug/l

0.80

1874

6427

Examination and observation for other reasons

1664

4992

2.07

145.68

2.1

1.8

2.67

2.43

ug/l

0.27

1494

4458

Intestinal stricture

1116

4945

2.37

145.39

2.4

1.9

2.82

2.20

ug/l

0.86

997

4316

Other or unspecified ileus, impaction or obstruction

734

2679

2.91

144.61

2.4

1.9

2.91

2.35

ug/l

0.46

662

2342

Paroxysmal tachycardia

562

1441

3.41

144.10

2.1

1.7

2.93

1.82

ug/l

0.74

495

1289

Gastrointestinal diseases

1466

3384

2.21

144.01

2.0

1.8

2.03

2.20

ug/l

0.20

1303

2932

Other arthritis (FG)

939

3857

2.53

143.86

2.0

1.51

2.20

ug/l

1.51

836

3432

Diseases of the skin and subcutaneous tissue

2884

8446

1.74

143.38

2.1

1.9

2.18

2.25

ug/l

0.08

2561

7374

Atherosclerosis, excluding cerebral and coronary sclerosis

1547

6156

2.09

143.37

2.1

1.9

2.37

2.29

ug/l

0.10

1378

5303

Injuries to the head

3006

11788

1.69

142.04

2.1

2.0

2.16

2.29

ug/l

0.19

2587

10440

Unspecified kidney failure

483

1416

3.75

140.51

2.6

1.7

4.04

2.19

ug/l

0.92

441

1202

Diabetic nephropathy, excluding more controls

619

1716

3.26

139.78

2.4

2.0

3.48

2.12

ug/l

1.12

571

1507

Ulcer of lower limb, not elsewhere classified

626

2155

3.15

139.01

2.2

1.9

2.26

2.45

ug/l

0.14

561

1879

Other diseases of pericardium

261

482

6.24

138.72

2.6

1.8

0.80

2.52

ug/l

1.44

237

433

Mycoses

894

3665

2.56

138.56

2.6

1.9

2.09

2.20

ug/l

0.11

802

3219

Seropositive rheumatoid arthritis

845

3360

2.62

138.52

2.0

1.9

1.67

2.21

ug/l

0.65

758

2959

Other chronic obstructive pulmonary disease, including avohilmo

1823

8099

1.94

138.17

2.1

1.9

1.76

2.30

ug/l

1.76

1613

7115

Hyperkalaemia

314

685

5.23

137.91

2.6

1.8

2.32

2.61

ug/l

0.14

285

584

Chronic ulcer of skin, not elsewhere classified

376

945

4.49

137.55

2.5

1.9

2.72

2.16

ug/l

0.26

325

825

Acute upper respiratory infections of multiple and unspecified sites

1981

8061

1.88

137.49

2.1

2.0

1.60

2.36

ug/l

3.20

1748

7116

Fall on same level

3106

10535

1.67

137.38

2.1

2.0

2.24

2.29

ug/l

0.06

2725

9373

Benign neoplasm: Colon

1385

5126

2.14

136.48

2.1

1.9

1.87

2.14

ug/l

0.56

1212

4480

Myocardial infarction, without ST-elevation

1479

6875

2.07

136.35

2.0

1.9

2.22

2.21

ug/l

0.01

1304

5941

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

394

1028

4.25

136.21

2.4

1.7

2.18

1.71

ug/l

0.43

352

879

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

417

1138

4.08

135.51

2.5

1.9

1.19

2.06

ug/l

1.11

359

971

ILD, hospital admissions 1, main diag only

612

2116

3.15

135.27

2.4

1.9

2.01

2.37

ug/l

0.21

559

1827

Convulsions, not elsewhere classified

630

2149

3.00

135.07

2.2

1.8

2.59

2.37

ug/l

0.18

547

1884

GI-bleeding

1165

5413

2.25

134.90

2.2

1.9

2.48

2.14

ug/l

0.30

1027

4697

COPD, hospital admissions

1612

7067

2.01

134.79

2.2

1.9

1.69

2.23

ug/l

1.69

1426

6179

Neurological diseases, wide definition

726

1217

3.06

134.08

2.2

1.8

1.67

2.25

ug/l

0.47

647

1087

Other diseases of the digestive system

1156

5373

2.25

133.79

2.2

1.9

2.44

2.15

ug/l

0.25

1016

4669

Symptoms and signs involving cognition, perception, emotional state and behaviour

2690

11256

1.71

133.43

2.1

2.0

2.09

2.31

ug/l

0.36

2316

9995

COPD, early/later onset

1614

7099

1.99

132.60

2.1

1.9

1.69

2.23

ug/l

1.69

1428

6202

AV-block

657

2139

2.95

130.77

2.1

1.8

1.59

2.37

ug/l

1.24

553

1845

Major coronary heart disease event excluding revascularizations

2126

8269

1.83

130.61

2.1

2.0

1.86

2.25

ug/l

0.87

1900

7237

Major coronary heart disease event

2266

8659

1.80

130.59

2.1

2.0

1.96

2.23

ug/l

0.46

2022

7599

Hypothyroidism, drug reimbursement

285

372

5.63

130.22

2.6

1.5

2.05

1.57

ug/l

0.34

260

324

Other systemic involvement of connective tissue

909

3862

2.46

130.04

2.1

1.9

1.21

2.42

ug/l

4.01

784

3369

Angina pectoris

1910

7030

1.89

130.02

2.1

1.9

1.91

2.34

ug/l

0.86

1711

6146

Spondylopathies

2354

8241

1.77

128.99

2.0

1.9

2.04

2.28

ug/l

0.34

2054

7265

Secondary uncertain malignant neoplasm

570

1946

3.17

128.41

2.2

1.9

2.33

2.53

ug/l

0.10

522

1697

Other arrhythmias

1556

6132

1.98

127.57

2.0

1.9

1.53

2.15

ug/l

2.12

1370

5418

Psychiatric diseases

3014

9212

1.67

127.45

2.1

2.0

2.13

2.30

ug/l

0.24

2630

8199

Factors influencing health status and contact with health services

925

1840

2.58

126.32

2.0

1.8

1.84

2.73

ug/l

1.01

817

1655

Genitourinary diseases

1642

4179

2.01

126.27

2.3

1.9

2.45

1.68

ug/l

1.13

1474

3723

Mental and behavioural disorders due to psychoactive substance use

1742

8940

1.89

126.20

2.2

2.0

2.37

2.09

ug/l

0.52

1546

7960

Obesity related asthma

1012

4554

2.31

126.16

2.3

2.0

2.02

2.25

ug/l

0.21

905

4046

Lung diseases due to external agents

615

2207

2.99

126.15

2.4

1.8

2.62

2.44

ug/l

0.11

542

1893

Other pleural conditions

487

1538

3.46

125.74

2.2

1.8

4.80

2.50

ug/l

0.36

443

1327

Diverticular disease of intestine

2123

7997

1.81

125.73

2.1

1.9

1.81

2.29

ug/l

1.07

1868

7035

Cellulitis

736

2885

2.68

125.44

2.5

1.9

2.12

2.24

ug/l

0.11

664

2544

Sequelae with surgical and medical care as external cause

749

2972

2.67

125.37

2.6

1.9

1.94

2.32

ug/l

0.45

688

2600

Valvular operations

552

1870

3.14

124.88

2.2

1.8

1.60

2.21

ug/l

0.86

467

1641

Benzodiazepine use

2742

11940

1.66

124.03

2.1

2.0

2.04

2.30

ug/l

0.56

2365

10558

Purpura and other haemorrhagic conditions

528

1754

3.22

124.00

2.5

1.9

2.39

2.36

ug/l

0.02

483

1537

Retention of urine

1239

5095

2.14

123.62

2.1

1.9

2.57

2.02

ug/l

0.63

1060

4489

Dorsalgia

2698

8775

1.69

123.58

2.0

1.9

1.80

2.28

ug/l

1.48

2367

7736

Dermatitis

1709

9350

1.87

122.65

2.2

2.0

1.73

2.39

ug/l

1.83

1540

8202

Substance abuse

1694

8819

1.88

122.41

2.2

2.0

2.28

2.10

ug/l

0.31

1502

7854

Concussion

1248

5264

2.10

121.97

2.1

1.9

1.69

2.20

ug/l

0.87

1080

4737

COPD related to multimorbidity

1421

6155

2.03

121.49

2.1

1.9

1.73

2.20

ug/l

1.22

1252

5363

Pacemaker

1231

5931

2.11

120.28

2.1

1.9

1.98

2.26

ug/l

0.46

1040

5124

Pneumocystosis

158

207

10.49

120.23

3.1

1.9

0.99

3.03

ug/l

0.79

148

185

Nerve, nerve root and plexus disorders

2934

11497

1.63

120.07

2.1

2.0

2.34

2.22

ug/l

0.16

2591

10098

Hyperlipidaemia, other/unspecified

1261

5957

2.08

119.25

2.0

1.9

2.19

2.31

ug/l

0.13

1125

5215

Cutaneous abscess, furuncle and carbuncle

773

3179

2.53

118.48

2.4

1.9

3.20

2.22

ug/l

0.65

714

2812

Chronic periodontitis

586

2122

2.94

117.70

2.4

1.9

2.82

2.06

ug/l

0.39

519

1895

Malignant neoplasm of digestive organs

1343

6804

2.02

117.69

2.0

1.9

2.19

2.33

ug/l

0.16

1214

5878

Any mental disorder

3058

9573

1.62

117.63

2.1

2.0

2.11

2.29

ug/l

0.28

2654

8505

Unspecified acute lower respiratory infection

547

1908

3.03

117.21

2.6

1.9

1.45

2.42

ug/l

1.27

505

1694

Benign neoplasms

1750

5331

1.89

116.80

2.1

1.9

1.88

2.04

ug/l

0.22

1541

4696

Senile cataract

1924

6695

1.83

116.77

2.2

2.0

3.13

2.09

ug/l

0.66

1694

6000

Other specified/unspecified arthritis

815

3456

2.45

116.58

2.0

1.9

1.38

2.08

ug/l

1.49

721

3067

Rheumatoid arthritis, including avohilmo

1172

5765

2.10

116.21

2.1

1.9

1.55

2.31

ug/l

1.60

1045

5051

Lower back pain or/and sciatica

2761

11921

1.63

116.10

2.1

2.0

1.72

2.36

ug/l

2.52

2428

10498

Abnormal findings on examination of blood, without diagnosis

1534

7732

1.92

115.64

2.2

2.0

2.29

2.09

ug/l

0.21

1381

6805

Cerebrovascular diseases

2261

9649

1.72

114.72

2.1

2.0

2.15

ug/l

0.00

1917

8561

Peripheral artery operations in Hilmo

560

2012

2.98

114.48

2.3

1.8

2.32

2.75

ug/l

0.34

512

1715

Asthma/COPD (KELA code 203)

2489

10692

1.67

113.96

2.0

2.22

2.34

ug/l

0.16

2212

9391

Coagulation defects, purpura and other haemorrhagic conditions

651

2528

2.71

113.33

2.6

1.9

2.44

2.47

ug/l

0.02

588

2220

Iron deficiency anaemia secondary to blood loss (chronic)

614

2322

2.81

113.29

2.2

1.9

2.92

2.10

ug/l

0.68

540

2000

Misadventures to patients during surgical and medical care

510

1748

3.10

113.07

2.5

1.9

1.62

2.26

ug/l

0.79

449

1547

Peripheral arterial reconstruction

721

2966

2.60

112.63

2.2

1.9

2.39

2.45

ug/l

0.04

638

2558

Amputation

469

1547

3.30

112.51

2.4

1.9

2.33

2.41

ug/l

0.05

428

1323

Myocardial infarction, strict

1544

6074

1.92

110.88

2.1

2.0

1.97

2.27

ug/l

0.39

1375

5290

Diseases of liver

1047

5035

2.16

110.55

2.4

2.0

2.19

2.22

ug/l

0.03

951

4464

Other antidepressants

2903

9522

1.62

110.37

2.1

2.0

1.96

2.36

ug/l

0.87

2514

8439

Colorectal cancer, excluding all cancers (controls excluding all cancers)

883

3841

2.32

110.04

2.0

1.9

1.82

2.08

ug/l

0.41

792

3316

Persons encountering health services for examination and investigation

1832

5077

1.84

109.57

2.0

1.8

1.98

2.46

ug/l

0.80

1595

4521

Disorders of mineral metabolism

331

887

4.05

109.37

2.7

1.9

2.66

2.06

ug/l

0.26

299

789

Endocarditis

204

374

6.26

109.28

2.7

1.7

1.47

3.12

ug/l

0.87

185

329

Type 1 diabetes, wide definition, subgroup 1

604

2289

2.74

109.18

2.4

1.9

3.06

2.16

ug/l

0.99

560

1990

Other infectious diseases

374

1095

3.74

109.01

2.6

1.9

2.43

2.37

ug/l

0.02

343

952

Other necrotizing vasculopathies (FG)

290

712

4.51

108.91

2.2

1.9

1.20

1.41

ug/l

0.24

252

630

Noninfective enteritis and colitis

1273

6586

1.98

108.26

2.1

2.0

3.61

2.16

ug/l

0.64

1140

5809

Undetermined asthma, excluding more controls

329

879

3.90

107.26

2.2

1.7

1.38

3.29

ug/l

1.58

298

759

Neurological diseases

2212

6561

1.72

106.63

2.1

1.9

2.31

2.35

ug/l

0.03

1955

5843

Non-follicular lymphoma

439

1441

3.33

106.50

2.7

1.9

2.70

2.45

ug/l

0.11

409

1266

Candidiasis

459

1538

3.16

105.74

2.8

1.9

1.61

2.07

ug/l

0.52

408

1363

Acute peritonitis

326

894

4.05

105.30

2.7

1.9

3.29

1.68

ug/l

1.41

312

776

Sulfasalazine

777

3375

2.37

104.86

2.1

1.9

1.67

2.20

ug/l

0.53

678

2988

Cough

1079

5113

2.08

104.29

2.2

1.9

2.17

2.40

ug/l

0.19

947

4512

Other CVD

740

3190

2.45

103.63

2.1

1.9

1.81

2.51

ug/l

0.93

621

2743

All influenza (not pneumonia)

422

1356

3.25

103.53

2.2

1.8

1.52

2.54

ug/l

1.12

377

1177

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

830

3097

2.35

103.49

2.0

1.9

1.71

1.79

ug/l

0.07

748

2683

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

643

2584

2.56

102.65

2.3

1.9

2.31

2.06

ug/l

0.21

557

2309

Substance use, excluding alcohol

576

2207

2.72

102.38

2.2

2.0

1.86

2.24

ug/l

0.38

513

1970

Vocal cord dysfunction

343

892

3.70

102.27

2.4

1.8

1.49

2.03

ug/l

0.54

299

797

Disorders resulting from impaired renal tubular function

217

451

5.62

101.77

2.8

2.1

2.82

1.97

ug/l

0.44

206

405

1735

8982

1.77

101.70

2.2

2.0

2.43

2.09

ug/l

0.68

1543

7978

Sleep disorders (combined)

2617

10865

1.61

101.37

2.1

2.0

1.84

2.29

ug/l

1.05

2288

9648

Cytomegalovirus infection, IBD co-morbidity

157

243

7.85

100.89

3.5

2.1

1.26

2.65

ug/l

0.58

146

223

Calcific aortic valvular stenosis, operated

1094

5425

2.06

100.83

2.1

1.9

2.07

2.27

ug/l

0.26

952

4659

Calcific aortic valvular stenosis

1094

5425

2.06

100.83

2.1

1.9

2.07

2.27

ug/l

0.26

952

4659

1666

8779

1.78

100.62

2.2

2.0

2.43

2.11

ug/l

0.61

1479

7806

Other and unspecified dermatitis

1378

7506

1.88

100.51

2.2

1.9

1.69

2.16

ug/l

1.35

1242

6590

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2636

10918

1.60

100.30

2.2

1.9

2.48

2.21

ug/l

0.40

2327

9626

Other necrotizing vasculopathies

332

952

3.84

100.14

2.2

1.9

1.29

2.02

ug/l

0.65

290

831

Calcific aortic valvular stenosis, diagnosis (helper)

1091

5421

2.06

99.98

2.1

1.9

2.07

2.27

ug/l

0.27

949

4656

Operations 2 for CAVS

1091

5421

2.06

99.98

2.1

1.9

2.07

2.27

ug/l

0.27

949

4656

Cholelithiasis, broad definition with cholecystitis

2361

10060

1.64

99.86

2.1

1.9

2.38

2.16

ug/l

0.31

2098

8788

Type 1 diabetes

704

2992

2.43

99.61

2.3

1.9

2.77

2.05

ug/l

0.96

656

2607

Other retinal disorders

1897

9052

1.73

99.39

2.1

2.0

2.91

2.03

ug/l

1.47

1644

7949

Cytomegaloviral disease

157

247

7.63

99.13

3.5

2.0

1.26

2.61

ug/l

0.56

146

224

Suppurative and necrotic conditions of lower respiratory tract

295

792

4.19

98.75

2.8

1.9

2.01

2.36

ug/l

0.17

270

693

Calcific aortic valvular stenosis, including rheumatic fever

1091

5444

2.05

98.51

2.1

1.9

2.07

2.28

ug/l

0.28

949

4679

Gastroduodenal ulcer

932

4481

2.16

98.27

2.2

1.9

2.61

2.09

ug/l

0.53

837

3905

Alcohol use disorder, Swedish definition

1602

8505

1.79

98.21

2.2

2.0

2.32

2.16

ug/l

0.26

1423

7566

Disorders of other endocrine glands

1166

5970

1.97

97.66

2.3

1.9

2.43

2.23

ug/l

0.18

1034

5196

Episodal and paroxysmal disorders

2877

9510

1.57

97.49

2.2

1.9

1.82

2.38

ug/l

1.34

2529

8378

Pneumonitis due to solids and liquids

379

1202

3.44

97.24

2.6

1.9

2.67

2.56

ug/l

0.05

328

1035

Other complications of surgical and medical care, not elsewhere classified

351

1055

3.55

97.13

2.6

1.9

3.28

2.06

ug/l

0.47

317

939

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

330

957

3.70

96.71

2.4

1.9

2.68

2.14

ug/l

0.25

291

850

Acute upper respiratory infections

2733

11063

1.57

96.14

2.1

2.0

1.80

2.42

ug/l

1.99

2392

9719

Other reaction to severe stress, and adjustment disorders

831

3845

2.21

95.81

2.3

2.0

1.63

1.99

ug/l

0.58

758

3423

Other/unspecified cytomegaloviral diseases

139

201

8.53

95.35

3.5

2.2

1.35

3.03

ug/l

0.58

131

184

Non-allergic asthma (mode), excluding more controls

437

1486

3.00

94.82

2.2

1.7

2.50

2.65

ug/l

0.06

392

1291

Undetermined asthma

329

963

3.55

93.67

2.2

1.7

1.38

3.15

ug/l

1.59

298

835

External causes of morbidity and mortality

1705

4848

1.79

93.53

2.0

1.9

2.69

2.41

ug/l

0.21

1510

4313

Type 1 diabetes, wide definition

617

2545

2.50

93.47

2.4

1.9

3.00

2.19

ug/l

0.91

573

2211

Fitting and adjustment of other devices

1067

5085

2.02

93.37

1.9

1.8

1.70

2.32

ug/l

1.28

873

4392

Disorders of choroid and retina

2295

10532

1.62

93.21

2.1

2.0

2.55

2.20

ug/l

0.49

1989

9288

Other dorsopathies, not elsewhere classified

2609

8793

1.59

92.86

2.1

1.9

1.68

2.27

ug/l

1.97

2270

7753

Viral infections characterized by skin and mucous membrane lesions

1121

5862

1.96

92.74

2.2

2.0

3.76

2.18

ug/l

0.63

1015

5170

Certain disorders involving the immune mechanism

616

2565

2.51

92.54

2.6

1.9

2.05

2.24

ug/l

0.13

566

2279

Symptoms and signs concerning food and fluid intake

325

958

3.58

92.10

2.2

1.7

2.92

2.30

ug/l

0.30

281

827

Other dialysis

183

359

5.96

91.67

2.5

2.1

2.02

1.44

ug/l

0.42

176

325

Disorders of calcium metabolism

259

663

4.26

91.56

2.8

2.0

2.86

2.29

ug/l

0.18

232

589

Falls/tendency to fall

2809

9145

1.56

91.44

2.1

2.0

2.38

2.32

ug/l

0.07

2446

8142

Covid-19 suspected case

516

1979

2.69

91.19

2.1

1.9

1.28

2.20

ug/l

1.69

470

1758

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

825

3906

2.20

91.07

2.1

1.9

1.70

2.30

ug/l

0.75

740

3434

Cholangitis (primary sclerosing, PSC)

276

745

4.06

90.77

2.2

1.9

2.58

2.18

ug/l

0.21

254

644

Other/unspecified seropositive rheumatoid arthritis

836

3989

2.18

90.41

2.0

1.9

1.69

2.29

ug/l

0.76

751

3509

Seropositive rheumatoid arthritis, wide

843

4039

2.17

90.17

2.0

1.9

1.68

2.30

ug/l

0.80

756

3548

Multiple myeloma and malignant plasma cell neoplasms

237

582

4.59

89.64

2.5

1.7

2.30

1.72

ug/l

0.37

216

504

Acute sinusitis

1206

6064

1.89

89.20

2.2

2.0

1.99

2.33

ug/l

0.48

1065

5395

Cardiac arrest

235

471

4.58

89.19

2.5

1.7

3.82

2.30

ug/l

0.42

205

412

Ascites

303

882

3.73

88.90

2.5

1.9

1.16

2.49

ug/l

1.44

287

764

Poisoning by drugs, medicaments and biological substances

605

2536

2.46

88.62

2.2

2.0

2.84

2.17

ug/l

0.42

531

2258

Hypotension

628

2701

2.46

88.60

2.0

1.8

1.86

2.41

ug/l

0.60

531

2300

Multiple myeloma, excluding all cancers (controls excluding all cancers)

237

587

4.54

88.60

2.5

1.7

2.30

1.71

ug/l

0.38

216

510

Stroke, including SAH

1912

8659

1.67

88.31

2.1

1.9

2.33

2.18

ug/l

0.16

1621

7633

Mental and behavioural disorders due to alcohol

1436

8015

1.78

87.85

2.2

2.0

2.47

2.13

ug/l

0.57

1274

7139

Diseases of peritoneum

407

1422

3.07

87.77

2.6

1.9

3.10

2.38

ug/l

0.47

380

1245

Diabetic retinopathy, excluding more controls

841

2186

2.27

87.70

2.2

2.0

2.84

2.08

ug/l

0.88

763

1928

Protozoal diseases

171

330

6.10

87.39

3.1

2.0

0.99

2.27

ug/l

0.74

157

295

Early onset COPD

745

3452

2.25

87.22

2.3

2.0

1.89

2.29

ug/l

0.49

682

3070

Osteomyelitis

294

857

3.77

86.49

2.4

1.9

2.02

2.54

ug/l

0.29

261

757

Unspecified haematuria

1306

6254

1.84

86.10

2.1

2.0

2.65

2.07

ug/l

0.76

1112

5537

Persons encountering health services in other circumstances, wide

3149

11056

1.50

85.93

2.1

2.0

1.75

2.41

ug/l

2.52

2808

9691

Pyothorax

237

604

4.46

85.66

2.9

1.9

1.86

1.91

ug/l

0.02

218

526

Extreme obesity with alveolar hypoventilation

209

483

4.88

85.51

2.5

2.0

1.57

1.64

ug/l

0.04

187

429

Secondary and unspecified malignant neoplasm of lymph nodes

359

1191

3.27

85.35

2.3

1.9

1.86

2.32

ug/l

0.24

328

1046

Supplementary factors related to causes of morbidity and mortality classified elsewhere

843

4131

2.10

84.43

2.3

2.0

2.68

2.21

ug/l

0.36

724

3645

Asthma, hospital admissions , main diagnosis only

2070

11760

1.60

84.04

2.1

2.0

2.06

2.28

ug/l

0.32

1830

10317

Gonarthrosis [arthrosis of knee](FG)

1999

7294

1.64

83.01

2.0

2.53

2.39

ug/l

0.13

1747

6454

Adrenocortical insufficiency

180

377

5.38

82.89

2.9

2.0

1.79

1.98

ug/l

0.08

165

342

Use of hypnotics and sedatives

2784

10755

1.52

82.84

2.2

2.0

2.27

2.13

ug/l

0.22

2466

9499

Decubitus ulcer and pressure area

281

820

3.79

82.81

2.8

1.8

2.43

2.29

ug/l

0.06

247

709

Asthma, including avohilmo

2986

11770

1.49

82.37

2.1

2.0

2.04

2.33

ug/l

0.58

2660

10320

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1276

7219

1.81

82.09

2.2

2.0

2.35

2.16

ug/l

0.26

1128

6442

Intracranial injury

1529

8787

1.72

81.70

2.2

2.0

1.85

2.19

ug/l

0.58

1288

7760

Other and unspecified drugs and medicaments

316

994

3.41

81.69

2.4

2.0

2.64

2.14

ug/l

0.22

279

882

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

707

2710

2.27

81.58

2.0

1.8

1.84

1.79

ug/l

0.04

637

2335

Sleep apnoea

2395

10621

1.55

81.54

2.1

2.0

1.81

2.28

ug/l

1.08

2096

9447

Cholelithiasis

2198

9902

1.58

81.44

2.0

1.9

2.38

2.17

ug/l

0.26

1943

8639

Thrombocytopenia, unspecified

306

950

3.51

81.38

2.5

1.9

2.46

2.13

ug/l

0.15

282

838

Polymyalgia rheumatica

505

2051

2.62

81.11

2.0

1.8

1.08

2.39

ug/l

2.84

429

1755

Stroke, excluding SAH

1809

8293

1.66

81.05

2.1

1.9

2.34

2.20

ug/l

0.15

1541

7283

Soft tissue disorders

2628

9007

1.54

80.79

2.0

1.73

2.48

ug/l

1.92

2312

7919

Other viral diseases

695

3203

2.22

80.68

2.5

2.0

1.46

2.20

ug/l

1.57

627

2844

Schizophrenia or delusion, excluding more controls

740

3479

2.16

80.44

2.2

2.0

2.00

1.99

ug/l

0.01

661

3104

Obesity, other/unspecified

798

3898

2.10

80.25

2.3

2.0

1.86

2.14

ug/l

0.35

714

3455

Pain (limb, back, neck, head abdominally)

1948

6001

1.65

80.18

2.0

1.9

1.91

2.32

ug/l

0.71

1708

5256

Polyneuropathies and other disorders of the peripheral nervous system

726

3447

2.20

80.12

2.5

1.9

2.02

2.35

ug/l

0.38

657

3011

Poisoning by medicine

539

2252

2.47

79.61

2.2

2.0

2.97

2.06

ug/l

0.57

481

2006

Osteoporosis with pathological fracture (FG)

260

736

3.83

79.52

2.2

1.8

1.65

1.66

ug/l

0.01

230

625

Alcohol use disorder, ICD-based

1183

6626

1.83

79.13

2.2

2.0

2.31

2.19

ug/l

0.16

1047

5910

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

534

2105

2.51

78.86

2.0

1.8

1.86

1.79

ug/l

0.05

486

1806

Non-allergic asthma (mode)

437

1643

2.71

78.57

2.2

1.7

2.50

2.72

ug/l

0.09

392

1439

Other noninfective gastroenteritis and colitis

696

3261

2.20

78.45

2.2

1.9

2.41

2.23

ug/l

0.11

621

2855

Mood disorders, excluding more controls

2303

9113

1.56

78.34

2.1

2.0

2.04

2.31

ug/l

0.48

2036

8106

Cardiomyopathy

526

2198

2.49

78.25

2.2

1.8

4.50

2.24

ug/l

0.40

478

1941

Other diseases of biliary tract

334

1120

3.20

77.62

2.2

1.9

2.23

2.51

ug/l

0.16

308

965

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

211

529

4.46

77.54

2.6

1.7

3.90

1.72

ug/l

0.79

192

464

Diffuse large B-cell lymphoma, helper endpoint

211

529

4.46

77.54

2.6

1.7

3.90

1.72

ug/l

0.79

192

464

COPD-related respiratory insufficiency

473

1914

2.64

76.73

2.5

1.8

1.82

2.53

ug/l

0.65

405

1652

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

363

1283

3.03

76.71

2.5

1.9

2.75

2.10

ug/l

0.38

324

1132

Dizziness and giddiness

1952

10119

1.59

76.18

2.0

1.75

2.35

ug/l

1.42

1699

8955

Cystitis

2089

8180

1.58

76.13

2.1

1.9

2.22

2.10

ug/l

0.18

1802

7185

Amputation of toe

327

1105

3.24

75.81

2.4

1.9

2.48

2.51

ug/l

0.01

299

958

Other neurological diseases

2007

10397

1.58

75.58

2.1

2.0

2.04

2.21

ug/l

0.24

1752

9099

Coronary revascularization (ANGIO or CABG)

1410

5782

1.75

75.27

2.1

1.9

2.19

2.29

ug/l

0.09

1239

5021

Dermatitis and eczema

2710

12107

1.49

74.92

2.2

2.0

1.87

2.34

ug/l

1.36

2427

10620

Other disorders of adrenal gland

193

462

4.59

74.87

2.8

2.0

1.72

1.77

ug/l

0.03

178

414

Anxiety disorders, excluding more controls

1901

7959

1.61

74.69

2.2

1.9

2.03

2.38

ug/l

0.59

1680

7097

ILD-related respiratory insufficiency

195

481

4.72

74.30

3.2

1.8

2.56

2.17

ug/l

0.11

173

420

Epilepsy

848

4352

2.00

73.82

2.6

1.9

2.53

2.27

ug/l

0.23

726

3815

Other cataract

1225

5413

1.80

73.73

2.0

3.10

2.01

ug/l

0.43

1081

4834

Other and unspecified polyneuropathies, also in other diseases

650

3058

2.23

73.66

2.5

1.9

2.03

2.43

ug/l

0.42

586

2669

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

605

2769

2.28

73.05

1.9

1.8

2.01

1.99

ug/l

0.02

544

2383

Secondary thrombocytopenia

133

9.45

72.84

3.2

1.9

5.04

3.99

ug/l

0.13

121

Other external causes of accidental injury

2128

6856

1.57

72.78

2.0

2.25

2.34

ug/l

0.09

1843

6110

Acute pancreatitis

620

2876

2.24

72.35

2.4

1.9

2.77

2.25

ug/l

0.50

551

2516

Deposits [accretions] on teeth

251

708

3.65

72.12

2.5

2.0

2.92

2.02

ug/l

0.51

225

634

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

664

3170

2.17

71.62

2.1

2.0

2.31

2.16

ug/l

0.14

600

2842

Delirium, not induced by alcohol and other psychoactive substances

427

1702

2.66

71.11

2.6

1.9

1.71

2.08

ug/l

0.34

364

1478

Coxarthrosis [arthrosis of hip](FG)

1472

6434

1.69

70.82

2.0

1.9

2.66

2.46

ug/l

0.14

1278

5680

Diseases of the myoneural junction and muscle

425

1694

2.65

70.78

2.3

1.9

2.42

2.30

ug/l

0.08

345

1486

Type of accident

760

3834

2.04

70.34

2.3

1.9

2.52

2.19

ug/l

0.23

647

3383

Pneumonia due to Streptococcus pneumoniae

169

382

4.80

70.25

2.3

1.7

3.94

2.40

ug/l

0.69

152

324

Injuries to the thorax

1256

7407

1.74

70.15

2.2

2.0

1.96

2.16

ug/l

0.28

1086

6532

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

404

1566

2.67

70.10

2.3

2.0

2.62

1.97

ug/l

0.54

351

1408

Ischaemic Stroke, excluding all haemorrhages

1686

8020

1.63

70.05

2.0

1.9

2.37

2.23

ug/l

0.15

1433

7018

Personality disorders, excluding more controls

538

2371

2.32

70.03

2.2

2.0

2.75

1.96

ug/l

0.77

492

2129

Other (seronegative) rheumatoid arthritis, wide

593

2740

2.25

69.94

2.2

1.9

1.71

2.24

ug/l

0.42

519

2398

Injuries to the abdomen, lower back, lumbar spine and pelvis

1059

5915

1.82

69.84

2.2

1.9

2.43

2.27

ug/l

0.15

903

5156

Multiple myeloma and malignant plasma cell neoplasms

237

695

3.82

69.81

2.5

1.8

2.30

2.40

ug/l

0.03

216

602

Accidents

2111

6856

1.56

69.73

2.0

2.21

2.34

ug/l

0.13

1830

6110

Spinal stenosis

1479

7078

1.68

69.63

2.1

1.9

2.20

2.31

ug/l

0.11

1264

6236

Spondyloarthritis

525

2307

2.36

69.47

2.2

1.9

1.68

2.42

ug/l

0.47

467

2023

Gastric ulcer

618

2913

2.21

69.46

2.3

1.9

2.32

2.07

ug/l

0.24

556

2543

Other/unspecified rheumatoid arthritis

438

1786

2.59

69.44

2.2

1.9

1.98

2.13

ug/l

0.08

387

1553

Familial hypercholesterolemia

540

2413

2.35

69.43

2.1

1.9

2.50

ug/l

0.00

478

2081

Diabetic nephropathy

624

2934

2.23

69.28

2.4

2.0

3.46

2.13

ug/l

1.15

575

2609

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

643

3060

2.15

69.27

2.3

2.0

2.31

2.09

ug/l

0.19

557

2728

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

457

1865

2.50

68.60

2.0

1.8

3.40

2.39

ug/l

0.66

410

1572

COPD, hospital admissions 1, only main diagnosis

1135

5557

1.80

68.43

2.1

1.9

1.66

2.22

ug/l

1.43

1007

4827

Sleep apnoea, including avohilmo

2442

10775

1.49

68.39

2.1

2.0

1.86

2.27

ug/l

0.88

2126

9587

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

577

2669

2.25

67.87

2.0

1.8

1.49

2.09

ug/l

1.50

516

2290

Benign neoplasm of colon, rectum, anus and anal canal

1738

10092

1.59

67.39

2.1

2.0

2.04

2.21

ug/l

0.29

1538

8850

Chronic pancreatitis

425

1743

2.57

66.61

2.4

1.9

3.00

2.52

ug/l

0.27

398

1543

Viral hepatitis, IBD co-morbidity

140

280

5.22

66.48

2.4

1.9

1.34

3.34

ug/l

0.65

127

256

Continuous positive airway pressure

420

1444

2.58

66.45

2.0

1.8

1.10

2.20

ug/l

1.46

348

1285

Viral pneumonia (known virus, not influenza)

135

269

5.81

66.41

2.6

1.8

2.84

2.57

ug/l

0.05

116

237

Injury, poisoning and certain other consequences of external causes

1315

3841

1.74

66.04

2.0

1.9

2.66

2.48

ug/l

0.11

1171

3398

Disorders of thyroid, IBD co-morbidities

367

978

2.79

65.76

2.2

1.8

0.88

2.36

ug/l

2.28

326

880

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

302

1051

3.07

65.66

2.3

1.7

1.90

1.71

ug/l

0.13

277

891

Unspecified mental disorder

968

5393

1.83

65.57

2.1

2.0

2.29

2.10

ug/l

0.23

863

4786

Methotrexate

396

1574

2.61

65.51

2.1

1.9

1.72

2.31

ug/l

0.34

351

1391

Hernia

2367

10968

1.48

65.24

2.1

2.0

2.15

2.30

ug/l

0.21

2091

9666

Sequelae of cerebrovascular disease

1099

5583

1.78

64.92

2.0

1.9

2.51

2.27

ug/l

0.16

867

4869

Conductive and sensorineural hearing loss

2142

9978

1.51

64.35

2.0

2.20

2.28

ug/l

0.09

1834

8848

Allergic asthma (mode), excluding more controls

384

1478

2.59

64.17

2.1

1.7

2.33

2.79

ug/l

0.24

349

1297

Abnormalities of heart beat

836

4448

1.90

63.83

1.9

1.92

2.42

ug/l

0.46

723

3895

Diseases of the musculoskeletal system and connective tissue

1248

3631

1.75

63.75

2.0

2.09

2.38

ug/l

0.26

1106

3214

Gastro-oesophageal reflux disease

1693

9694

1.57

63.60

2.1

2.0

1.99

2.18

ug/l

0.29

1460

8545

Sensorineural hearing loss

2071

9717

1.52

63.48

1.9

2.0

2.30

2.31

ug/l

0.01

1770

8615

Injuries to the hip and thigh

1296

7219

1.68

63.39

2.2

1.9

2.71

2.19

ug/l

0.61

1092

6299

Discitis, unspecified

111

194

6.86

63.37

2.6

1.9

4.61

3.00

ug/l

0.19

105

174

Pyogenic arthritis

257

833

3.30

63.24

2.3

1.9

2.13

1.91

ug/l

0.14

233

744

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

176

449

4.37

63.21

2.6

1.7

6.64

1.86

ug/l

0.91

154

387

Lymphoid leukaemia

222

661

3.65

63.09

2.3

1.7

1.86

1.82

ug/l

0.03

199

570

L01XE Protein kinase inhibitors

249

800

3.41

63.00

2.2

1.9

7.02

2.28

ug/l

0.42

235

718

Arthropathies

2122

7174

1.52

62.98

2.0

2.30

2.33

ug/l

0.02

1851

6347

Suicide or other Intentional self-harm

584

2787

2.15

62.72

2.3

2.0

2.46

2.17

ug/l

0.24

510

2493

Immunodeficiency with predominantly antibody defects

127

251

5.68

62.53

3.3

2.1

1.21

2.62

ug/l

0.64

121

234

Dorsopathies

2505

8808

1.47

62.24

2.1

1.9

1.88

2.27

ug/l

0.74

2193

7767

Other disorders of kidney and ureter

436

1869

2.46

62.06

2.5

1.9

2.13

2.64

ug/l

0.41

403

1647

Gonarthrosis

1717

6311

1.59

62.03

2.0

1.9

2.36

2.34

ug/l

0.01

1493

5594

Pericarditis

158

376

4.61

61.82

2.4

1.8

0.68

2.06

ug/l

1.05

142

332

Idiopathic gout

364

1450

2.70

61.41

2.4

1.9

1.28

2.40

ug/l

1.35

323

1264

Other symptoms and signs involving the digestive system and abdomen

428

1816

2.44

61.41

2.1

1.9

2.04

2.19

ug/l

0.10

371

1585

Dysphagia

672

3411

2.03

61.34

2.2

1.9

1.60

2.47

ug/l

1.65

579

2973

Benign neoplasms

2428

9352

1.47

61.13

2.0

2.06

2.12

ug/l

0.09

2134

8273

Acute pancreatitis (for exclusion)

620

3069

2.10

61.12

2.4

1.9

2.77

2.34

ug/l

0.39

551

2702

Noninfectious colitis NAS

399

1648

2.52

61.12

2.2

2.0

2.98

2.26

ug/l

0.31

352

1442

Other embolism and thrombosis

420

1780

2.47

61.04

2.2

1.9

1.71

2.32

ug/l

0.60

380

1557

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

142

315

5.03

60.99

2.7

1.7

0.96

1.70

ug/l

0.81

136

280

Missing teeth due to accident, extraction or parodontitis

388

1590

2.57

60.85

2.4

1.9

2.51

2.20

ug/l

0.15

332

1419

Cardiomyopathy (excluding other)

388

1588

2.55

60.71

2.3

1.8

5.70

2.19

ug/l

0.48

354

1405

Other and unspecified myopathies

326

1234

2.82

60.71

2.3

1.9

2.34

2.19

ug/l

0.08

259

1078

Immunodeficiencies

189

519

3.95

60.60

3.3

2.0

1.52

1.79

ug/l

0.15

177

458

Cardiomyopathies, Primary/intrinsic

379

1537

2.58

60.51

2.3

1.8

5.59

2.27

ug/l

0.43

346

1360

Preparatory care for dialysis

201

584

3.82

59.94

2.1

2.0

3.15

2.60

ug/l

0.15

191

525

Open wound of head

1356

8356

1.63

59.78

1.9

2.0

2.32

2.22

ug/l

0.09

1156

7400

Problems related to lifestyle

300

1088

2.88

59.75

2.2

2.0

2.82

2.35

ug/l

0.25

274

974

Kela-code for severe mental illness

883

4932

1.83

59.49

2.1

2.0

2.34

2.13

ug/l

0.24

788

4365

Colorectal cancer

747

3985

1.95

59.39

1.9

1.87

2.27

ug/l

0.53

670

3461

Glomerulonephritis

340

1328

2.70

59.07

2.8

2.0

5.24

2.00

ug/l

1.36

312

1179

Direct fill therapy

386

1596

2.52

58.98

2.5

2.0

1.77

2.22

ug/l

0.44

342

1443

Tubulo-interstitial nephritis, not specified as acute or chronic

233

741

3.33

58.94

2.2

1.8

2.04

1.84

ug/l

0.09

208

624

Diffuse large B-cell lymphoma

211

640

3.66

58.94

2.6

1.9

3.90

2.43

ug/l

0.41

192

566

Chronic periodontitis, complicated

341

1339

2.71

58.91

2.3

2.0

2.89

2.36

ug/l

0.15

301

1203

Idiopathic pulmonary fibrosis

321

1234

2.81

58.43

2.2

1.9

1.39

2.55

ug/l

1.19

290

1064

Other postsurgical states

220

681

3.45

58.40

2.1

1.8

3.31

2.24

ug/l

0.48

201

606

Complications of internal orthopaedic prosthetic devices, implants and grafts

657

3384

2.01

57.84

2.1

1.8

2.18

2.40

ug/l

0.13

556

2937

Explicit fungal Sepsis

14.79

57.77

3.4

1.7

1.62

0.34

ug/l

1.77

Other disorders of ear

2315

10747

1.45

57.50

2.0

2.28

2.22

ug/l

0.07

1986

9534

Schizophrenia or delusion

740

3956

1.91

57.46

2.2

2.0

2.00

1.98

ug/l

0.02

661

3508

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2696

10947

1.42

57.40

2.1

2.0

1.64

2.39

ug/l

2.92

2390

9615

Other intervertebral disc disorders

2043

8480

1.49

57.39

2.1

1.9

2.00

2.26

ug/l

0.43

1771

7489

Mental and behavioural disorders due to opioids

125

261

5.12

56.99

2.9

2.0

1.89

2.61

ug/l

0.24

113

239

Neurotic, stress-related and somatoform disorders

1950

9378

1.50

56.81

2.2

2.0

2.09

2.26

ug/l

0.27

1727

8308

Myeloid leukaemia

124

262

5.31

56.61

2.9

1.8

6.36

1.54

ug/l

0.78

118

229

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

479

2220

2.26

56.60

2.4

2.0

2.32

2.50

ug/l

0.13

432

1964

Sub-endpoint used in defining T1D endpoints

786

4236

1.87

56.42

2.3

1.9

2.88

2.24

ug/l

0.85

731

3666

Phlebitis and thrombophlebitis (not including DVT)

624

3183

2.02

56.31

2.2

1.9

1.73

2.26

ug/l

0.65

549

2794

Schizophrenia, schizotypal and delusional disorders

742

4007

1.89

55.84

2.2

2.0

2.01

ug/l

0.00

659

3552

Haemorrhage, not elsewhere classified

149

367

4.43

55.69

2.2

1.6

3.59

1.66

ug/l

0.36

137

311

Anxiety disorders

1971

9510

1.49

55.62

2.2

2.0

2.07

2.28

ug/l

0.33

1742

8424

Unspecified misadventure during surgical and medical care

217

692

3.40

55.38

2.7

2.0

2.04

1.78

ug/l

0.14

187

615

Drug-induced osteoporosis with pathological fracture

101

184

6.61

55.36

2.7

1.7

2.02

3.57

ug/l

0.44

162

Coxarthrosis

1349

5745

1.62

55.21

2.0

1.9

2.82

2.41

ug/l

0.31

1173

5090

Allergic asthma (mode)

384

1587

2.41

55.19

2.1

1.8

2.33

2.80

ug/l

0.25

349

1396

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

196

591

3.62

54.86

2.1

1.7

2.48

1.61

ug/l

0.55

170

512

Cholecystitis

451

2064

2.28

54.71

2.3

1.9

2.18

2.50

ug/l

0.25

401

1767

Unknown and unspecified causes of morbidity

209

654

3.34

54.03

2.1

1.8

2.77

2.61

ug/l

0.06

195

568

Depression

2161

10369

1.45

53.74

2.2

2.0

2.14

2.28

ug/l

0.23

1909

9162

Mood disorders

2390

11133

1.43

53.55

2.2

2.0

2.07

2.30

ug/l

0.44

2115

9820

Other/unspecified dorsalgia

913

5289

1.75

53.27

2.1

1.9

2.35

2.42

ug/l

0.05

791

4644

Disorders of oesophagus in diseases classified elsewhere

116

246

5.44

53.20

2.6

1.8

1.28

2.19

ug/l

0.33

105

214

Abnormal findings on diagnostic imaging of other body structures

369

1571

2.45

53.08

2.1

1.9

1.73

2.28

ug/l

0.47

323

1382

Drug-induced adrenocortical insufficiency

180

6.31

52.76

2.9

1.8

1.04

3.51

ug/l

0.87

163

Familial hypercholesterolemia, with ischemic heart disease

354

1493

2.52

52.62

2.1

1.8

2.40

2.84

ug/l

0.25

314

1265

Viral and other specified intestinal infections

420

1836

2.28

52.57

2.5

1.9

2.34

2.24

ug/l

0.06

378

1588

Mood [affective] disorders

2377

11116

1.42

52.53

2.2

2.0

2.08

2.30

ug/l

0.42

2106

9804

Other diseases of anus and rectum

781

4375

1.83

52.30

2.1

1.9

2.43

2.24

ug/l

0.13

669

3828

Crohn disease

344

1427

2.50

52.10

2.0

7.07

1.89

ug/l

0.68

317

1277

Vascular disorders of the intestines

258

938

2.94

51.97

2.4

1.8

2.92

2.54

ug/l

0.18

236

805

Other specific joint derangements/joint disorders

1550

6819

1.54

51.75

2.1

2.0

2.06

2.29

ug/l

0.25

1344

6050

Alcohol abuse, main dg, excluding more controls

396

1753

2.34

51.68

2.1

2.0

3.06

2.19

ug/l

0.67

353

1582

Non-selective monoamine reuptake inhibitors

995

5800

1.70

51.58

2.1

1.9

2.42

2.52

ug/l

0.08

859

5140

Benign neoplasm of other and ill-defined parts of digestive system

446

2077

2.22

51.53

2.2

1.8

2.99

1.93

ug/l

1.00

386

1802

Biological medication for rheuma

366

1568

2.41

51.43

2.1

1.59

2.07

ug/l

0.42

320

1427

Emergency coronary revascularization (for ACS)

1641

7896

1.53

51.39

2.1

1.9

2.12

2.22

ug/l

0.11

1441

6880

Exclusions for E4_PCOS_BROAD

429

1967

2.25

51.32

2.6

2.0

1.82

2.27

ug/l

0.53

388

1748

Fracture of rib(s), sternum and thoracic spine

831

4780

1.79

51.26

2.2

2.0

1.93

2.16

ug/l

0.25

703

4203

Non-small cell lung cancer

534

2681

2.08

51.01

2.0

1.9

1.86

2.70

ug/l

0.73

486

2311

Shoulder lesions

1960

8270

1.47

50.94

2.1

2.0

1.80

2.51

ug/l

1.44

1750

7298

Dental operations

1788

6164

1.51

50.91

2.0

1.9

2.37

2.41

ug/l

0.04

1540

5387

Inflammatory bowel disease

751

4196

1.83

50.73

2.0

4.12

2.06

ug/l

0.54

675

3719

Zoster [herpes zoster]

520

2590

2.08

50.51

2.3

1.9

5.62

2.22

ug/l

0.62

461

2243

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

137

346

4.42

50.01

2.4

1.6

6.96

2.05

ug/l

0.65

115

298

Alcohol dependence

756

4262

1.82

49.90

2.2

2.0

2.32

2.30

ug/l

0.02

680

3796

Congenital malformations, deformations and chromosomal abnormalities

1198

7265

1.60

49.78

2.4

2.0

2.26

2.15

ug/l

0.14

1069

6463

Speech therapy

734

4108

1.84

49.73

2.1

1.9

1.72

2.32

ug/l

1.03

687

3597

Shock, not elsewhere classified

8.83

49.36

4.7

1.5

13.42

2.62

ug/l

1.48

Nonhereditary hypogammaglobulinemia

9.10

49.21

2.9

2.1

1.35

1.62

ug/l

0.12

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

804

2948

1.81

49.19

1.9

1.8

1.80

2.12

ug/l

0.41

713

2511

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

804

2948

1.81

49.19

1.9

1.8

1.80

2.12

ug/l

0.41

713

2511

Hernia of abdominal wall

1183

7528

1.60

49.02

2.2

2.0

2.04

2.18

ug/l

0.17

1064

6656

Arthrosis

1770

6592

1.50

49.01

1.9

2.52

2.33

ug/l

0.17

1527

5839

Disorders of adult personality and behaviour

574

2975

1.97

48.93

2.3

2.0

2.61

1.95

ug/l

0.67

518

2659

Polyarthrosis

539

2626

2.03

48.87

1.9

1.8

1.50

2.30

ug/l

1.56

447

2304

Combinations of oral blood glucose lowering drugs

781

4478

1.79

48.80

2.0

2.20

2.26

ug/l

0.06

728

3967

Exposure to unspecified factor

2250

12520

1.41

48.68

2.0

2.50

2.22

ug/l

0.42

1946

11066

Unspecified fall

1196

7572

1.60

48.66

2.1

1.9

2.37

2.28

ug/l

0.08

1011

6658

Sciatica+with lumbago

1161

6972

1.61

48.58

2.2

1.9

1.80

2.25

ug/l

1.07

1039

6181

Other viral diseases, not elsewhere classified

435

2044

2.18

48.51

2.3

2.0

1.36

2.42

ug/l

1.93

388

1817

Ventral hernia

665

3646

1.88

48.28

2.3

1.9

2.12

2.10

ug/l

0.02

595

3209

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

223

781

3.05

48.14

2.2

1.7

2.27

1.70

ug/l

0.30

211

666

Charcot foot

159

6.29

47.98

2.6

2.0

3.44

3.29

ug/l

0.02

142

Hodgkin lymphoma

108

232

5.07

47.95

2.4

1.7

0.59

1.43

ug/l

1.20

102

207

Persons encountering health services in other circumstances

873

5169

1.72

47.83

1.9

2.0

1.53

2.28

ug/l

1.79

768

4548

Disorders of parathyroid gland

588

3070

1.95

47.82

2.2

1.9

3.25

2.48

ug/l

0.43

516

2634

Artificial opening status

196

642

3.28

47.73

3.4

1.8

3.15

2.71

ug/l

0.14

180

567

Other obstructive and reflux uropathy

147

399

3.92

47.69

2.3

1.7

5.39

1.94

ug/l

0.92

135

339

Benign neoplasm: Colon

1424

9300

1.53

47.65

2.1

2.0

1.84

2.26

ug/l

1.16

1249

8158

Unstable angina pectoris

1127

5900

1.62

47.20

2.2

1.9

2.19

2.25

ug/l

0.06

1004

5092

Seropositive rheumatoid arthritis, strict definition

423

2001

2.19

47.15

2.0

1.23

1.94

ug/l

1.14

376

1772

Diseases of the eye and adnexa

1832

6279

1.48

47.03

2.1

2.0

2.14

2.09

ug/l

0.05

1632

5635

Morphin

192

5.72

47.00

1.6

1.8

1.05

1.90

ug/l

0.53

172

Status epilepticus

146

401

3.95

46.93

4.1

1.8

2.57

1.57

ug/l

0.44

122

352

Fracture of lumbar spine and pelvis

621

3362

1.90

46.87

2.3

1.8

1.94

2.35

ug/l

0.46

511

2892

Traumatic subdural haemorrhage

399

1820

2.24

46.68

2.2

1.9

2.03

2.44

ug/l

0.33

329

1613

Pain in joint

1278

5442

1.57

46.67

2.1

2.0

1.94

2.34

ug/l

0.54

1114

4794

Symptoms and signs involving the skin and subcutaneous tissue

1594

10849

1.48

46.60

2.1

2.0

2.00

2.26

ug/l

0.37

1403

9544

Coronary artery bypass grafting

871

3926

1.74

46.55

2.1

1.9

1.91

2.27

ug/l

0.42

764

3351

Lymphoid leukaemia

222

794

3.01

46.42

2.3

1.8

1.86

2.28

ug/l

0.23

199

699

Other gastritis (incl. Duodenitis)

634

3467

1.88

46.41

2.2

1.9

2.75

2.07

ug/l

0.48

573

3051

Infection of intervertebral disc (pyogenic)

153

6.57

46.03

2.2

2.1

0.98

3.65

ug/l

0.78

136

Symptoms and signs involving the nervous and musculoskeletal systems

1379

9206

1.52

45.57

2.1

2.0

2.44

2.13

ug/l

0.33

1206

8098

Other and unspecified local infections of skin and subcutaneous tissue

286

1170

2.56

45.09

2.2

1.9

1.84

2.04

ug/l

0.13

258

1036

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

158

471

3.63

44.96

2.9

1.7

1.66

1.81

ug/l

0.08

141

405

Myocarditis

120

292

4.29

44.91

2.3

1.8

1.30

2.72

ug/l

0.72

113

266

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

308

1308

2.47

44.80

1.9

1.8

2.37

1.65

ug/l

0.57

277

1122

Other diseases of intestine

364

1659

2.29

44.72

2.7

1.9

3.46

2.49

ug/l

0.45

322

1453

DVT of lower extremities

546

2892

1.95

44.33

2.3

1.9

2.51

2.31

ug/l

0.13

483

2517

Aortic aneurysm

698

3918

1.81

44.27

2.1

1.9

1.68

2.29

ug/l

1.13

607

3402

Diseases of oral cavity, salivary glands and jaws

2287

8469

1.40

44.26

2.0

1.9

2.08

2.28

ug/l

0.27

2001

7423

Giant cell arteritis

173

554

3.42

44.17

1.7

1.8

1.23

1.96

ug/l

0.51

148

474

Personality disorders

538

2830

1.94

43.95

2.2

2.0

2.75

1.95

ug/l

0.83

492

2537

Other local infections of skin and subcutaneous tissue

299

1263

2.47

43.92

2.2

1.9

1.79

2.23

ug/l

0.33

267

1113

Rare circulating lymphoid malignancy

142

403

3.90

43.91

2.7

1.9

0.96

2.03

ug/l

0.74

136

358

Respiratory conditions due to other external agents

106

245

4.93

43.74

2.3

1.9

3.78

2.77

ug/l

0.17

216

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

391

1782

2.19

43.56

2.7

2.0

2.77

2.27

ug/l

0.35

357

1593

Non-Hodgkin lymphoma, all

178

585

3.33

43.56

2.7

1.8

2.36

2.15

ug/l

0.06

166

500

Polycystic ovarian syndrome, consortium definition

1290

5073

1.55

43.56

2.1

1.9

3.27

2.09

ug/l

0.49

1098

4442

Colectomy operation

511

2669

1.99

43.53

2.3

1.9

5.22

2.34

ug/l

0.52

464

2326

Benign neoplasm: Colon, unspecified

602

3290

1.87

43.42

2.3

1.8

1.64

2.03

ug/l

0.68

514

2872

Acidosis

107

251

4.86

43.38

2.4

2.0

1.85

2.64

ug/l

0.29

224

Statin medication

1564

5948

1.49

43.24

2.0

2.36

2.21

ug/l

0.13

1394

5263

Depression or dysthymia

1717

6640

1.46

43.18

2.1

2.0

1.97

2.38

ug/l

0.64

1505

5955

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

129

348

4.12

43.04

2.3

1.7

1.02

1.69

ug/l

0.63

113

300

Chronic lymphocytic leukaemia, helper endpoint

129

348

4.12

43.04

2.3

1.7

1.02

1.69

ug/l

0.63

113

300

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

362

1675

2.25

42.86

2.0

1.8

2.36

1.73

ug/l

0.56

324

1438

Fibrosis and cirrhosis of liver

249

982

2.69

42.76

2.4

2.0

1.56

2.18

ug/l

0.50

223

869

Anxiety (asthma-related co-morbidities)

1101

5546

1.58

42.67

2.3

2.0

2.53

2.11

ug/l

0.59

973

4947

Left ventricular outflow tract obstruction (LVOTO), broad definition

288

1214

2.48

42.49

2.5

2.1

1.91

2.16

ug/l

0.15

265

1110

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

295

1262

2.45

42.23

1.9

1.8

2.45

1.64

ug/l

0.64

264

1080

Other joint disorders

1905

7166

1.43

42.00

2.0

1.57

2.33

ug/l

1.79

1664

6341

Schizophrenia

397

1914

2.13

41.88

2.2

2.0

2.26

2.02

ug/l

0.18

360

1729

Colorectal adenocarcinoma

605

3380

1.85

41.72

1.9

2.01

2.37

ug/l

0.39

544

2932

Dermatitis due to substances taken internally

175

579

3.20

41.60

2.5

1.9

1.20

1.77

ug/l

0.44

155

503

Other abnormalities of plasma proteins

188

5.53

41.25

2.2

1.9

0.58

3.25

ug/l

1.01

163

Coronary angioplasty

1053

5177

1.60

41.07

2.0

1.9

2.16

2.27

ug/l

0.09

922

4470

Injuries to the knee and lower leg

2748

11874

1.34

40.81

2.1

2.0

2.06

2.29

ug/l

0.47

2390

10488

Spondylosis

1308

7555

1.51

40.71

2.0

1.9

2.27

2.25

ug/l

0.02

1154

6676

646

3500

1.81

40.62

1.9

1.8

3.57

2.41

ug/l

0.57

531

2980

Elevated blood glucose level

256

1047

2.57

40.52

2.2

2.0

1.73

1.76

ug/l

0.02

228

924

Focal epilepsy

540

2929

1.89

40.51

2.5

1.9

2.83

2.34

ug/l

0.31

455

2578

Myeloid leukaemia

124

341

4.05

40.30

2.9

1.9

6.36

2.33

ug/l

0.59

118

300

Arthropathies in other diseases classified elsewhere

136

395

3.71

40.25

2.3

2.1

3.11

1.45

ug/l

0.83

122

359

Intestinal adhesions without obstruction

263

1093

2.53

40.23

2.4

1.9

1.94

2.18

ug/l

0.17

233

944

Aortic valve malfunction, age under 60 years

271

1141

2.48

40.18

2.5

2.1

1.98

1.85

ug/l

0.08

249

1046

Adult respiratory distress syndrome

158

5.94

40.05

3.9

2.0

1.19

1.91

ug/l

0.52

140

Specific personality disorders

463

2392

1.97

40.00

2.3

2.0

2.58

1.87

ug/l

0.69

418

2143

Other skin changes

476

2498

1.97

39.91

2.1

1.9

2.65

2.35

ug/l

0.15

426

2191

Cirrhosis of liver, NAS

191

685

3.01

39.85

2.4

2.0

1.80

1.95

ug/l

0.09

170

610

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

338

1568

2.25

39.84

1.9

1.7

1.53

1.79

ug/l

0.41

306

1339

Organic, including symptomatic, mental disorders

1379

6783

1.50

39.81

2.0

1.9

2.65

2.14

ug/l

0.63

1124

5963

Fracture of femur

754

4123

1.71

39.74

2.2

1.8

3.56

2.43

ug/l

0.89

630

3512

Tumor necrosis factor alpha inhibitors

311

1390

2.30

39.70

2.0

2.1

1.56

2.21

ug/l

0.53

274

1264

5-aminosalicylic acid

433

2192

2.02

39.70

2.0

1.9

5.41

2.41

ug/l

0.43

391

1934

Cholecystectomy

1682

10560

1.43

39.63

2.0

1.9

2.29

2.28

ug/l

0.02

1492

9233

Other condition

351

1654

2.19

39.49

2.4

2.0

3.61

2.11

ug/l

0.72

319

1476

Mental and behavioural disorders due to tobacco

249

1018

2.56

39.41

2.1

1.65

1.82

ug/l

0.11

224

919

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

240

967

2.61

39.28

2.4

1.9

1.45

2.06

ug/l

0.48

214

847

Open wound of lower leg

388

1904

2.11

39.26

2.3

1.9

2.66

2.46

ug/l

0.12

340

1680

Budesonide

296

1307

2.33

38.89

2.0

1.9

7.21

2.45

ug/l

0.48

266

1158

Smoking dependency

249

1025

2.55

38.85

2.1

1.65

1.85

ug/l

0.13

224

925

Hepatic failure, not elsewhere classified

147

462

3.46

38.65

3.4

1.9

3.46

2.11

ug/l

0.59

131

408

SLE (Finngen)

113

297

4.06

38.51

2.1

1.8

1.48

1.27

ug/l

0.13

106

262

Other diseases of liver

444

2301

1.99

38.46

2.3

1.9

1.94

2.62

ug/l

0.79

411

2054

Herpesviral [herpes simplex] infections

300

1344

2.31

38.34

2.3

1.9

1.23

1.70

ug/l

0.50

274

1194

Sequelae of other external causes

179

630

3.01

38.31

2.3

2.0

3.75

1.64

ug/l

1.10

165

550

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

168

571

3.09

38.01

1.9

1.8

2.02

1.17

ug/l

0.62

161

478

Generalized skin eruption due to drugs and medicaments

140

432

3.48

37.67

2.5

1.9

1.30

2.02

ug/l

0.43

126

381

854

4755

1.63

37.19

1.9

3.29

2.32

ug/l

0.62

702

4077

Benign neoplasm: Rectum

431

2239

1.99

37.15

2.0

1.9

2.61

1.76

ug/l

0.64

387

1945

Other diseases of pancreas

238

983

2.55

37.06

2.8

1.9

3.66

2.20

ug/l

0.74

216

863

Sulfonylureas

1036

5409

1.56

37.05

2.0

1.9

2.23

2.36

ug/l

0.11

910

4650

Invasive ventilation

238

984

2.55

37.00

3.0

2.0

1.38

2.19

ug/l

0.80

225

869

Other disorders of lacrimal gland

786

4866

1.65

36.69

2.1

1.9

2.02

2.11

ug/l

0.07

692

4292

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

333

1589

2.18

36.55

2.0

1.8

1.79

1.81

ug/l

0.01

295

1367

Other anxiety disorders

791

4322

1.64

36.48

2.3

2.0

2.33

2.08

ug/l

0.28

696

3843

Other symptoms and signs involving the circulatory and respiratory systems

189

701

2.82

36.41

2.2

2.0

1.35

2.11

ug/l

0.48

159

611

Emotionally unstable personality disorder

231

941

2.52

36.30

2.3

2.1

2.66

1.80

ug/l

0.48

207

851

Other symptoms and signs involving cognitive functions and awareness

1130

7125

1.51

36.19

2.1

1.9

2.59

2.20

ug/l

0.46

929

6278

Amputation of foot

124

368

3.78

36.19

2.3

1.9

1.31

2.53

ug/l

0.66

113

323

Duodenal ulcer

352

1723

2.13

36.17

2.2

1.8

3.05

2.37

ug/l

0.28

320

1494

Later onset COPD

883

4409

1.62

36.10

2.0

1.9

1.60

2.32

ug/l

1.65

759

3781

Hypothyroidism, strict autoimmune

1592

7480

1.42

35.84

2.0

1.9

1.79

2.25

ug/l

1.23

1397

6530

Diabetic retinopathy

1036

4286

1.57

35.80

2.2

2.1

2.72

2.27

ug/l

0.55

929

3837

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

369

1842

2.08

35.67

1.8

2.21

1.92

ug/l

0.22

318

1595

Benign neoplasm: Rectum, anus and anal canal

474

2573

1.89

35.67

2.0

1.8

2.40

1.98

ug/l

0.28

425

2234

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

293

1343

2.27

35.66

2.0

1.8

1.91

1.77

ug/l

0.11

265

1155

Alcohol abuse, main dg

396

2028

2.01

35.54

2.1

2.0

3.06

2.13

ug/l

0.75

353

1818

Carpal tunnel syndrome

1360

8564

1.45

35.54

2.1

1.9

2.53

2.24

ug/l

0.28

1212

7538

All anxiety disorders

1110

5962

1.51

35.52

2.3

2.0

2.52

2.19

ug/l

0.43

981

5307

Deforming dorsopathies

618

3625

1.74

35.41

2.2

1.9

2.69

2.17

ug/l

0.44

547

3241

Malignant neoplasm of colon

450

2421

1.93

35.21

1.9

1.46

2.38

ug/l

1.74

403

2084

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

1204

5573

1.50

35.07

2.0

1.9

2.34

2.12

ug/l

0.23

1035

4854

Ulcerative colitis, NAS

336

1630

2.12

35.01

2.1

2.0

6.00

2.23

ug/l

0.44

306

1455

malignant neoplasm of female genital organs

374

1893

2.04

34.87

2.0

1.9

3.70

1.72

ug/l

1.48

336

1629

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

574

2663

1.78

34.71

1.8

2.09

2.18

ug/l

0.07

492

2273

Disorders of eyelid, lacrimal system and orbit

1971

11485

1.36

34.64

2.1

2.0

2.34

2.23

ug/l

0.11

1716

10097

Other blood glucose lowering drugs, excl. Insulins

471

2581

1.88

34.57

2.0

1.9

1.75

2.34

ug/l

0.71

417

2224

Rotator cuff syndrome

1486

7835

1.43

34.30

2.0

1.70

2.52

ug/l

1.92

1334

6923

Temporal arteritis

146

492

3.23

34.25

1.7

1.8

1.09

2.02

ug/l

0.62

122

420

Emphysema

240

1032

2.45

34.25

2.1

1.9

1.16

2.80

ug/l

1.72

217

901

Diabetic retinopathy, strict definition

557

2819

1.80

34.22

2.4

2.1

2.78

2.19

ug/l

0.64

500

2526

Diseases of the ear and mastoid process

2653

10308

1.31

34.16

2.0

2.41

2.19

ug/l

0.30

2297

9170

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

165

588

2.91

34.12

2.3

2.1

1.97

2.06

ug/l

0.04

148

533

Acute generalized exanthematous pustulosis

147

496

3.15

34.00

2.4

1.9

1.31

1.86

ug/l

0.35

132

439

Hyperparathyroidism

491

2704

1.85

33.98

2.2

1.9

2.84

2.32

ug/l

0.26

437

2304

Hypertensive Renal Disease

133

425

3.35

33.85

2.2

1.7

6.04

2.80

ug/l

0.59

126

371

Amputation of ankle bones

106

296

3.99

33.81

2.7

1.9

2.66

2.68

ug/l

0.00

100

255

Dental pulpitis 4

2541

10098

1.32

33.81

2.0

1.84

2.28

ug/l

1.33

2254

8842

Seronegative rheumatoid arthritis

301

1421

2.19

33.80

2.1

1.9

1.75

1.63

ug/l

0.05

265

1259

Dental pulpitis 1

2541

10102

1.32

33.76

2.0

1.84

2.28

ug/l

1.32

2253

8846

Diseases of pulp and periapical tissues, including avohilmo

2537

10083

1.32

33.75

2.0

1.84

2.29

ug/l

1.37

2251

8828

Pneumonia derived septicemia

127

396

3.45

33.71

2.3

1.8

3.32

2.06

ug/l

0.61

114

349

Follicular lymphoma

140

463

3.23

33.63

2.3

1.7

0.57

1.68

ug/l

2.36

127

406

Acute alcohol intoxication, ICD10

488

2726

1.84

33.42

2.1

2.96

2.30

ug/l

0.51

437

2445

Collagenous colitis

243

1059

2.39

33.39

2.1

2.0

1.20

2.09

ug/l

0.85

224

934

Other benign neoplasms of skin

754

4636

1.62

33.26

2.0

1.9

1.78

2.07

ug/l

0.43

648

4012

Urticaria and erythema

731

4549

1.63

33.24

2.2

2.0

1.57

2.11

ug/l

0.72

641

4026

Other specified/unspecified systemic involvement of connective tissue

168

616

2.87

33.22

2.5

2.0

1.69

2.14

ug/l

0.24

146

534

Visual disturbances and blindness

1141

7833

1.48

33.07

2.1

1.9

2.43

2.11

ug/l

0.26

962

6897

Focal epilepsy, strict definition

488

2735

1.83

33.06

2.5

1.9

3.02

2.36

ug/l

0.41

407

2406

Acute posthaemorrhagic anaemia

134

437

3.30

33.05

2.4

1.7

2.29

1.34

ug/l

0.47

117

370

Other headache syndromes

829

5323

1.58

32.92

2.1

1.9

2.34

2.25

ug/l

0.07

737

4694

Osteonecrosis

183

707

2.74

32.86

2.2

2.0

3.21

1.80

ug/l

0.78

165

638

Mixed connective tissue disease

183

705

2.72

32.86

2.3

2.0

1.96

2.00

ug/l

0.02

156

621

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

195

777

2.65

32.85

1.8

1.7

3.05

1.75

ug/l

0.45

177

666

Hodgkin lymphoma, hilmo

108

309

3.78

32.82

2.4

1.9

0.59

2.35

ug/l

1.13

102

274

Benign neoplasm: Sigmoid colon

429

2321

1.90

32.71

2.0

1.9

1.95

1.79

ug/l

0.15

386

2015

Other symptoms and signs involving the nervous and musculoskeletal systems

916

6032

1.54

32.57

2.1

2.0

2.21

2.07

ug/l

0.14

803

5319

Spondylopathies (FG)

304

1462

2.13

32.35

2.1

1.9

0.81

2.24

ug/l

3.36

270

1328

Giant cell arteritis with polymyalgia rheumatica

146

509

3.11

32.29

1.7

1.9

1.09

2.12

ug/l

0.72

122

438

Superficial injury of head

519

2979

1.78

32.27

1.9

2.14

2.52

ug/l

0.32

437

2602

Secondary right heart disease

155

558

2.98

32.15

2.6

1.8

1.76

1.98

ug/l

0.09

139

480

Ulcerative colitis

545

3175

1.75

32.12

2.1

2.0

4.80

2.24

ug/l

0.47

487

2812

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

1100

5114

1.50

32.11

2.0

1.9

2.51

2.07

ug/l

0.49

947

4441

Acute alcohol intoxication

644

3928

1.67

32.05

2.1

2.0

2.87

2.35

ug/l

0.48

575

3489

Follow-up examination after treatment for conditions other than malignant neoplasms

903

3834

1.56

32.03

2.0

1.8

3.77

2.57

ug/l

0.91

788

3410

Crohn's disease NAS

176

673

2.73

31.98

2.0

3.40

1.55

ug/l

0.51

162

601

Disorders of lacrimal system

934

6208

1.53

31.90

2.1

1.9

1.93

2.17

ug/l

0.21

820

5445

Inflammatory diseases of the central nervous system

228

986

2.41

31.87

2.4

2.0

3.64

2.11

ug/l

0.38

208

871

Insulin, fast-acting (human)

323

1598

2.07

31.84

2.4

1.9

3.00

2.50

ug/l

0.30

308

1398

Chronic lymphocytic leukaemia

129

424

3.36

31.84

2.3

1.8

1.02

1.95

ug/l

0.60

113

370

Gonarthrosis,primary

2224

10668

1.33

31.65

2.0

2.54

2.22

ug/l

0.42

1925

9435

Bipolar affective disorders

363

1875

1.97

31.54

2.0

2.10

1.92

ug/l

0.13

327

1676

Selective serotonin reuptake inhibitors

2367

9543

1.32

31.40

2.0

2.10

2.36

ug/l

0.38

2067

8457

Degeneration of macula and posterior pole

1251

7256

1.45

31.31

1.9

3.35

2.05

ug/l

1.42

1050

6321

Diseases of spleen

184

4.72

31.26

2.5

1.8

2.74

3.09

ug/l

0.07

162

Unspecified jaundice

167

632

2.79

31.22

2.1

1.9

2.45

3.19

ug/l

0.26

144

536

Other disorders involving the immune mechanism, not elsewhere classified

112

339

3.56

31.21

2.8

2.0

1.96

2.46

ug/l

0.14

104

305

Injuries to the shoulder and upper arm

1920

12120

1.34

31.17

2.0

2.17

2.26

ug/l

0.11

1667

10707

Temporomandibular joint disorders

303

1476

2.09

31.03

2.0

1.35

2.43

ug/l

1.20

271

1326

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

170

649

2.72

30.94

2.5

2.0

5.38

1.61

ug/l

0.98

154

579

Other or ill-defined heart diseases

148

526

2.94

30.94

2.1

1.8

2.02

2.14

ug/l

0.05

141

471

Lumbar disc prolapse

1385

7872

1.41

30.90

2.2

2.0

1.75

2.25

ug/l

1.12

1211

6994

Psoriasis

653

4034

1.65

30.86

2.0

2.34

2.02

ug/l

0.32

584

3589

Sarcoidosis

343

1762

2.01

30.70

2.3

1.9

2.32

2.34

ug/l

0.01

310

1582

Other and unspecified nonorganic psychotic disorders

367

1927

1.94

30.39

2.3

2.0

1.75

1.87

ug/l

0.10

320

1731

Soft tissue disorders related to use, overuse and pressure

618

3781

1.67

30.37

2.2

2.0

1.50

2.41

ug/l

1.05

542

3345

Mental and behavioural disorders due to sedatives or hypnotics

176

691

2.65

30.31

2.0

2.1

2.31

1.97

ug/l

0.17

154

624

Other and unspecified disorders of skin and subcutaneous tissue

193

795

2.55

30.24

1.9

1.81

1.67

ug/l

0.07

149

705

Complications of cardiac and vascular prosthetic devices, implants and grafts

266

3.97

30.19

2.2

1.9

1.85

1.81

ug/l

0.01

229

Other pulmonary heart/vessel disease

163

622

2.79

30.19

2.6

1.8

3.40

2.54

ug/l

0.18

147

538

Parodontitis or operation codes

2075

11660

1.32

30.16

2.1

2.0

3.19

2.08

ug/l

0.80

1803

10331

Neuromuscular dysfunction of bladder

254

1177

2.24

30.15

2.3

2.0

2.08

2.43

ug/l

0.17

209

1035

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

220

4.27

30.11

2.2

1.7

4.02

1.56

ug/l

0.60

187

Malignant neoplasm of respiratory system and intrathoracic organs

636

3615

1.66

30.07

2.0

1.9

1.79

2.53

ug/l

0.78

574

3109

Dermatophytosis

355

1861

1.97

30.05

2.3

1.9

2.80

2.75

ug/l

0.02

319

1651

IBD patients in KELA-register

477

2727

1.78

30.04

2.0

5.14

2.25

ug/l

0.47

429

2437

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

133

457

3.13

30.04

2.1

1.7

1.16

1.99

ug/l

1.09

124

396

Crohn's disease of small intestine

173

677

2.66

29.98

2.0

10.86

1.70

ug/l

0.59

158

605

Other arthrosis

1196

5984

1.45

29.87

2.1

1.9

2.66

2.37

ug/l

0.22

1037

5321

Parodontitis

2071

11660

1.32

29.87

2.1

2.0

3.18

2.09

ug/l

0.79

1800

10330

Post-traumatic stress disorder

140

490

2.93

29.80

2.4

2.0

1.61

2.26

ug/l

0.32

126

439

Thoracic aortic aneurysm

396

2160

1.90

29.78

2.3

1.9

1.36

2.51

ug/l

1.85

339

1901

Secondary malignant neoplasm of respiratory and digestive organs

185

4.76

29.69

1.7

2.0

3.54

3.12

ug/l

0.05

162

Leisure time condition

421

2333

1.85

29.69

2.2

1.9

1.41

2.58

ug/l

1.92

339

2057

Other and unspecified types of non-Hodgkin lymphoma, hilmo

158

600

2.83

29.68

2.9

1.9

1.66

1.92

ug/l

0.13

141

528

Chronic periodontitis, including avohilmo

2062

11658

1.32

29.67

2.1

2.0

3.15

2.09

ug/l

0.74

1792

10330

Systemic lupus erythematosus

113

354

3.39

29.66

2.1

2.0

1.48

1.82

ug/l

0.14

106

311

Pneumococcal septicemia

123

408

3.24

29.55

2.2

1.9

3.41

1.97

ug/l

0.73

110

358

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

461

2591

1.78

29.41

2.2

2.0

1.71

1.97

ug/l

0.29

406

2293

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

105

318

3.56

29.28

2.7

1.9

2.08

2.54

ug/l

0.12

284

Sicca syndrome [Sjögren]

219

966

2.35

29.26

2.4

2.0

1.33

2.08

ug/l

0.65

197

850

In situ neoplasms

702

4252

1.60

29.26

2.0

1.8

2.36

2.06

ug/l

0.24

601

3655

Cerebral palsy and other paralytic syndromes

294

1455

2.09

29.25

2.5

2.0

2.26

2.16

ug/l

0.04

248

1286

Psoriatic and enteropathic arthropathies

270

1293

2.15

29.21

2.2

1.9

1.90

2.13

ug/l

0.16

243

1178

Drug-induced cataract

281

3.78

29.16

2.6

1.9

3.12

2.40

ug/l

0.18

258

Arterial embolism and thrombosis

196

828

2.49

29.14

2.4

1.8

1.45

2.70

ug/l

0.93

176

699

Other inflammatory liver diseases

188

779

2.53

29.06

2.2

2.0

2.83

1.69

ug/l

0.67

170

695

Somatoform disorder

347

1820

1.95

28.99

2.2

2.0

1.68

2.06

ug/l

0.34

287

1617

Papulosquamous disorders

879

5893

1.52

28.87

2.0

2.30

2.19

ug/l

0.11

773

5245

Acute myeloid leukaemia and myelodysplastic syndromes

237

4.09

28.81

2.4

1.8

6.55

2.86

ug/l

0.48

209

Total colectomy operation

135

478

3.00

28.72

2.4

2.0

13.31

1.73

ug/l

0.60

126

434

Total colectomy

135

478

3.00

28.72

2.4

2.0

13.31

1.73

ug/l

0.60

126

434

Abnormal results of function studies

217

961

2.34

28.71

2.5

2.0

1.66

2.17

ug/l

0.36

191

860

Cystic kidney disease

116

380

3.27

28.45

2.6

1.9

3.81

2.12

ug/l

0.58

110

339

Adjustment and management of implanted device

473

2750

1.77

28.43

1.9

1.8

2.16

2.47

ug/l

0.29

419

2356

Other abnormal uterine and vaginal bleeding

508

2111

1.75

28.34

1.9

2.16

2.03

ug/l

0.10

410

1852

Superficial injury of hip and thigh

377

2051

1.89

28.30

2.2

1.9

2.64

2.43

ug/l

0.07

324

1766

Focal epilepsy, mode (most common among epilepsy diagnosis)

449

2573

1.79

28.28

2.5

1.9

3.18

2.46

ug/l

0.42

375

2262

Other degenerative diseases of the nervous system

632

2973

1.64

28.09

1.9

1.8

3.08

2.30

ug/l

0.45

495

2643

Other diseases of arteries and capillaries

254

1211

2.18

28.09

2.2

1.9

3.41

2.46

ug/l

0.26

225

1041

Transport accidents

907

5430

1.50

28.01

2.1

2.0

2.11

2.07

ug/l

0.04

808

4856

Adalimumab

195

833

2.42

27.92

2.1

2.2

1.27

1.93

ug/l

0.50

173

761

severe traumatic brain injury, does not include concussion

591

3662

1.65

27.87

2.4

1.9

2.29

2.30

ug/l

0.01

483

3171

Transient ischemic attack

1321

7932

1.40

27.84

2.0

1.9

2.10

2.19

ug/l

0.11

1158

6933

Stomatitis and related lesions

205

899

2.36

27.70

2.3

2.0

1.52

1.61

ug/l

0.07

175

805

Cardiodefibrillation

991

6866

1.47

27.63

2.0

1.9

2.20

2.13

ug/l

0.07

878

6010

Benign neoplasm: Caecum

253

1215

2.16

27.46

2.2

1.7

1.32

1.61

ug/l

0.47

229

1042

Paracetamol of NSAID medication

407

1097

1.89

27.45

1.9

2.33

2.15

ug/l

0.09

353

980

Dental pulpitis 2

1777

6824

1.35

27.36

1.9

2.0

2.21

2.37

ug/l

0.18

1545

5964

Dental caries 3

2046

8008

1.32

27.21

1.9

2.0

1.75

2.37

ug/l

1.79

1781

7034

Inflammatory bowel disease, strict (require KELA)

477

2806

1.73

27.20

2.0

5.14

2.22

ug/l

0.47

429

2505

Other and unspecified effects of external causes

522

3145

1.69

27.15

2.2

2.0

1.63

2.27

ug/l

0.95

459

2773

Crystal arthropathies, rheuma endpoint

228

4.03

27.13

2.3

1.8

0.43

1.04

ug/l

1.48

201

Other disorders of glucose regulation and pancreatic internal secretion

228

1056

2.24

27.11

2.0

1.9

3.42

2.05

ug/l

0.90

199

916

Abscess of lung

175

4.53

26.97

2.6

2.0

1.23

1.63

ug/l

0.20

157

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

810

3258

1.55

26.88

2.0

3.63

2.09

ug/l

1.21

701

2892

Injuries to the ankle and foot

1310

8684

1.39

26.85

2.0

2.03

2.11

ug/l

0.10

1168

7726

Attention to artificial openings

127

453

2.98

26.74

2.8

1.8

2.29

2.41

ug/l

0.03

111

400

Acquired absence of limb

104

5.89

26.71

2.7

1.8

4.08

4.87

ug/l

0.09

Exposure to other specified factors

1512

10575

1.35

26.61

2.1

2.0

2.06

2.21

ug/l

0.18

1321

9392

Visual disturbances

1015

7126

1.44

26.24

2.1

2.0

2.42

2.06

ug/l

0.27

871

6291

Pneumothorax

211

963

2.29

26.19

2.6

1.9

2.11

2.79

ug/l

0.29

179

843

Chronic nephritic syndrome

137

515

2.83

26.16

2.4

1.9

5.23

2.08

ug/l

0.63

129

464

Viral warts

225

1050

2.21

26.12

2.2

2.0

3.08

2.10

ug/l

0.56

209

942

Other Crohn's disease

163

663

2.54

26.08

1.9

2.1

1.80

1.88

ug/l

0.04

152

594

Disorder of lipoprotein metabolism, unspecified

361

1994

1.87

25.99

1.9

2.36

2.57

ug/l

0.12

309

1738

Other and unspecified tonsillitis

530

2729

1.67

25.95

2.0

2.1

1.71

2.35

ug/l

0.96

489

2475

Bronchiectasis

233

1111

2.19

25.93

2.4

1.9

1.28

3.07

ug/l

2.12

201

957

Other disorders of nervous system

196

872

2.35

25.92

1.9

2.0

3.02

1.77

ug/l

0.28

172

780

Postmenopausal osteoporosis with pathological fracture

173

730

2.50

25.90

2.0

1.8

1.53

2.00

ug/l

0.34

153

615

Artificial joint operation, meniscal resection

2179

11345

1.29

25.86

1.9

2.0

2.25

2.29

ug/l

0.05

1908

10012

Congenital malformations of the urinary system

153

608

2.63

25.85

2.6

2.0

4.08

2.10

ug/l

0.90

143

541

Diabetic neuropathy

370

2064

1.86

25.73

2.2

2.1

2.13

2.38

ug/l

0.21

336

1852

Infective dermatitis

292

1511

1.99

25.68

2.0

1.9

1.50

2.75

ug/l

1.24

264

1341

Dental caries 2 and operation codes, only avohilmo

835

7573

0.68

25.61

1.9

2.1

1.56

2.23

ug/l

1.34

730

6709

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

144

560

2.70

25.52

2.2

1.7

1.35

1.75

ug/l

0.38

132

471

Other crystal arthropathies

238

3.86

25.51

2.3

1.8

0.43

1.85

ug/l

2.26

211

Myalgia

455

2691

1.72

25.47

2.0

1.9

1.38

2.41

ug/l

1.70

393

2374

Osteonecrosis due to drugs

149

4.83

25.45

2.0

1.99

3.97

ug/l

0.45

130

Cervical disc disorders

829

5637

1.49

25.44

2.1

2.0

2.30

2.17

ug/l

0.09

727

5031

SLE, strict definition

105

346

3.22

25.39

2.2

2.0

1.53

1.82

ug/l

0.11

306

SLE, ICD10

105

346

3.22

25.39

2.2

2.0

1.53

1.82

ug/l

0.11

306

Vascular diseases of the intestine

132

497

2.83

25.15

2.6

1.8

3.80

2.20

ug/l

0.71

120

417

Parodontitis and operation codes

1917

11548

1.30

25.14

2.1

2.0

3.33

2.08

ug/l

0.86

1666

10251

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

217

1016

2.21

25.10

2.1

1.7

4.46

2.02

ug/l

0.95

186

855

Benign neoplasm of other and unspecified endocrine glands

264

1328

2.04

25.09

2.3

1.8

2.50

1.52

ug/l

0.98

232

1153

Unspecified urinary incontinence

223

1057

2.19

25.05

1.9

2.07

1.88

ug/l

0.10

167

923

Vasculitis limited to skin, not elsewhere classified

294

3.45

25.00

2.7

1.9

3.52

2.79

ug/l

0.20

257

Benign neoplasm: Small intestine

120

431

2.95

24.96

2.5

1.7

3.89

1.70

ug/l

0.93

101

376

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

1026

4977

1.44

24.92

1.9

2.50

2.06

ug/l

0.45

872

4326

Disorders of sclera, cornea, iris and ciliary body

1146

8289

1.40

24.91

2.1

2.0

2.15

ug/l

0.01

1037

7302

Paralytic ileus

132

500

2.80

24.85

2.8

1.9

4.08

2.17

ug/l

0.38

118

428

Malignant neoplasm of bronchus and lung

540

3147

1.65

24.84

2.0

1.8

1.93

2.65

ug/l

0.60

487

2692

Chronic tubulo-interstitial nephritis

110

377

3.06

24.74

2.3

1.8

6.64

1.81

ug/l

0.78

104

320

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

178

776

2.39

24.61

2.2

1.8

1.13

1.64

ug/l

0.66

160

662

Rheumatism, unspecified

302

1601

1.93

24.57

2.2

1.9

2.45

1.92

ug/l

0.36

268

1423

Cardiomyopathy, other and unspecified

201

922

2.26

24.52

2.2

1.9

1.36

2.44

ug/l

0.91

184

814

Injury of other and unspecified intrathoracic organs

189

848

2.33

24.51

2.3

2.0

1.33

2.28

ug/l

0.57

157

759

Fracture of shoulder and upper arm

788

5342

1.50

24.51

2.0

1.9

2.85

2.35

ug/l

0.38

685

4686

L02BX Other hormone antagonists and related agents

206

966

2.28

24.50

1.9

2.45

2.48

ug/l

0.00

185

847

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

105

357

3.21

24.48

2.5

1.8

2.32

2.18

ug/l

0.04

304

Multiple myeloma

105

357

3.21

24.48

2.5

1.8

2.32

2.18

ug/l

0.04

304

Dental caries, including avohilmo

1943

7666

1.31

24.47

1.9

2.0

2.06

2.31

ug/l

0.34

1691

6717

272

1396

1.99

24.34

2.4

2.0

2.43

2.27

ug/l

0.09

249

1246

Hyperplasia of prostate

1040

4182

1.44

24.29

1.9

2.1

1.87

2.22

ug/l

0.46

916

3767

Dental caries 1

1943

7673

1.31

24.27

1.9

2.0

2.06

2.30

ug/l

0.34

1691

6724

Benign neoplasm of other and ill-defined parts of digestive system

446

2669

1.72

24.25

2.2

1.9

2.99

2.34

ug/l

0.46

386

2345

Other ulcerative colitis

150

610

2.56

24.15

2.3

2.1

10.20

1.71

ug/l

0.44

137

548

Sequelae of injuries, of poisoning and of other consequences of external causes

508

3142

1.65

24.03

2.5

2.0

1.94

2.30

ug/l

0.37

448

2814

Dental caries 3 and operation codes

2176

8764

1.28

24.01

2.0

1.87

2.31

ug/l

1.10

1880

7708

Excessive, frequent and irregular menstruation

704

2547

1.55

24.00

2.1

1.9

1.93

1.96

ug/l

0.03

593

2240

Diaphragmatic hernia

849

5873

1.47

23.98

2.2

1.9

2.17

2.06

ug/l

0.10

742

5153

Open wound of ankle and foot

251

1263

2.05

23.96

2.1

2.0

2.76

2.20

ug/l

0.29

223

1120

Dental caries 1 and operation codes

2112

8483

1.29

23.81

2.0

1.87

2.31

ug/l

1.06

1831

7445

Other and unspecified vasculitis limited to skin

273

3.49

23.77

2.8

1.8

2.53

2.97

ug/l

0.11

237

Amputation of thigh

114

413

2.97

23.56

2.5

1.8

2.08

3.49

ug/l

0.50

100

337

Malnutrition

221

3.79

23.50

2.4

2.1

3.23

3.37

ug/l

0.02

185

Microscopic polyangiitis

7.08

23.38

2.6

1.6

0.79

5.35

ug/l

0.58

Internal derangement of knee

777

5290

1.48

23.31

2.0

1.53

1.98

ug/l

0.78

667

4710

Fracture of lower leg, including ankle

1166

8514

1.38

23.31

2.2

2.0

1.97

2.12

ug/l

0.23

1020

7518

Nonorganic sleeping disorders, excluding more controls

322

1769

1.85

23.29

2.2

1.9

2.19

2.01

ug/l

0.10

286

1572

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

1029

5043

1.42

23.27

1.9

2.50

2.07

ug/l

0.44

873

4379

Special screening examination for other diseases and disorders

188

855

2.26

23.24

2.3

1.8

1.95

3.24

ug/l

0.64

170

762

Complications following infusion, transfusion and therapeutic injection

163

4.32

23.22

2.9

1.9

1.78

1.89

ug/l

0.03

144

Benign neoplasm: Transverse colon

244

1234

2.05

23.08

2.3

1.8

1.68

1.69

ug/l

0.01

226

1067

Vitreous haemorrhage

272

1429

1.97

23.07

2.3

2.0

3.20

2.49

ug/l

0.27

247

1252

Diseases of male genital organs

1320

4918

1.37

22.99

2.0

2.1

2.28

2.19

ug/l

0.09

1183

4425

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

172

762

2.35

22.96

1.9

1.7

2.87

1.78

ug/l

0.52

154

651

Hypoglycaemia, other or unspecified

181

820

2.29

22.84

1.9

2.0

3.71

1.77

ug/l

1.29

155

714

Acute gastritis

208

997

2.16

22.77

2.3

1.9

2.27

2.45

ug/l

0.07

189

873

Other and unspecified nerve root and plexus disorders, also in other diseases

402

2381

1.72

22.57

2.1

2.0

1.81

2.17

ug/l

0.21

343

2136

Tobacco use

141

577

2.55

22.52

2.1

2.26

1.80

ug/l

0.24

129

526

Postprocedural disorders of digestive system, not elsewhere classified

109

394

2.95

22.51

2.9

2.0

3.39

1.96

ug/l

0.51

101

348

Dissection of aorta

117

440

2.84

22.48

2.4

1.8

1.07

3.08

ug/l

1.13

102

374

Behavioural syndromes associated with physiological disturbances and physical factors

547

3493

1.58

22.41

2.2

2.0

1.98

2.15

ug/l

0.14

490

3083

Other specified/unspecified necrotizing vasculopathies

168

4.23

22.38

3.3

1.8

1.16

3.29

ug/l

0.63

146

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

292

1590

1.91

22.31

2.0

1.9

2.48

2.53

ug/l

0.02

263

1389

Benign neoplasm: Skin of other and unspecified parts of face

241

1226

2.02

22.29

1.9

1.8

1.26

1.80

ug/l

0.67

202

1045

Varicose veins

1448

8300

1.33

22.28

2.1

1.9

2.25

2.27

ug/l

0.02

1271

7263

Recurrent or chronic depression

714

3460

1.51

22.18

2.2

2.0

2.27

2.46

ug/l

0.13

637

3130

Portal vein thrombosis

169

4.17

22.13

2.8

2.0

4.82

3.00

ug/l

0.29

154

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

109

398

2.92

22.12

2.1

1.7

2.20

1.81

ug/l

0.12

102

342

Diseases of external ear

731

4994

1.49

22.04

1.9

2.0

3.25

2.05

ug/l

0.79

576

4431

Other viral hepatitis

141

581

2.51

22.02

2.4

2.2

1.31

1.75

ug/l

0.36

130

530

Lichen simplex chronicus and prurigo

170

763

2.32

22.01

1.8

1.9

2.22

1.86

ug/l

0.21

152

676

Arterial embolism and thrombosis of lower extremity artery

123

479

2.73

21.98

2.2

1.7

1.89

2.99

ug/l

0.46

105

408

Convalescence

128

505

2.63

21.97

3.7

1.8

2.67

1.84

ug/l

0.43

448

Pleural plaque

309

1723

1.86

21.93

1.7

1.8

1.30

2.74

ug/l

2.36

270

1484

Systemic lupus erythematosus, unspecified

296

3.22

21.90

2.2

1.9

1.77

2.03

ug/l

0.08

265

Dental pulpitis 2, only avohilmo

1792

7112

1.30

21.85

1.9

2.0

2.03

2.37

ug/l

0.48

1551

6227

Superficial injury of lower leg

485

3036

1.62

21.83

2.1

1.9

2.00

2.32

ug/l

0.27

416

2675

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

319

1792

1.83

21.82

1.9

1.7

1.29

2.23

ug/l

1.85

273

1507

Colon adenocarcinoma

338

1937

1.80

21.74

1.9

1.53

2.40

ug/l

1.29

306

1663

Alcoholic liver disease

279

1510

1.91

21.68

2.4

1.9

2.63

2.58

ug/l

0.02

253

1344

Other specified/unspecified inflammatory spondylopathies

111

410

2.81

21.67

2.2

0.60

2.30

ug/l

1.60

102

371

Alcohol-induced chronic pancreatitis

191

907

2.20

21.59

2.5

2.1

2.76

1.80

ug/l

0.46

179

833

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

153

660

2.39

21.59

2.0

2.1

2.02

1.58

ug/l

0.23

141

595

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

776

3183

1.49

21.57

2.0

3.63

2.08

ug/l

1.16

671

2824

Functional dyspepsia

545

3519

1.57

21.50

2.0

1.9

1.58

2.08

ug/l

0.70

480

3108

Fibromyalgia

159

697

2.34

21.49

2.3

2.0

3.43

2.00

ug/l

0.53

130

620

Psoriasis vulgaris

427

2607

1.67

21.43

2.0

2.48

2.38

ug/l

0.06

380

2326

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

246

1279

1.98

21.43

2.1

1.8

1.46

1.69

ug/l

0.21

216

1104

Unspecified nephritic syndrome

276

3.32

21.34

3.1

2.0

4.16

2.47

ug/l

0.49

246

Benign neoplasm: Duodenum

276

3.31

21.31

2.5

1.7

3.69

1.65

ug/l

0.86

245

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

146

624

2.45

21.26

2.0

1.7

1.32

2.01

ug/l

0.55

131

532

Psychotic depression

143

603

2.45

21.22

2.1

2.24

1.98

ug/l

0.11

128

551

Other other unspecified disorders of the circulatory system

121

476

2.70

21.21

2.4

2.0

1.42

1.92

ug/l

0.24

421

Somnolence, stupor and coma

134

552

2.55

21.18

2.4

1.9

1.69

1.58

ug/l

0.07

121

480

Fracture of skull and facial bones

447

2766

1.64

21.16

2.5

2.0

2.31

2.33

ug/l

0.01

380

2461

Disorders of synovium and tendon

1061

6995

1.38

21.16

2.1

2.0

1.94

2.57

ug/l

0.63

960

6197

Use of disulfiram, acamprosate or naltrexone

207

1018

2.10

21.12

1.9

2.1

1.88

1.97

ug/l

0.04

193

934

Polyarteritis nodosa and related conditions

148

4.29

20.98

2.4

1.9

0.65

3.61

ug/l

0.90

131

Seborrhoeic dermatitis

244

1276

1.97

20.96

2.2

1.9

1.11

2.79

ug/l

2.06

207

1132

Schizoaffective disorder

168

764

2.26

20.92

2.4

2.1

2.39

1.95

ug/l

0.22

156

695

Benign neoplasm: Stomach

215

1077

2.06

20.86

2.0

1.8

2.72

1.48

ug/l

0.96

185

926

Disorders of skin appendages

881

6281

1.42

20.84

2.1

2.0

2.78

1.95

ug/l

0.70

788

5566

Follicular lymphoma, hilmo

140

596

2.49

20.78

2.3

1.9

0.57

1.74

ug/l

1.58

127

531

Crohn disease (strict definition, require KELA)

143

610

2.42

20.72

2.0

2.1

2.16

1.61

ug/l

0.28

131

548

Other disorders of bladder

321

1837

1.80

20.69

2.0

1.9

1.65

2.44

ug/l

0.77

273

1617

Hypoparathyroidism

110

418

2.78

20.63

2.3

2.0

2.92

1.93

ug/l

0.40

364

Small fibre neuropathy

358

2.98

20.61

2.6

1.9

0.86

2.10

ug/l

0.77

319

Speech and linguistic disorders, excluding more controls

117

425

2.64

20.54

2.3

2.0

3.42

2.31

ug/l

0.38

371

Phobic anxiety disorders

199

971

2.08

20.44

2.7

2.0

2.93

1.92

ug/l

0.49

171

869

Injuries to the elbow and forearm

1388

9604

1.32

20.42

1.9

2.0

1.98

2.29

ug/l

0.48

1214

8440

Poisoning by narcotics and psychodysleptics [hallucinogens]

103

4.85

20.42

1.7

1.8

2.70

3.53

ug/l

0.11

Abdominal aortic aneurysm (AAA)

314

1778

1.81

20.41

1.9

1.8

2.18

2.67

ug/l

0.36

275

1503

Psoriatic arthropathies

229

1182

1.99

20.34

2.2

2.0

1.82

2.00

ug/l

0.12

203

1080

Nonalcoholic fatty liver disease

208

1041

2.06

20.24

1.9

2.1

2.07

2.00

ug/l

0.04

193

939

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

157

711

2.33

20.20

2.0

1.8

2.68

3.07

ug/l

0.10

147

614

Meniscus derangement

1216

6232

1.35

20.13

1.9

1.83

2.33

ug/l

0.77

1050

5541

Early complications of trauma

122

493

2.60

20.12

2.6

2.0

2.03

1.84

ug/l

0.09

110

437

!Aliquae complicationes praecoces traumatis

122

493

2.60

20.12

2.6

2.0

2.03

1.84

ug/l

0.09

110

437

Exclusions for E4_PCOS_CONSORTIUM

1277

6023

1.34

20.06

2.2

1.9

1.98

2.13

ug/l

0.20

1113

5272

Abscess of anal and rectal regions

194

950

2.10

20.00

2.2

2.0

1.26

2.50

ug/l

1.34

173

850

Dental operations, only avohilmo

1770

7106

1.29

19.97

1.9

2.07

2.40

ug/l

0.57

1521

6243

Weight loss

242

1285

1.94

19.91

1.9

3.04

2.26

ug/l

0.32

202

1121

Migraine

737

4345

1.45

19.91

2.0

1.9

2.09

2.20

ug/l

0.10

647

3846

Adenocarcinoma and papilloma adenocarcinoma of rectum

275

1525

1.87

19.87

2.0

1.9

2.58

2.60

ug/l

0.01

246

1330

Gonarthrosis, primary, with knee surgery

1373

8611

1.32

19.79

1.9

2.0

2.58

2.33

ug/l

0.24

1194

7571

Dentofacial anomalies [including malocclusion]

464

2907

1.60

19.78

2.1

2.0

1.93

1.89

ug/l

0.03

416

2585

Other diseases of stomach and duodenum

172

812

2.20

19.71

1.9

1.53

2.23

ug/l

0.50

148

721

L04AC Interleukin inhibitors

118

473

2.59

19.67

2.2

2.1

1.78

1.19

ug/l

0.34

106

435

Irregular menses

656

3612

1.49

19.63

2.2

1.9

4.23

1.92

ug/l

0.52

579

3209

Acquired haemolytic anaemia

274

3.21

19.60

3.3

1.9

5.49

2.66

ug/l

0.38

236

Nonischemic cardiomyopathy

153

691

2.31

19.60

2.3

1.9

11.64

3.73

ug/l

0.40

138

606

Crohn disease (strict definition, require KELA, min 2 HDR)

139

601

2.39

19.56

2.0

2.1

2.20

1.63

ug/l

0.28

127

539

Complications of genitourinary prosthetic devices, implants and grafts

237

3.36

19.56

2.1

1.9

9.17

1.62

ug/l

0.72

210

Malignant neoplasm of rectum

274

1526

1.86

19.52

2.0

1.9

2.45

2.61

ug/l

0.07

247

1332

Aspergillosis

5.30

19.45

2.9

2.3

0.94

3.84

ug/l

0.50

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

125

521

2.52

19.35

1.9

1.8

0.97

1.55

ug/l

0.81

113

458

Diseases of salivary glands

408

2526

1.64

19.35

2.2

1.9

1.94

2.10

ug/l

0.14

365

2229

Benign neoplasm: Adrenal gland

163

758

2.23

19.34

2.1

1.8

2.36

1.61

ug/l

0.47

144

665

Late syphilis

153

4.11

19.33

2.5

2.2

4.95

3.67

ug/l

0.18

141

Haemophagocytic lymphohistiocytosis

18.34

19.28

4.5

1.6

2.13

0.32

ug/l

0.85

Other problems related to primary support group, including family circumstances

182

856

2.11

19.27

2.6

2.1

2.05

1.93

ug/l

0.06

167

771

Other sleep disorders

253

1376

1.89

19.21

2.1

1.9

1.33

2.95

ug/l

1.98

226

1216

Other noninfective disorders of lymphatic vessels and lymph nodes

100

375

2.80

19.20

2.2

1.9

1.86

1.92

ug/l

0.02

330

Other bursopathies

316

1839

1.76

19.12

2.1

2.0

1.76

2.66

ug/l

0.82

275

1622

Nontraumatic intracranial haemmorrhage

502

3277

1.56

19.07

2.5

1.9

2.57

2.50

ug/l

0.03

414

2856

Dipeptidyl peptidase 4 (DPP-4) inhibitors

306

1770

1.78

19.06

1.8

1.9

3.12

2.64

ug/l

0.17

270

1545

Primary gonarthrosis, bilateral

1202

7981

1.33

19.04

1.9

2.0

2.42

2.19

ug/l

0.25

1032

7018

Chronic viral hepatitis

115

462

2.57

19.03

2.6

2.2

1.48

1.97

ug/l

0.32

104

426

Polyarthritis, unspecified

108

423

2.68

19.02

2.1

2.0

1.85

1.42

ug/l

0.26

380

Corns and callosities

175

843

2.15

19.02

2.3

1.9

2.57

1.74

ug/l

0.42

155

752

Superficial injury of thorax

339

2013

1.72

19.02

2.3

2.0

1.64

2.47

ug/l

0.68

300

1778

Assault

233

1236

1.92

18.97

2.4

2.1

3.44

1.82

ug/l

0.75

204

1124

Ulcer of oesophagus

204

1042

2.03

18.97

2.4

1.9

4.84

2.63

ug/l

0.48

187

911

Malignant neoplasm of pancreas

192

962

2.09

18.94

2.2

1.9

1.61

2.53

ug/l

0.47

172

829

Malignant neoplasm of breast

917

4802

1.39

18.80

1.9

1.71

2.47

ug/l

1.07

804

4161

Congenital malformations of the circulatory system

282

1542

1.81

18.78

2.7

2.0

2.30

2.37

ug/l

0.03

252

1384

Postprocedural musculoskeletal disorders, not elsewhere classified

188

937

2.09

18.74

2.4

2.0

2.91

1.86

ug/l

0.38

167

824

Inflammatory diseases of female pelvic organs

964

5320

1.38

18.70

2.0

1.9

2.73

2.17

ug/l

0.53

815

4672

Other diseases of lip and oral mucosa

362

2197

1.68

18.69

2.1

1.9

2.19

2.18

ug/l

0.01

316

1938

Traumatic subarachnoid haemorrhage

103

400

2.70

18.47

2.7

1.8

3.50

1.95

ug/l

0.53

353

Asthma and allergy, excluding more controls

143

629

2.27

18.46

2.0

1.7

2.67

2.20

ug/l

0.12

134

552

Coxarthrosis, primary

1439

9750

1.30

18.46

1.9

2.0

2.72

2.18

ug/l

0.52

1237

8553

Other general symptoms and signs

342

2.80

18.46

1.9

1.8

1.36

2.04

ug/l

0.45

302

Viral haemorrhagic fevers, not elsewhere classified/unspecified

203

1044

2.01

18.43

2.4

2.1

2.16

2.14

ug/l

0.01

189

939

Left ventricular outflow tract obstruction, narrow definition

127

544

2.43

18.42

3.2

2.1

2.41

2.11

ug/l

0.11

116

493

Congenital malformations of heart and great arteries

253

1347

1.86

18.39

2.8

2.0

1.97

2.21

ug/l

0.16

228

1206

Other diseases of jaws

165

787

2.16

18.34

2.0

10.47

1.47

ug/l

0.54

151

705

Orchitis and epididymitis

249

1371

1.87

18.31

2.1

2.0

1.96

2.75

ug/l

0.54

223

1213

Recurring oral aphthae, including avohilmo

292

1684

1.77

18.24

2.1

2.0

2.43

2.21

ug/l

0.12

253

1485

Recurring oral aphthae

126

541

2.43

18.23

2.2

2.0

1.63

1.79

ug/l

0.07

108

475

Nephrotic syndrome

363

2.79

18.22

3.0

1.9

5.95

2.09

ug/l

0.49

325

Arthropod-borne viral fevers and viral haemorrhagic fevers

241

1318

1.88

18.12

2.4

2.0

2.04

2.12

ug/l

0.04

221

1186

Other hearing loss

675

4642

1.45

18.10

2.0

1.9

2.69

2.43

ug/l

0.15

579

4061

Persons with potential health hazards related to communicable diseases

579

3893

1.49

18.03

2.2

2.0

1.63

2.13

ug/l

0.76

528

3461

Implicit parasitic Sepsis

7.89

18.02

1.4

1.6

1.15

8.05

ug/l

0.46

Non-small cell lung cancer, adenocarcinoma

195

1001

2.04

18.01

1.8

1.9

3.05

2.73

ug/l

0.08

177

869

Non-small cell lung cancer, adenocarcinoma, helper endpoint

195

1001

2.04

18.01

1.8

1.9

3.05

2.73

ug/l

0.08

177

869

Viral hepatitis

156

733

2.19

17.98

2.5

2.1

1.30

1.75

ug/l

0.45

141

668

Lesion of ulnar nerve

311

1839

1.73

17.77

2.2

1.9

1.60

2.25

ug/l

0.64

267

1655

Umbilical hernia

599

4114

1.48

17.75

2.0

2.00

2.12

ug/l

0.12

548

3672

Oesophageal varices

125

543

2.42

17.74

2.6

2.0

2.83

1.97

ug/l

0.34

114

480

Injury of intra-abdominal organs

241

3.20

17.71

2.5

1.9

2.28

2.26

ug/l

0.00

216

Benign neoplasm: Colon, unspecified

602

4148

1.48

17.68

2.3

1.9

1.64

2.25

ug/l

1.08

514

3646

Dental caries 3, only avohilmo

2025

8371

1.25

17.58

1.9

2.0

1.70

2.38

ug/l

2.14

1757

7365

Artrosis, including avohilmo

1912

8442

1.25

17.50

1.9

2.0

2.41

2.26

ug/l

0.14

1651

7528

Crohn's disease of large intestine

120

512

2.42

17.49

2.1

5.22

1.65

ug/l

0.75

111

460

Etanercept

129

568

2.34

17.46

2.0

2.2

1.81

1.74

ug/l

0.02

115

515

Reactive arthropathies

196

1013

1.98

17.43

2.3

2.0

3.02

2.04

ug/l

0.23

182

916

Urticaria

521

3488

1.51

17.41

2.1

2.0

1.60

2.11

ug/l

0.47

455

3091

Spondylolisthesis/Spondylolysis

382

2392

1.63

17.38

2.2

1.9

2.53

2.29

ug/l

0.15

349

2143

Aneurysms, operations, SAH

382

2396

1.63

17.36

2.3

1.9

2.31

2.46

ug/l

0.08

321

2131

Chronic gastritis

648

4537

1.45

17.35

1.9

2.10

2.20

ug/l

0.10

550

3963

Childhood asthma (age<16), excluding more controls

112

357

2.51

17.34

2.3

1.7

3.92

2.15

ug/l

0.62

101

313

Congenital malformations of aortic and mitral valves

112

467

2.51

17.32

3.3

2.0

2.60

2.24

ug/l

0.12

102

420

Disorders of the thyroid gland

2058

10958

1.24

17.30

2.0

1.66

2.24

ug/l

2.04

1806

9629

Disorders of muscles

228

1245

1.88

17.15

2.3

2.0

1.49

2.94

ug/l

1.38

196

1100

Haemorrhoids and perianal venous thrombosis

640

4481

1.45

17.02

2.0

1.9

1.76

2.25

ug/l

0.52

556

3925

Other juvenile arthritis

261

3.00

17.01

2.4

2.1

1.22

1.82

ug/l

0.44

233

Acute and transient psychotic disorders

234

1290

1.85

17.01

2.3

2.0

2.05

1.88

ug/l

0.09

204

1155

IgA nephropathy (IgA glomerulonephritis)

275

3.02

16.98

2.4

2.1

2.26

2.54

ug/l

0.05

248

Other disorders of bone

373

2334

1.62

16.97

1.9

2.0

2.51

2.47

ug/l

0.02

330

2102

Right hemicolectomy

175

884

2.06

16.92

2.3

1.8

1.57

2.18

ug/l

0.41

158

759

Other diseases of hard tissues of teeth

1259

7259

1.30

16.85

2.1

2.0

2.06

2.17

ug/l

0.16

1111

6454

Disorders of continuity of bone

191

990

1.98

16.85

2.5

2.0

2.33

1.96

ug/l

0.27

171

893

Amiodarone users

281

1651

1.76

16.73

2.0

1.9

1.78

2.48

ug/l

0.56

249

1448

Asthma and allergy

143

656

2.18

16.71

2.0

1.8

2.67

2.05

ug/l

0.16

134

578

Post-traumatic wound infection, not elsewhere classified

266

3.02

16.70

2.3

2.0

1.48

2.52

ug/l

0.41

239

Anosmia

4.89

16.64

2.0

1.5

3.55

1.88

ug/l

0.23

Pruritus

225

1236

1.86

16.60

2.4

1.9

2.61

2.35

ug/l

0.13

205

1083

Hypothyroidism, other/unspecified

1892

10134

1.24

16.58

2.1

2.0

1.75

2.23

ug/l

1.63

1662

8905

Reactive arthropathies, FINNGEN

154

744

2.13

16.56

2.2

2.0

0.96

1.44

ug/l

0.73

143

670

Haemolytic anaemias

399

2.61

16.54

3.3

2.0

4.72

2.08

ug/l

0.46

347

Neuralgia and neuritis, unspecified

124

551

2.33

16.53

2.2

2.1

2.22

1.76

ug/l

0.20

103

484

Childhood asthma (age<16)

112

366

2.45

16.50

2.3

1.7

3.92

2.12

ug/l

0.63

101

321

Mixed and other personality disorders

154

745

2.12

16.45

2.2

2.1

2.85

1.76

ug/l

0.50

139

679

Other disorders of white blood cells

143

676

2.20

16.44

2.8

1.8

1.92

1.86

ug/l

0.03

129

600

Personal history of risk-factors, not elsewhere classified

4.73

16.42

2.1

1.8

2.61

1.35

ug/l

0.29

Juvenile arthritis (FINNGEN)

311

2.77

16.36

2.3

2.0

1.13

1.67

ug/l

0.43

282

Benign neoplasm: Descending colon

158

777

2.11

16.35

2.0

1.8

1.56

1.66

ug/l

0.10

143

668

Myeloproliferative diseases

222

1227

1.87

16.27

2.1

1.9

1.44

2.52

ug/l

1.02

200

1070

Malignant neoplasm of corpus uteri

190

999

1.96

16.23

2.2

1.8

4.96

1.62

ug/l

1.27

161

855

Acute lymphadenitis

126

567

2.29

16.22

2.2

2.0

1.86

1.90

ug/l

0.01

115

502

Vitamin deficiency

124

557

2.31

16.16

2.5

1.9

2.51

1.54

ug/l

0.45

111

488

Vitamin deficiency, wide

124

557

2.31

16.16

2.5

1.9

2.51

1.54

ug/l

0.45

111

488

Erythema intertrigo

283

2.94

16.16

2.2

1.9

2.93

2.68

ug/l

0.06

246

Pulmonary oedema

225

3.20

15.98

3.7

1.9

8.18

3.09

ug/l

0.46

183

Other epidermal thickening

114

498

2.39

15.90

2.4

1.9

2.47

1.82

ug/l

0.25

108

440

Hyperosmolality and hypernatraemia

165

3.64

15.87

2.3

1.8

12.03

3.37

ug/l

0.61

140

Myelodysplastic syndrome

114

4.36

15.85

1.9

2.0

7.90

3.56

ug/l

0.23

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1065

7996

1.32

15.85

2.1

2.0

1.50

2.24

ug/l

2.24

917

7111

Wegener granulomatosis

190

3.42

15.84

2.6

1.9

2.53

2.72

ug/l

0.04

170

Panic disorder

217

1194

1.84

15.78

2.6

2.0

2.14

1.88

ug/l

0.13

197

1055

Other fall from one level to another

446

2958

1.53

15.71

2.2

2.0

1.75

2.32

ug/l

0.68

392

2621

Hypothyreosis and Thyroxine purchase for inclusion criteria

1939

10474

1.23

15.67

2.0

1.74

2.21

ug/l

1.58

1702

9201

Other meningitis

146

3.73

15.61

2.1

1.8

1.23

3.30

ug/l

0.52

129

Dental caries 1, only avohilmo

1931

8051

1.24

15.56

1.9

2.0

1.96

2.33

ug/l

0.60

1676

7066

Paraplegia, diplegia of upper limbs

267

2.95

15.49

3.0

2.1

3.56

2.56

ug/l

0.12

238

Any event in hilmo or specialist outpatient

+∞

15.42

1.8

0.0

13.35

—

ug/l

—

Malignant neoplasm of breast, HER2-negative

875

4789

1.36

15.39

1.8

1.9

1.77

2.45

ug/l

0.89

768

4153

Abnormal weight loss

216

1204

1.85

15.39

1.9

3.23

2.31

ug/l

0.33

177

1052

Disorders of ocular muscles, binocular movement, accommodation and refraction

820

6033

1.36

15.37

2.3

2.0

3.19

2.04

ug/l

1.17

710

5362

Viral infections of the central nervous system

156

780

2.06

15.34

2.0

2.1

1.18

1.69

ug/l

0.38

133

688

Benign neoplasm: Rectum

431

2865

1.54

15.27

2.0

1.9

2.61

2.31

ug/l

0.16

387

2504

Sleep disorders

383

2473

1.57

15.27

2.3

1.9

1.94

2.14

ug/l

0.14

342

2194

Acute bronchiolitis

297

2.65

15.21

2.4

2.0

2.36

3.23

ug/l

0.29

255

Presbycusis

362

2306

1.60

15.20

1.9

1.8

3.62

2.70

ug/l

0.34

311

1950

Injuries to the neck

420

2771

1.54

15.19

2.1

2.0

2.81

2.25

ug/l

0.24

380

2444

Localized swelling, mass and lump of skin and subcutaneous tissue

639

4571

1.42

15.17

2.2

2.0

1.78

2.18

ug/l

0.52

568

4054

Other metabolic disorders

221

1240

1.81

15.17

2.4

2.0

2.33

1.94

ug/l

0.20

199

1107

Other disorders of veins

749

5496

1.38

15.12

2.0

1.9

2.19

2.12

ug/l

0.04

637

4829

Intestinal malabsorption

114

509

2.33

15.11

2.9

1.9

1.80

1.77

ug/l

0.01

101

451

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

164

3.49

15.10

1.9

1.7

1.71

2.17

ug/l

0.13

146

Fracture of foot, except ankle

427

2834

1.53

15.00

2.1

2.0

2.66

2.10

ug/l

0.45

386

2520

Visual impairment including blindness (binocular or monocular)

170

885

1.98

15.00

2.0

1.8

3.25

2.22

ug/l

0.39

128

753

Secondary parkinsonism, excluding more controls

271

2.87

14.98

2.3

1.9

1.08

1.67

ug/l

0.48

243

Need for other prophylactic measures

136

654

2.15

14.98

1.8

2.0

2.11

1.83

ug/l

0.13

129

581

Other diseases of oesophagus

237

1367

1.78

14.98

2.0

1.9

3.09

2.49

ug/l

0.21

209

1190

Malignant neoplasm of urinary organs

265

1580

1.73

14.96

2.0

1.9

1.55

2.41

ug/l

0.94

236

1386

Speech disturbances, not elsewhere classified

220

1244

1.82

14.96

2.0

1.9

3.19

2.37

ug/l

0.36

178

1076

Any dementia, excluding more controls

880

4577

1.35

14.96

1.8

1.9

2.97

2.28

ug/l

0.56

681

3999

Chronic sinusitis

831

6208

1.35

14.90

2.2

2.0

2.12

2.29

ug/l

0.13

734

5487

Listeriosis

7.85

14.84

2.5

1.6

1.13

0.36

ug/l

1.00

Benign neoplasm: Ascending colon

269

1610

1.71

14.83

2.1

1.8

1.82

1.70

ug/l

0.11

240

1380

Cardiac murmurs and other cardiac sounds

160

805

2.00

14.81

2.1

2.0

2.62

2.24

ug/l

0.14

141

711

Hypopituitarism

146

722

2.08

14.81

2.7

2.0

2.73

2.40

ug/l

0.14

132

656

Fall involving bed

416

2.50

14.80

2.2

1.9

2.00

2.32

ug/l

0.11

355

Polycythaemia vera

403

2.50

14.75

2.4

1.7

1.16

1.63

ug/l

0.39

351

Bicuspidal aortic valve syndrome

422

2.45

14.68

3.3

2.0

1.88

2.31

ug/l

0.19

384

Subarachnoid haemorrhage

256

1518

1.73

14.67

2.6

1.9

1.90

2.27

ug/l

0.23

210

1332

Car occupant injured in other and unspecified transport accidents

343

2181

1.60

14.66

2.1

2.0

1.95

2.54

ug/l

0.51

308

1934

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

372

2311

1.57

14.66

1.9

1.8

1.14

2.25

ug/l

3.13

334

1964

Benign neoplasm: Duodenum

340

2.67

14.63

2.5

1.9

3.69

2.25

ug/l

0.45

300

Parkinson's disease, excluding more controls

309

1871

1.64

14.62

1.9

1.8

2.21

2.35

ug/l

0.08

255

1664

Follow-up care involving plastic surgery

331

2.63

14.61

2.2

1.8

0.86

2.16

ug/l

1.30

290

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

212

1074

1.81

14.58

2.0

2.1

2.78

1.87

ug/l

0.48

191

963

Olecranon bursitis

171

902

1.96

14.58

2.4

2.0

1.05

2.90

ug/l

1.86

154

801

Other specified and unspecified personality disorders

171

899

1.94

14.50

2.1

2.16

1.67

ug/l

0.27

158

819

Other chondrocalcinosis

176

3.47

14.49

2.5

1.8

0.44

3.21

ug/l

1.01

155

Acute laryngitis and tracheitis

163

829

1.96

14.38

1.9

2.0

1.58

2.07

ug/l

0.28

141

736

Congenital iodine-deficiency syndrome/hypothyroidism

347

2.60

14.38

2.4

2.0

1.19

2.51

ug/l

0.80

298

Gingivitis and periodontal diseases

1971

8384

1.22

14.35

2.0

1.9

2.15

2.26

ug/l

0.13

1709

7361

Benign neoplasm: Small intestine

120

562

2.24

14.33

2.5

1.9

3.89

1.98

ug/l

0.71

101

498

Alzheimer disease, excluding more controls

420

1852

1.54

14.33

1.8

3.11

2.59

ug/l

0.17

319

1640

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

165

3.44

14.32

1.6

0.77

1.42

ug/l

0.71

144

Infective bursitis

391

2.51

14.32

2.4

2.2

0.85

1.19

ug/l

0.55

351

Adenocarcinoma and ductal carcinoma of pancreas

109

492

2.34

14.31

2.1

1.9

2.20

1.82

ug/l

0.11

102

431

Conjunctivitis (acute, non atopic)

501

3455

1.46

14.29

2.0

1.9

1.17

2.20

ug/l

2.49

444

3055

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

108

4.10

14.23

2.5

1.8

11.34

3.81

ug/l

0.35

Cervicobrachial syndrome

413

2754

1.52

14.23

2.1

2.0

1.21

2.26

ug/l

2.29

370

2471

Emotional disorders starting during childhood or adolecense, excluding more controls

140

3.48

14.22

2.0

1.7

3.99

1.31

ug/l

0.61

115

Keratitis

685

5011

1.38

14.21

2.0

2.61

2.16

ug/l

0.43

622

4415

Insomnia

281

1717

1.66

14.19

2.3

2.0

1.76

2.17

ug/l

0.24

250

1539

Myocardial infarction, with ST-elevation

465

3188

1.49

14.17

2.1

1.9

1.66

2.44

ug/l

1.24

423

2757

Hypothyroidism, strict autoimmune, 3 medication purchases required

1724

9619

1.23

14.14

2.0

1.9

1.80

2.21

ug/l

1.16

1499

8446

Dissociative [conversion] disorders

290

2.70

14.07

2.3

2.0

1.10

2.37

ug/l

0.58

257

Other symptoms and signs involving general sensations and perceptions

100

436

2.39

14.06

1.9

1.8

0.64

1.35

ug/l

1.44

375

Other ill-defined and unspecified causes of mortality

179

972

1.91

14.05

2.2

1.8

2.13

2.54

ug/l

0.20

166

829

Use of biperiden

132

644

2.12

14.02

2.1

2.03

1.75

ug/l

0.12

118

577

Menorrhagia

617

2418

1.42

14.01

2.1

1.9

2.43

1.97

ug/l

0.37

512

2125

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

110

499

2.28

14.00

2.0

1.7

1.04

1.38

ug/l

0.24

434

Other specified/unspecified spondylopathies

311

2.68

13.96

1.8

2.1

1.48

2.23

ug/l

0.31

273

Other specified/unspecified bacterial intestinal infections

153

789

2.00

13.90

1.9

2.10

2.26

ug/l

0.07

136

693

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

150

767

2.01

13.89

2.0

1.7

1.04

1.64

ug/l

0.65

126

665

Moderate visual impairment, binocular

384

2.49

13.87

1.9

1.8

4.14

2.35

ug/l

0.35

318

Mental retardation, excluding more controls

287

2.68

13.84

1.9

2.1

2.00

2.43

ug/l

0.12

255

Encephalitis

300

2.69

13.83

2.4

2.2

0.68

2.35

ug/l

0.99

264

Presence of other devices

511

3576

1.45

13.81

2.2

1.8

2.31

2.41

ug/l

0.04

441

3107

Other aneurysm

152

787

2.01

13.76

2.3

1.9

1.23

2.88

ug/l

1.29

129

676

Melanocytic naevi

437

2966

1.49

13.76

2.2

1.9

2.35

1.75

ug/l

0.43

392

2594

Extrapyramidal and movement disorders

811

6124

1.34

13.75

2.0

1.9

1.84

2.22

ug/l

0.53

687

5387

Anterior Iridocyclitis

413

2778

1.51

13.73

2.1

2.0

1.59

2.35

ug/l

0.84

371

2462

Strabismus

483

3340

1.46

13.73

2.6

1.9

2.94

2.23

ug/l

0.48

412

2959

Syphilis

290

2.72

13.72

2.3

2.1

3.98

2.41

ug/l

0.35

259

Cholangitis (primary sclerosing, PSC), with reimbursement 202

154

3.43

13.68

1.9

1.7

1.48

1.22

ug/l

0.14

141

Focal brain injury

148

758

2.00

13.64

2.5

1.9

1.59

2.34

ug/l

0.50

119

673

Benign neoplasm: Rectum, anus and anal canal

474

3286

1.47

13.63

2.0

1.9

2.40

2.25

ug/l

0.09

425

2869

Acute and subacute iridocyclitis

391

2605

1.52

13.63

2.1

1.9

1.66

2.39

ug/l

0.74

350

2295

Benign lipomatous neoplasm

503

3516

1.45

13.63

2.0

1.9

2.52

1.97

ug/l

0.38

445

3080

Other misadventures during surgical and medical care

252

2.87

13.60

2.5

1.9

1.13

2.68

ug/l

0.66

224

Amenorrhoea

408

2.37

13.59

2.1

1.9

1.08

2.04

ug/l

1.02

362

Lesion of lateral popliteal nerve

126

612

2.13

13.58

2.7

2.0

3.41

2.63

ug/l

0.21

115

544

Pain associated with micturition

243

1450

1.71

13.57

2.1

1.9

1.42

1.86

ug/l

0.40

206

1270

Injuries to the wrist and hand

1994

12051

1.21

13.55

2.0

1.92

2.28

ug/l

0.69

1727

10680

Rheumatoid lung disease

5.83

13.55

2.6

1.8

2.69

5.56

ug/l

0.25

Spondylopathies in diseases classified elsewhere

157

3.49

13.51

1.8

2.0

1.10

3.48

ug/l

0.67

139

Arthropathic psoriasis

237

1408

1.72

13.46

2.2

2.0

1.90

2.38

ug/l

0.39

210

1274

343

2.58

13.38

2.5

1.8

1.19

2.30

ug/l

0.52

296

Acute pharyngitis

214

1225

1.76

13.36

2.1

2.42

2.08

ug/l

0.16

192

1106

Spontaneous rupture of synovium and tendon

192

1080

1.83

13.30

2.1

1.47

2.88

ug/l

1.25

170

959

Parkinson's disease, strict definition, excluding more controls

284

1738

1.63

13.27

1.9

1.8

2.10

2.29

ug/l

0.10

233

1544

Female infertility, associated with anovulation

369

2.42

13.26

2.0

1.9

2.98

1.61

ug/l

0.28

324

Ovarian cyst

597

2461

1.41

13.24

2.0

1.9

2.06

1.98

ug/l

0.06

509

2168

Iridocyclitis

453

3126

1.47

13.23

2.1

1.9

1.49

2.38

ug/l

1.20

408

2748

Personal history of certain other diseases

3.99

13.22

1.7

1.5

0.90

3.44

ug/l

0.43

Other/unspecified synovitis and tenosynovitis

237

1416

1.71

13.15

1.9

2.0

0.98

2.85

ug/l

3.25

217

1255

Irritable bowel syndrome

470

3268

1.45

13.10

2.0

1.9

1.90

2.15

ug/l

0.21

413

2872

Acute suppurative otitis media

354

2166

1.54

13.05

2.3

2.0

1.64

1.84

ug/l

0.14

317

1928

Adverse effects, not elsewhere classified

332

2156

1.56

13.00

2.2

2.0

1.29

2.23

ug/l

1.76

286

1913

Cervicalgia

403

2734

1.49

12.85

1.9

1.94

2.29

ug/l

0.31

358

2432

Other diseases of spinal cord

348

2.50

12.83

2.9

2.0

2.13

2.26

ug/l

0.03

312

Benign neoplasm: Sigmoid colon

429

2955

1.48

12.81

2.0

1.9

1.95

2.31

ug/l

0.35

386

2588

Malignant neoplasm of bladder

209

1222

1.77

12.79

1.8

3.09

2.78

ug/l

0.12

180

1053

Malignant neoplasm of kidney, except renal pelvis

238

1442

1.70

12.73

2.0

1.54

2.39

ug/l

0.86

215

1262

Polyuria

497

3519

1.43

12.71

1.9

2.0

1.47

2.07

ug/l

0.99

417

3118

Melanocytic naevi, other sites/unspecified

134

680

2.01

12.68

2.2

1.8

2.08

1.82

ug/l

0.14

129

594

Nonorganic sleeping disorders

322

2089

1.56

12.67

2.2

2.0

2.19

ug/l

0.00

286

1858

Other and unspecified disorders of white blood cells

104

483

2.24

12.64

3.0

1.8

2.48

1.91

ug/l

0.25

430

Disorders of psychological development

149

723

1.93

12.58

2.2

2.1

3.27

1.99

ug/l

0.59

126

635

Diplopia

284

1799

1.61

12.56

2.1

1.9

1.78

2.34

ug/l

0.28

253

1585

Other female pelvic inflammatory diseases

270

1687

1.62

12.52

2.3

1.9

2.30

1.89

ug/l

0.25

221

1500

Sequelae of injuries of neck and trunk

346

2.48

12.51

2.8

2.0

1.34

2.53

ug/l

0.66

307

Other endocrine disorders

426

2.27

12.50

2.0

1.90

2.32

ug/l

0.17

374

Benign neoplasm: Caecum

253

1565

1.66

12.48

2.2

1.9

1.32

2.51

ug/l

1.79

229

1370

Psoriatic arthropathies, ICD10

221

1317

1.71

12.46

2.2

2.1

1.83

1.90

ug/l

0.05

196

1180

Other psoriatic arthropathies

216

1280

1.73

12.44

2.2

2.0

1.86

1.94

ug/l

0.06

192

1146

Other follicular disorders

139

720

1.98

12.44

2.3

2.0

0.94

1.90

ug/l

1.25

121

652

Alzheimer’s disease (Atypical or mixed), excluding more controls

196

974

1.79

12.38

1.7

1.8

2.57

2.43

ug/l

0.04

147

835

Wet age-related macular degeneration

436

2980

1.47

12.33

1.8

2.68

2.56

ug/l

0.06

358

2521

Nummular dermatitis

190

1091

1.79

12.32

2.4

1.9

1.70

2.27

ug/l

0.41

175

966

Other encephalitis

288

2.62

12.31

2.5

2.2

0.73

2.40

ug/l

0.94

255

Mixed hyperlipidaemia

108

515

2.18

12.29

2.1

2.0

4.07

2.51

ug/l

0.49

456

Appendectomy

1176

9087

1.25

12.20

2.1

2.0

1.96

2.11

ug/l

0.20

1061

8045

Obsessive-compulsive disorder

403

2.30

12.19

1.8

2.0

1.64

2.24

ug/l

0.24

357

Paralytic strabismus

171

956

1.84

12.19

1.9

3.88

2.20

ug/l

0.49

143

843

Systemic sclerosis (FG)

237

2.79

12.18

2.1

1.20

1.02

ug/l

0.17

209

Dental pulpitis 3

114

387

2.14

12.17

2.2

1.9

3.51

1.93

ug/l

0.66

103

337

Pain in thoracic spine

273

1724

1.61

12.14

1.9

1.10

2.33

ug/l

2.34

248

1547

Other benign neoplasms of connective and other soft tissue

176

992

1.81

12.06

2.1

1.8

2.85

1.57

ug/l

0.72

159

860

Leiomyoma of uterus

624

2563

1.38

12.06

2.0

1.8

1.43

2.15

ug/l

1.50

527

2214

KRA_PSY_EATING, excluding more controls

373

2.33

11.95

2.2

1.8

2.24

2.02

ug/l

0.07

330

Injuries to unspecified part of trunk, limb or body region

206

1220

1.73

11.92

2.4

2.0

2.55

1.93

ug/l

0.31

177

1078

Oesophagitis

135

706

1.97

11.88

2.0

1.9

2.42

2.39

ug/l

0.01

119

622

Other disorders of the musculoskeletal system and connective tissue

310

2030

1.56

11.86

2.3

1.9

2.15

2.30

ug/l

0.07

273

1791

Squamous cell neoplasms and carcinomas of the skin

319

2107

1.55

11.84

1.9

1.8

1.29

2.53

ug/l

2.19

273

1798

Disorders of vestibular function (Vertigo)

965

7558

1.28

11.81

1.9

1.57

2.22

ug/l

1.74

814

6640

Non-small cell lung cancer, squamous

146

788

1.92

11.75

2.0

1.8

1.32

2.91

ug/l

1.04

131

678

Non-small cell lung cancer, squamous, helper endpoint

146

788

1.92

11.75

2.0

1.8

1.32

2.91

ug/l

1.04

131

678

Speech and linguistic disorders

119

569

2.04

11.72

2.4

2.0

3.38

2.20

ug/l

0.45

496

Benign neoplasm: Other and unspecified parts of small intestine

165

3.16

11.69

3.0

1.7

5.11

2.06

ug/l

0.56

141

Cachexia

5.97

11.67

2.0

1.6

1.78

0.60

ug/l

0.94

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

109

3.70

11.66

2.3

2.1

0.67

3.44

ug/l

0.60

102

Superficial injury of abdomen, lower back and pelvis

280

1800

1.58

11.57

1.9

2.0

2.92

2.43

ug/l

0.24

244

1591

Nail disorders

165

926

1.82

11.54

2.4

2.0

2.84

1.72

ug/l

0.59

150

829

Artificial joint re-operation

173

989

1.81

11.52

2.0

1.9

1.89

2.09

ug/l

0.11

147

872

L02BB Anti-androgens

267

1710

1.61

11.51

1.9

2.34

2.46

ug/l

0.04

237

1465

Migraine with aura

320

2116

1.53

11.50

2.0

1.9

2.11

2.17

ug/l

0.04

271

1882

Ill-defined and unknown causes of mortality

188

1101

1.76

11.50

2.2

1.8

2.08

2.51

ug/l

0.23

174

940

Thyroiditis, ILD-related definition

193

1132

1.73

11.50

1.9

2.0

9.40

1.99

ug/l

0.49

170

1002

Malignant neoplasm of oesophagus

362

2.40

11.46

2.3

2.0

0.86

2.28

ug/l

0.95

322

Lichen simplex chronicus

411

2.28

11.45

1.7

1.9

2.06

2.01

ug/l

0.02

363

Asthma mixed form (mode), excluding more controls

351

2.35

11.44

1.8

1.7

0.79

3.72

ug/l

1.54

293

Abnormal findings on examination of urine, without diagnosis

111

550

2.09

11.43

2.0

1.9

1.71

1.96

ug/l

0.13

101

489

Problems related to social environment

286

2.54

11.42

2.4

1.8

1.61

2.69

ug/l

0.39

246

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

4.17

11.41

2.6

1.7

1.86

2.10

ug/l

0.06

Open wound of forearm

195

1152

1.73

11.40

2.1

2.0

1.25

2.11

ug/l

0.69

166

1021

Myeloproliferative diseases (CML excluded)

190

1118

1.75

11.39

2.1

1.9

1.36

2.35

ug/l

0.92

168

976

Meningitis

111

550

2.08

11.36

2.4

2.1

1.01

1.82

ug/l

0.71

100

487

Malignant neoplasm of mesothelium and soft tissue

120

614

2.03

11.36

2.3

1.9

0.74

1.92

ug/l

1.30

111

535

Mental and behavioural disorders due to use of other stimulants, including caffeine

188

2.91

11.35

2.5

2.1

3.24

1.48

ug/l

0.64

174

Persistent mood disorders

357

2427

1.49

11.32

2.3

1.9

2.31

2.29

ug/l

0.01

314

2137

Other renal tubulo-interstitial diseases

200

2.86

11.31

2.3

1.7

2.84

2.72

ug/l

0.02

171

Use of pramipexole

474

3401

1.42

11.31

2.1

1.9

2.48

2.25

ug/l

0.16

412

2981

Pregnancy hypertension

525

3434

1.39

11.31

1.9

2.0

1.61

2.00

ug/l

0.55

470

3057

Pre-eclampsia

268

1715

1.58

11.22

1.9

2.0

1.78

1.85

ug/l

0.05

242

1534

6-mercaptopurine

190

2.87

11.12

1.6

2.0

1.44

1.14

ug/l

0.14

171

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

108

3.66

11.12

2.0

1.8

2.30

1.80

ug/l

0.10

Left bundle-branch block

151

836

1.85

11.09

2.1

1.8

2.22

2.14

ug/l

0.03

133

727

Dental pulpitis 4, only avohilmo

2385

10688

1.17

11.07

2.0

1.71

2.30

ug/l

2.54

2112

9378

L01XX Other antineoplastic agents

150

833

1.87

11.06

2.5

1.9

1.35

2.22

ug/l

0.59

133

728

Postprocedural endocrine and metabolic disorders, not elsewhere classified

192

1137

1.71

11.05

2.5

2.0

2.46

1.96

ug/l

0.23

172

1015

Hyperkinetic disorders, excluding more controls

401

2.21

11.04

1.7

2.0

1.77

1.47

ug/l

0.13

351

Right bundle-branch block

404

2.26

11.04

2.0

1.7

4.37

2.56

ug/l

0.46

359

Protein-energy malnutrition of moderate and mild degree

4.18

10.99

2.8

1.9

4.80

5.69

ug/l

0.06

Other mental disorders due to brain damage and dysfunction and to physical disease

266

1718

1.58

10.95

2.0

1.9

1.68

1.93

ug/l

0.23

225

1504

D07AA Corticosteroids, weak (group I)

256

1631

1.59

10.94

2.0

2.63

2.20

ug/l

0.16

226

1448

Mental disorders, not otherwise specified

134

716

1.91

10.93

2.2

2.0

1.81

1.82

ug/l

0.00

119

642

Oesophageal obstruction

100

486

2.14

10.93

2.4

1.9

1.00

2.46

ug/l

0.83

425

Generalized anxiety disorder

204

1231

1.68

10.88

2.2

2.0

2.99

1.83

ug/l

0.66

184

1091

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

103

506

2.10

10.84

2.0

1.7

2.36

1.78

ug/l

0.23

440

Other enthesopathies

540

3981

1.37

10.80

2.0

1.51

2.45

ug/l

1.77

469

3550

Intracerebral haemorrhage

301

2003

1.53

10.76

2.4

1.9

3.19

2.48

ug/l

0.21

247

1729

Benign neoplasm of other and unspecified endocrine glands

264

1707

1.58

10.76

2.3

2.0

2.50

2.33

ug/l

0.09

232

1521

Asthma and opportunity respiratory infection

118

612

2.00

10.74

2.6

1.9

1.26

2.54

ug/l

0.85

108

531

Cerebral cysts

116

596

2.00

10.73

2.9

1.9

1.87

1.84

ug/l

0.01

103

526

Urolithiasis

726

5602

1.31

10.68

2.0

2.58

2.20

ug/l

0.43

639

4957

Benign neoplasm of mouth and pharynx

197

1189

1.69

10.63

2.1

1.8

1.10

1.63

ug/l

0.74

167

1033

Bronchitis, not specified as acute or chronic

185

1099

1.72

10.62

2.3

2.0

3.64

2.68

ug/l

0.18

154

971

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

328

2.38

10.62

1.9

1.7

2.81

1.83

ug/l

0.27

288

Renal tubulo-interstitial disorders in diseases classified elsewhere

112

3.58

10.61

2.9

2.0

6.44

4.04

ug/l

0.17

Other/unspecified reactive arthropathies

142

783

1.86

10.60

2.1

0.99

1.85

ug/l

0.96

131

695

Medicines for HER+ breast cancer

617

4534

1.34

10.58

1.9

2.04

2.41

ug/l

0.31

531

3959

Benign neoplasm: Transverse colon

244

1562

1.60

10.51

2.3

1.9

1.68

2.46

ug/l

0.72

226

1370

Intentional self-harm by sharp object

163

2.98

10.51

2.1

1.9

4.77

2.50

ug/l

0.35

150

Malignant neoplasm of liver and intrahepatic bile ducts

100

495

2.12

10.48

2.0

1.9

1.25

2.18

ug/l

0.71

427

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

594

3893

1.34

10.43

1.9

2.0

1.75

2.36

ug/l

0.66

531

3454

Assault by bodily force

129

692

1.90

10.43

2.4

2.1

4.16

1.96

ug/l

0.56

114

634

Other and unspecified psoriasis

152

861

1.81

10.43

2.0

2.24

1.79

ug/l

0.25

133

766

Event of undetermined intent

122

645

1.94

10.37

2.4

2.1

1.70

1.74

ug/l

0.02

105

580

Benign neoplasm: Skin of other and unspecified parts of face

241

1542

1.60

10.33

1.9

1.26

2.40

ug/l

1.33

202

1333

Erythema multiforme

240

2.61

10.32

2.7

1.9

1.39

2.77

ug/l

0.46

211

Prurigo nodularis

308

2.42

10.30

2.0

1.8

3.36

2.44

ug/l

0.27

269

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

540

4001

1.36

10.30

1.9

2.0

1.31

2.01

ug/l

1.45

476

3562

Pre-eclampsia or eclampsia

287

1902

1.52

10.30

1.9

2.0

1.67

1.79

ug/l

0.09

261

1700

Open wound of hip and thigh

326

2.35

10.25

2.1

2.0

1.89

2.29

ug/l

0.12

290

Amyloidosis

248

2.59

10.21

2.6

1.9

1.07

3.23

ug/l

1.04

218

Complications of other internal prosthetic devices, implants and grafts

424

2.17

10.20

2.0

1.9

1.03

1.48

ug/l

0.49

373

Other diseases of upper respiratory tract

2457

11096

1.16

10.19

2.0

1.94

2.42

ug/l

1.02

2162

9750

Left hemicolectomy

336

2.36

10.16

2.4

2.0

2.37

2.15

ug/l

0.06

296

Alcohol withdrawal state with delirium

175

1041

1.73

10.14

2.3

2.0

3.03

2.16

ug/l

0.36

161

944

Clear cell adenocarcinoma of kidney

125

676

1.92

10.11

1.9

0.97

1.86

ug/l

1.00

113

601

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

288

1922

1.52

10.08

2.0

7.38

2.21

ug/l

0.51

256

1725

Ingrowing nail

110

568

1.99

10.06

2.4

2.1

2.69

1.75

ug/l

0.38

100

506

Systemic sclerosis

262

2.51

10.00

2.1

1.9

1.20

2.22

ug/l

0.44

237

Dental pulpitis 1, only avohilmo

2375

10729

1.16

10.00

1.9

2.0

1.71

2.29

ug/l

2.52

2100

9418

Impacted cerumen

222

1406

1.62

10.00

1.8

1.9

4.80

2.34

ug/l

0.40

138

1230

Follow-up examination after treatment for malignant neoplasms

214

1342

1.62

9.96

2.2

1.8

1.88

2.42

ug/l

0.37

179

1194

Symptoms and signs involving speech and voice

640

4902

1.32

9.95

2.1

1.9

2.22

2.27

ug/l

0.04

546

4309

Ulcerative colitis (strict definition, require KELA)

297

2001

1.50

9.93

2.0

7.21

2.20

ug/l

0.51

263

1799

Gingival hyperplasia

351

2.27

9.88

2.1

1.9

2.90

1.58

ug/l

0.57

316

Other overlap syndromes

187

2.81

9.87

2.0

1.9

2.75

2.71

ug/l

0.01

169

Benign neoplasm: Stomach

215

1356

1.62

9.85

2.0

2.72

2.50

ug/l

0.10

185

1191

Other and unspecified haemorrhagic conditions

165

2.94

9.84

1.8

0.50

2.58

ug/l

0.67

148

Mental retardation

344

2.27

9.82

1.9

2.0

2.00

2.21

ug/l

0.06

311

Radiculopathy

354

2476

1.45

9.81

2.0

1.9

5.66

2.39

ug/l

0.38

314

2180

Emotional disorders and disorders of social functioning with onset specific to childhood

211

2.61

9.81

2.0

1.7

3.66

1.36

ug/l

0.61

181

Dementia in Alzheimer disease

434

2683

1.41

9.80

1.6

1.8

3.17

2.33

ug/l

0.55

308

2266

malignant neoplasm of male genital organs

1081

5576

1.24

9.79

2.0

3.05

2.05

ug/l

0.95

930

4944

Any dementia

918

5171

1.27

9.77

1.8

1.9

2.88

2.28

ug/l

0.48

707

4482

Coxarthrosis, primary, with hip surgery

1065

8234

1.24

9.76

1.9

1.89

2.15

ug/l

0.33

921

7204

Allergic urticaria

144

818

1.79

9.71

2.1

0.76

1.73

ug/l

1.60

121

725

Systemic sclerosis, icd10

266

2.48

9.70

2.1

1.9

1.20

2.09

ug/l

0.38

242

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

343

2.28

9.60

2.1

1.8

2.14

1.92

ug/l

0.09

297

Other disorders of gingiva or/and edentulous alveolar ridge

107

557

1.97

9.60

2.2

1.9

2.25

1.45

ug/l

0.47

493

Asthma mixed form (mode)

379

2.18

9.60

1.8

0.79

3.42

ug/l

1.50

323

Primary coxarthrosis, bilateral

647

4995

1.31

9.59

1.9

2.47

2.20

ug/l

0.15

556

4359

Abnormalities of gait and mobility

266

1775

1.53

9.48

2.2

1.9

3.72

2.19

ug/l

0.43

228

1534

Monoarthritis, not elsewhere classified

463

2.07

9.47

1.8

2.1

2.22

1.27

ug/l

0.43

414

Benign neoplasm of meninges

174

1050

1.69

9.47

2.3

1.8

2.58

1.68

ug/l

0.50

137

906

Congenital malformations of trachea and bronchus

3.63

9.45

3.6

2.0

1.28

3.83

ug/l

0.42

Abnormal findings on diagnostic imaging of central nervous system

423

2.11

9.44

2.2

2.0

2.04

1.92

ug/l

0.04

377

Fracture at wrist and hand level

611

4680

1.32

9.43

2.1

2.0

2.49

2.21

ug/l

0.20

524

4174

Acquired absence of organs, not elsewhere classified

131

3.18

9.42

2.4

1.8

2.51

4.36

ug/l

0.33

115

Opening and dilatation of root channel of tooth

118

638

1.89

9.40

2.4

2.1

1.18

1.71

ug/l

0.43

102

576

Persons encountering health services for specific procedures, not carried out

126

695

1.85

9.38

2.1

1.8

2.85

2.26

ug/l

0.24

118

618

Pre-eclampsia or poor fetal growth

351

2459

1.43

9.37

1.9

2.0

1.83

1.89

ug/l

0.04

312

2190

Myositis

308

2.34

9.37

2.7

2.0

1.18

1.35

ug/l

0.07

271

Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)

4.35

9.34

2.2

1.9

2.91

2.17

ug/l

0.12

Idiopathic thrombocytopenic purpura

347

2.25

9.33

2.0

1.9

0.99

2.07

ug/l

0.62

310

Migraine without aura

227

1462

1.57

9.31

1.9

1.47

1.90

ug/l

0.32

200

1299

Visual field defects

191

1188

1.64

9.30

2.4

1.9

2.29

2.67

ug/l

0.15

155

1042

Ankylosing spondylitis

172

1040

1.68

9.29

2.1

2.0

0.99

2.29

ug/l

2.73

154

947

Endocrine disorders, other/unspecified

199

2.68

9.26

1.7

1.8

1.72

2.50

ug/l

0.19

180

Universal erythroderma, KELA reimbursement

171

2.85

9.26

1.9

2.1

0.93

1.98

ug/l

0.88

153

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

317

2195

1.46

9.25

2.0

6.79

2.38

ug/l

0.47

281

1966

Other benign neoplasms of skin

754

5958

1.28

9.23

2.0

1.9

1.78

2.30

ug/l

0.91

648

5223

Collapsed vertebra, not elsewhere classified

3.61

9.22

1.7

0.28

5.54

ug/l

1.01

Crohn disease (strict definition, all UC cases excluded)

502

2.00

9.20

1.7

2.0

1.78

1.67

ug/l

0.04

448

Specific development disorders of speech and language

409

2.08

9.19

2.5

1.9

3.01

2.57

ug/l

0.11

351

Mucosal proctocolitis

220

1415

1.58

9.18

2.1

2.0

7.46

2.28

ug/l

0.38

200

1272

Diffuse brain injury

368

2.18

9.15

3.4

1.9

2.42

1.74

ug/l

0.19

331

Toxic effects of substances chiefly nonmedicinal as to source

204

1293

1.60

9.10

2.1

2.0

1.67

2.17

ug/l

0.38

186

1167

Carcinoma in situ of other and unspecified digestive organs

287

2.37

9.10

2.0

1.8

1.55

1.75

ug/l

0.12

249

Parodontitis, under 40 years and operation codes

454

2.03

9.08

2.0

1.9

1.08

1.62

ug/l

0.61

394

Parodontitis, operation under 40 years and operation codes

454

2.03

9.08

2.0

1.9

1.08

1.62

ug/l

0.61

394

Striking against or struck by other objects

556

4231

1.32

9.03

2.1

1.49

2.27

ug/l

1.46

481

3767

Tuberculosis, IBD comorbidity

180

1113

1.66

9.00

2.1

1.8

4.15

2.15

ug/l

0.41

153

954

Redundant prepuce, phimosis and paraphimosis

392

2820

1.40

9.00

2.2

2.1

3.09

2.31

ug/l

0.39

348

2533

Dental caries 2, only avohilmo

887

8651

0.80

8.98

2.0

1.66

2.12

ug/l

0.93

777

7706

Impingement syndrome of shoulder

486

3637

1.35

8.96

2.2

2.0

2.88

2.48

ug/l

0.17

428

3260

Other symptoms and signs involving the urinary system

234

1539

1.55

8.95

1.9

3.91

2.04

ug/l

0.64

217

1358

L02BG Aromatase inhibitors

500

3758

1.34

8.95

1.9

2.09

2.05

ug/l

0.03

435

3302

Mental retardation, wide definition

398

2.11

8.93

1.9

2.0

2.16

2.02

ug/l

0.04

357

Otitis externa

395

2863

1.40

8.93

1.9

2.0

2.39

2.26

ug/l

0.09

332

2544

Benign neoplasm: Prostate

4.07

8.90

1.8

1.9

1.16

2.04

ug/l

0.37

Vascular syndromes of brain in cerebrovascular disorders

119

660

1.86

8.90

2.0

1.9

1.41

1.88

ug/l

0.21

106

582

Parodontitis, under 40 years

478

1.99

8.89

1.9

1.09

1.61

ug/l

0.62

417

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

322

2.27

8.88

1.7

1.6

3.29

1.82

ug/l

0.34

278

Personal history of other diseases and conditions

133

755

1.77

8.82

2.6

1.9

1.52

2.34

ug/l

0.60

112

670

Other and unspecified urticaria

315

2199

1.45

8.81

2.2

2.0

1.34

2.14

ug/l

1.10

269

1959

Volvulus

323

2.26

8.80

2.3

1.8

3.14

2.51

ug/l

0.16

272

Parodontitis, under 40 years, or operation codes

480

1.98

8.79

1.9

1.09

1.61

ug/l

0.61

419

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

582

4478

1.31

8.79

2.2

1.9

4.18

2.23

ug/l

0.36

505

3967

Migraine with aura and triptan purchases

190

1192

1.61

8.78

2.0

1.05

1.92

ug/l

1.19

161

1063

Hydrocephalus

179

1114

1.65

8.75

2.2

1.9

1.83

2.23

ug/l

0.21

151

960

Mixed disorders of conduct and emotions, excluding more controls

3.78

8.65

2.7

1.8

4.34

6.39

ug/l

0.14

Vitamin B12 deficiency anaemia

242

1616

1.53

8.62

1.9

3.86

2.22

ug/l

0.88

217

1381

Superficial injury of forearm

166

1015

1.66

8.60

1.7

2.1

1.31

1.83

ug/l

0.48

146

904

Coeliac disease

216

1406

1.56

8.60

2.1

1.9

2.20

2.16

ug/l

0.02

190

1248

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

460

2.02

8.59

2.1

1.8

1.02

1.69

ug/l

0.63

398

Panniculitis affecting regions of neck and back

405

2.08

8.58

2.5

2.1

2.40

2.15

ug/l

0.07

363

Dementia

994

5615

1.23

8.57

1.8

1.9

3.06

2.22

ug/l

0.83

774

4901

Other noninflammatory disorders of uterus, except cervix

413

2054

1.39

8.56

2.1

1.9

1.58

2.08

ug/l

0.66

357

1806

Diseases of inner ear

1106

8987

1.21

8.55

2.0

1.76

2.18

ug/l

0.90

934

7899

Sacroiliitis, not elsewhere classified

351

2.15

8.54

2.1

2.2

0.94

2.64

ug/l

1.16

320

Heartburn

180

1126

1.62

8.51

1.9

1.37

2.40

ug/l

0.92

141

984

Chronic hepatitis, not elsewhere classified

367

2.14

8.49

2.5

2.0

1.19

1.76

ug/l

0.31

326

therapeutic use

368

2.15

8.48

1.8

1.9

1.50

1.44

ug/l

0.03

333

Abnormal findings on antenatal screening of mother

378

2.09

8.45

2.2

2.0

2.97

1.68

ug/l

0.20

330

Sequelae of injuries of head

114

634

1.85

8.40

3.5

2.0

2.09

1.72

ug/l

0.12

571

Hypothermia

247

2.43

8.40

1.9

2.0

1.08

2.64

ug/l

0.67

217

conjunctival haemorrhage

170

1057

1.65

8.38

2.0

1.9

3.38

2.35

ug/l

0.30

153

931

Atopic dermatitis, strict definition with reimbursement

387

2737

1.38

8.32

2.0

1.31

2.24

ug/l

1.50

342

2437

Dementia, including avohilmo

1059

6035

1.22

8.31

1.8

1.9

2.97

2.20

ug/l

0.80

826

5273

Alcohol-induced acute pancreatitis

474

1.99

8.29

2.3

2.1

4.55

2.18

ug/l

0.71

430

Benign neoplasm: Adrenal gland

163

1006

1.66

8.28

2.1

2.0

2.36

1.60

ug/l

0.46

144

907

Mild mental retardation

210

2.51

8.27

1.8

2.0

2.75

2.51

ug/l

0.04

191

Generalized epilepsy

370

2.10

8.24

2.8

1.9

1.08

2.12

ug/l

0.66

327

Maltreatment syndromes

390

2.06

8.22

2.4

2.1

2.74

1.97

ug/l

0.21

348

Congenital malformations of the respiratory system

164

2.75

8.22

3.3

2.2

1.42

3.01

ug/l

0.44

153

Dislocation, sprain and strain of joints and ligaments at neck level

230

1534

1.52

8.16

2.0

1.82

2.02

ug/l

0.14

205

1376

Acne

114

636

1.81

8.15

2.0

2.1

2.09

1.98

ug/l

0.05

104

571

Malignant neoplasm of breast, HER-positive

570

4359

1.30

8.14

1.8

1.9

2.10

2.41

ug/l

0.23

488

3809

Other intracranial haemorrhages

459

2.00

8.04

2.1

1.8

3.45

2.41

ug/l

0.25

407

Hidradenitis suppurativa

288

2.24

8.04

2.0

2.1

1.54

2.00

ug/l

0.18

264

Benign neoplasm: Skin, unspecified

361

2.10

8.02

2.1

1.7

2.77

1.89

ug/l

0.29

319

Calculus of kidney and ureter

651

5149

1.28

8.02

2.0

2.63

2.21

ug/l

0.46

578

4550

129

752

1.75

7.99

2.0

1.8

2.94

3.14

ug/l

0.05

116

616

Examination and encounter for administrative purposes

479

1.95

7.98

2.1

1.9

1.22

3.33

ug/l

1.43

427

Abnormal involuntary movements

254

1743

1.48

7.91

2.0

1.9

1.49

2.19

ug/l

0.83

224

1530

Suppurative and unspecified otitis media

514

3490

1.31

7.89

2.2

2.0

1.31

2.22

ug/l

1.60

456

3086

Degenerative macular diseases

276

1928

1.46

7.89

1.9

1.84

2.27

ug/l

0.29

236

1663

Tuberculosis, wide

184

1183

1.59

7.88

2.1

1.9

4.05

2.11

ug/l

0.40

157

1018

Burns and corrosions of external body surface, specified by site

196

1277

1.56

7.83

1.9

2.1

2.27

2.12

ug/l

0.07

171

1147

Psoriasis (vulgaris), strict definition

345

2.13

7.83

1.9

2.0

2.68

2.11

ug/l

0.11

317

Benign neoplasm: Other and unspecified parts of small intestine

205

2.52

7.83

3.0

1.9

5.11

3.22

ug/l

0.27

182

Superficial injury of ankle and foot

176

1119

1.59

7.79

2.0

2.22

1.69

ug/l

0.28

159

1000

Isolated proteinuria

333

2.15

7.78

2.1

2.0

2.43

2.29

ug/l

0.04

296

Cauda equina syndrome

135

2.90

7.75

3.3

2.0

1.54

3.80

ug/l

0.54

127

Benign neoplasm: Cerebral meninges

151

928

1.66

7.75

2.2

1.8

2.64

1.60

ug/l

0.51

118

797

Fracture of forearm

987

7658

1.21

7.74

1.9

2.0

2.13

2.42

ug/l

0.33

856

6712

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

124

2.99

7.74

1.9

1.6

6.10

1.78

ug/l

0.88

111

Chronic laryngitis and laryngotracheitis

281

1974

1.44

7.74

2.0

1.9

1.43

2.40

ug/l

1.19

235

1743

Malignant neoplasm of anus and anal canal

4.33

7.72

2.0

1.6

6.13

6.81

ug/l

0.04

Emotional disorders starting during childhood or adolescence

202

2.44

7.70

2.0

1.8

3.99

1.45

ug/l

0.57

174

Dental caries 2

929

8837

0.82

7.70

2.0

1.61

2.13

ug/l

1.17

813

7874

Trochanteric bursitis

240

1637

1.49

7.70

2.0

1.9

0.82

2.22

ug/l

3.47

201

1442

Malignant neoplasm of prostate

1049

5505

1.21

7.69

2.0

3.06

2.07

ug/l

0.90

901

4876

Other disorders of patella

261

1807

1.46

7.69

2.0

1.46

1.87

ug/l

0.48

228

1640

Inflammatory disorders of male genital organs, not elsewhere classified

165

2.69

7.65

2.4

2.1

3.98

0.93

ug/l

0.74

146

Chronic myeloid leukaemia [CML], BCR/ABL-positive

109

3.15

7.64

2.6

1.9

1.86

4.82

ug/l

0.51

Barrett oesophagus

114

655

1.79

7.62

2.6

2.0

2.09

2.76

ug/l

0.29

101

580

Benign lipomatous neoplasm of other sites/unspecified

161

1012

1.62

7.56

1.9

1.8

0.89

1.58

ug/l

1.68

141

864

Other and unspecified hydrocephalus

227

2.40

7.54

2.9

1.9

0.63

2.60

ug/l

0.91

197

Adhesive capsulitis of shoulder

324

2345

1.40

7.50

2.0

2.97

2.44

ug/l

0.18

296

2071

Benign neoplasm: Descending colon

158

994

1.63

7.50

2.0

1.9

1.56

2.42

ug/l

0.72

143

876

Malignant neoplasm of skin

1410

9088

1.18

7.47

1.9

2.39

2.19

ug/l

0.22

1183

7964

Disorders of speech understanding and production

304

2.14

7.46

2.7

2.0

3.47

2.92

ug/l

0.11

256

Contact with and exposure to communicable diseases

386

2858

1.35

7.44

2.2

2.1

1.37

1.87

ug/l

0.82

350

2545

Disorders of vitreous body and globe

1015

8269

1.21

7.41

2.1

2.0

3.55

2.12

ug/l

0.49

901

7289

Enthesopathies of lower limb, excluding foot

371

2747

1.36

7.41

2.3

2.0

1.85

2.27

ug/l

0.37

322

2468

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

386

2.01

7.39

2.2

1.8

1.84

1.48

ug/l

0.26

339

Polycystic ovarian syndrome, broad definition

102

568

1.81

7.39

2.0

1.8

2.71

1.42

ug/l

0.31

503

Arthropathy in Crohn disease

3.47

7.39

1.9

1.6

3.26

1.66

ug/l

0.24

Assault by unspecified means

155

2.66

7.38

3.1

2.0

3.20

2.51

ug/l

0.10

144

Drug-induced acute pancreatitis

9.12

7.36

1.5

1.8

4.29

19.43

ug/l

—

Inguinal hernia

1304

7477

1.18

7.36

2.0

2.24

2.14

ug/l

0.10

1147

6645

Oxicams

596

2656

1.29

7.32

1.9

2.0

1.77

2.24

ug/l

0.60

520

2367

Malignant neoplasm of rectosigmoid junction

212

2.44

7.31

2.2

2.0

2.28

3.04

ug/l

0.16

183

Dental pulpitis 3, only avohilmo

352

1.90

7.28

2.0

2.94

2.23

ug/l

0.26

308

Parodontitis or/and operation codes

1282

6468

1.19

7.28

2.1

2.70

1.78

ug/l

1.13

1129

5745

Open wound of wrist and hand

779

6289

1.23

7.27

1.9

2.0

1.90

2.20

ug/l

0.31

682

5625

Other specified disorders of kidney and ureter

411

1.99

7.27

2.5

1.9

0.96

1.94

ug/l

0.69

362

Haemangioma, any site

127

759

1.70

7.27

2.1

1.8

0.89

1.72

ug/l

1.75

111

660

Other secondary coxarthrosis

411

1.99

7.26

2.6

2.0

2.20

2.00

ug/l

0.04

367

Foreign body in alimentary tract

115

671

1.76

7.26

2.6

1.9

1.43

2.42

ug/l

0.65

104

597

Primary biliary cholangitis (PBC)

199

2.45

7.25

2.4

1.9

1.01

1.10

ug/l

0.09

174

Hypermobility syndrome

354

2.04

7.23

2.0

2.1

0.93

2.09

ug/l

0.74

328

Oter anti-inflammatory and antirheumatic agents, non-steroids

586

2546

1.29

7.22

1.9

2.0

3.21

2.26

ug/l

0.66

508

2271

Carcinoma in situ of skin of upper limb, including shoulder

264

2.26

7.21

2.4

1.6

4.39

1.82

ug/l

0.51

222

Benign neoplasm of middle ear and respiratory system

144

892

1.64

7.20

1.9

1.8

4.26

1.59

ug/l

1.09

130

773

Hallux valgus (acquired)

598

3414

1.28

7.20

1.9

2.34

2.64

ug/l

0.16

508

3012

Other congenital malformations of the digestive system

408

1.97

7.20

2.5

1.9

1.50

2.12

ug/l

0.33

362

Perforation of tympanic membrane

191

1264

1.54

7.17

2.0

1.17

2.09

ug/l

0.99

168

1115

Other shoulder lesions

162

1033

1.59

7.16

2.0

2.1

1.78

2.08

ug/l

0.18

141

933

Hyperhidrosis

187

2.46

7.16

1.9

1.8

0.57

1.75

ug/l

1.13

166

Benign neoplasm of major salivary glands

170

1097

1.58

7.15

2.4

1.8

2.65

1.50

ug/l

0.58

150

942

Correction of physiology of bite - demanding therapy visit

112

650

1.75

7.15

2.0

2.1

2.27

1.77

ug/l

0.20

590

Impotence

131

797

1.69

7.14

2.2

2.0

5.67

2.58

ug/l

0.47

121

708

Other and unspecified injuries of head

119

704

1.73

7.13

1.9

2.1

2.61

1.73

ug/l

0.33

101

618

Viral encephalitis, not elsewhere classified/unspecified

220

2.37

7.11

2.2

2.0

0.69

3.01

ug/l

1.01

191

Bacterial, viral and other infectious agents

150

941

1.62

7.11

2.4

2.1

3.42

1.75

ug/l

0.32

137

847

Corneal ulcer

316

2299

1.39

7.10

2.0

3.20

2.45

ug/l

0.40

288

2038

Secondary parkinsonism

381

2.02

7.07

2.3

1.8

1.08

2.00

ug/l

0.55

337

Diseases of appendix

1389

10885

1.17

7.05

2.1

2.0

1.89

2.26

ug/l

0.66

1255

9653

Benign paroxysmal vertigo

554

4370

1.28

7.04

2.0

1.9

1.37

2.36

ug/l

2.41

476

3842

Suggestive for eosinophilic asthma

184

1214

1.54

7.03

1.9

2.0

1.36

2.64

ug/l

1.10

162

1083

Other salmonella infections

415

1.96

7.03

2.2

1.9

2.10

2.02

ug/l

0.03

365

Polyhydramnios

258

2.21

7.01

1.6

1.9

1.14

2.55

ug/l

0.60

224

Flat foot [pes planus] (acquired)

160

1023

1.59

7.00

2.0

1.9

2.01

1.55

ug/l

0.29

142

931

Postprocedural disorders of nervous system

103

587

1.78

6.99

2.1

2.0

0.64

1.87

ug/l

1.60

532

Chorioretinal inflammation

320

2.10

6.98

2.1

1.9

1.98

1.42

ug/l

0.18

292

Haemangioma and lymphangioma, any site

134

821

1.66

6.98

2.1

1.8

0.85

1.68

ug/l

1.91

117

711

Secondary parkinsonism+Parkinsonism in other disease

390

2.00

6.97

2.4

1.8

1.07

1.98

ug/l

0.56

346

Surgical ablation of atrial fibrillation

3.73

6.97

2.6

2.3

0.53

4.77

ug/l

0.56

Inflammatory disease of uterus

174

1133

1.55

6.96

2.2

1.9

2.74

1.69

ug/l

0.61

148

1002

Burns and corrosions

239

1663

1.46

6.95

2.0

2.67

2.11

ug/l

0.28

210

1488

Other disorders of optic [2nd] nerve and visual pathways

123

740

1.70

6.94

2.2

1.9

1.63

1.77

ug/l

0.08

104

660

Nonsuppurative otitis media

317

1993

1.38

6.93

2.1

2.0

2.39

2.30

ug/l

0.04

278

1767

Pyoderma

210

2.38

6.92

2.4

1.9

2.79

2.88

ug/l

0.01

184

Drug-induced hypoglycaemia without coma

198

2.43

6.92

2.3

1.9

3.11

3.08

ug/l

0.00

170

Diseases of middle ear and mastoid

931

6345

1.21

6.90

2.1

2.0

1.73

2.15

ug/l

0.71

820

5597

In situ neoplasms

702

5701

1.24

6.90

2.0

1.9

2.36

2.23

ug/l

0.09

601

4968

Gastrojejunal ulcer

144

2.71

6.89

3.5

1.9

2.10

3.25

ug/l

0.21

127

Appendicitis, broad definition

1371

10792

1.17

6.88

2.1

2.0

1.90

2.25

ug/l

0.63

1240

9577

Other and unspecified intracranial injuries

356

2.03

6.88

2.4

1.9

1.52

2.11

ug/l

0.24

311

Orthopaedic devices associated with adverse incidents

244

2.29

6.88

1.8

0.50

2.79

ug/l

1.16

210

Other keratitis

189

1259

1.52

6.87

1.9

2.0

2.71

1.90

ug/l

0.43

170

1120

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1248

8422

1.18

6.84

1.9

2.41

2.21

ug/l

0.21

1048

7351

Ankylosing spondylitis, ICD10

166

1077

1.57

6.84

2.1

0.99

1.83

ug/l

1.58

149

975

Other hammer toe(s) (acquired)

330

2281

1.37

6.81

1.9

1.8

1.19

2.22

ug/l

2.02

282

2009

Acne vulgaris

460

1.87

6.80

2.2

2.1

2.09

1.98

ug/l

0.03

415

Other disorders of conjunctiva

294

2136

1.40

6.76

2.2

1.9

2.89

2.55

ug/l

0.14

265

1888

Disorders of optic nerve and visual pathways

162

1049

1.57

6.73

2.2

2.0

1.36

2.07

ug/l

0.63

138

934

Dental caries 2 and operation codes

914

8684

0.83

6.72

2.0

1.60

2.12

ug/l

1.14

801

7739

Social phobias

549

1.79

6.72

2.9

2.1

2.99

2.12

ug/l

0.23

494

Achilles tendinitis

195

1315

1.50

6.71

2.4

2.0

2.60

2.59

ug/l

0.00

174

1200

Disorders of tooth development and eruption

334

2.01

6.70

2.6

1.9

3.49

1.38

ug/l

0.74

300

Abnormal serum enzyme levels

689

5537

1.24

6.67

2.1

2.0

3.32

2.12

ug/l

0.91

637

4892

Alzheimer’s disease, wide definition, excluding more controls

338

1695

1.37

6.66

1.8

3.29

2.62

ug/l

0.20

253

1499

Other extrapyramidal and movement disorders in other diseases

437

3372

1.31

6.66

2.0

1.9

1.63

2.28

ug/l

0.76

368

2953

Scleritis and episcleritis

108

635

1.73

6.64

2.4

2.1

1.30

1.93

ug/l

0.48

101

563

Faecal incontinence

158

1022

1.57

6.62

2.0

1.8

1.24

1.98

ug/l

0.62

137

882

Malignant neoplasm of stomach

127

783

1.67

6.60

2.0

1.9

3.53

2.41

ug/l

0.34

114

681

Cerebral aneurysm, nonruptured

165

1079

1.56

6.60

2.0

3.51

1.97

ug/l

0.64

143

973

Tuberculosis

158

1026

1.57

6.57

2.1

1.9

1.63

2.51

ug/l

0.44

135

880

Coxibs

648

2763

1.26

6.57

1.8

2.0

1.60

2.29

ug/l

1.18

551

2459

Disturbances of skin sensation

426

3278

1.31

6.56

2.1

1.9

1.38

2.08

ug/l

0.96

362

2919

Cardiomyopathy in other diseases

4.06

6.56

2.4

1.6

1.38

7.60

ug/l

0.60

Tuberculosis of other organs

288

2.13

6.55

1.9

8.86

2.13

ug/l

0.49

247

Other specified disorders of muscle

335

2.03

6.54

2.4

2.2

1.42

1.22

ug/l

0.12

293

Disorders of parathyroid gland, other and/or unspecified

3.33

6.53

1.8

11.20

4.76

ug/l

0.27

Embolic stroke with flimmer

315

2.07

6.51

2.0

1.7

2.74

2.27

ug/l

0.09

264

Personal history of malignant neoplasm

328

2.03

6.50

2.0

1.8

2.78

2.33

ug/l

0.12

294

Hemiplegia

108

640

1.72

6.48

2.0

1.9

2.81

1.62

ug/l

0.45

561

Eating disorders

126

774

1.64

6.46

2.1

2.0

2.52

1.85

ug/l

0.31

115

683

Sequelae of injuries of upper limb

176

1172

1.52

6.46

2.3

2.1

1.65

1.94

ug/l

0.19

154

1057

Rash and other nonspecific skin eruption

184

1237

1.51

6.46

2.3

1.9

1.94

2.08

ug/l

0.07

167

1091

Other and unspecified injuries of lower leg

121

739

1.66

6.43

2.0

0.92

1.81

ug/l

1.13

659

Other orthopaedic follow-up care

566

1.76

6.43

2.2

1.8

2.90

2.41

ug/l

0.15

499

Pilonidal cyst

127

785

1.64

6.41

2.0

1.13

1.98

ug/l

0.85

113

714

Carcinoma in situ of other and unspecified sites

459

1.87

6.40

2.0

1.7

1.16

1.91

ug/l

0.58

401

Superficial injury of shoulder and upper arm

205

1410

1.47

6.40

1.9

1.65

2.08

ug/l

0.27

162

1246

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

124

763

1.65

6.40

2.5

1.8

14.11

1.68

ug/l

0.53

107

660

Fall on same level involving ice and snow

1050

8921

1.18

6.38

2.0

2.44

2.14

ug/l

0.32

912

7853

Acetic acid derivatives and related substances

657

2756

1.25

6.34

1.8

2.0

2.62

2.27

ug/l

0.19

569

2453

Retinal vascular disorders

275

2001

1.40

6.32

1.9

1.46

2.25

ug/l

0.96

234

1727

Glaucoma

1215

9171

1.17

6.30

1.9

2.17

ug/l

0.00

1049

8017

TMD related operations

250

1787

1.41

6.29

2.0

3.80

1.99

ug/l

0.55

216

1623

Carcinoma in situ of oral cavity, oesophagus and stomach

3.88

6.22

1.8

2.0

3.06

2.52

ug/l

0.12

Pure hyperglyceridaemia

254

2.16

6.17

2.5

2.0

3.99

2.47

ug/l

0.30

223

Diseases of tongue

124

772

1.64

6.17

1.9

2.0

1.76

1.71

ug/l

0.02

113

689

Melanocytic naevi of trunk

167

1110

1.52

6.17

2.1

1.8

3.35

1.62

ug/l

0.58

150

970

Retinal vascular occlusion

270

1968

1.39

6.16

1.9

1.48

2.18

ug/l

0.81

230

1701

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

457

1.85

6.15

2.2

1.9

2.00

1.90

ug/l

0.02

398

Fissure and fistula of anal and rectal regions

419

3251

1.30

6.11

2.1

1.9

1.63

2.21

ug/l

0.71

363

2889

Other secondary gonarthrosis

115

706

1.67

6.10

2.1

2.0

0.89

1.31

ug/l

0.80

100

631

Benign neoplasm of thyroid gland

303

2.03

6.03

2.1

1.8

1.00

1.55

ug/l

0.59

263

Alzheimer’s disease (Late onset), excluding more controls

323

1604

1.36

6.03

1.8

3.49

2.31

ug/l

0.38

244

1414

Disorders of vitreous body

970

8058

1.19

6.02

2.1

2.0

3.57

2.12

ug/l

0.47

861

7111

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

216

2.23

6.01

1.9

2.2

1.40

2.60

ug/l

0.61

191

Background retinopathy and retinal vascular changes

271

2.11

5.99

2.3

1.8

3.08

1.50

ug/l

0.59

237

Bell's palsy

217

1529

1.44

5.99

2.3

1.9

5.87

2.10

ug/l

0.89

189

1357

Heart failure and hypertrophic cardiomyopathy

245

2.19

5.98

2.3

1.9

1.50

2.56

ug/l

0.39

215

Papilloedema, unspecified

211

2.25

5.96

1.6

1.9

0.99

2.57

ug/l

0.62

190

Otitis externa, unspecified

182

1243

1.48

5.92

2.0

2.85

2.06

ug/l

0.42

163

1118

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

569

6898

0.81

5.92

2.0

1.53

2.37

ug/l

1.01

493

6086

Ethmoidectomy

229

1633

1.42

5.91

1.9

2.0

2.20

2.44

ug/l

0.08

196

1480

Vascular dementia

194

1298

1.47

5.90

1.9

1.8

3.10

2.27

ug/l

0.38

146

1088

Endovascular or surgical operations to intracerebral aneurysms

126

797

1.61

5.90

2.2

2.0

1.95

1.96

ug/l

0.01

111

712

Injury of unspecified body region

142

923

1.57

5.89

2.3

2.0

1.98

2.06

ug/l

0.03

120

811

Excessive vomiting in pregnancy

557

1.73

5.89

1.9

2.0

2.13

2.55

ug/l

0.18

501

Other and unspecified mood [affective] disorders

505

1.76

5.88

2.1

2.28

2.00

ug/l

0.08

450

Third [oculomotor] nerve palsy

233

2.20

5.88

1.8

1.9

3.15

2.86

ug/l

0.06

205

Unspecified dementia

253

1654

1.40

5.87

1.7

1.8

4.57

2.36

ug/l

0.64

205

1406

TMD related pain

272

2.07

5.84

1.8

2.0

1.83

2.12

ug/l

0.08

246

Abnormal spermatozoa

297

2221

1.36

5.83

1.8

2.0

2.33

2.31

ug/l

0.01

267

1964

Acute nasopharyngitis (common cold)

185

1263

1.47

5.82

2.2

1.67

2.24

ug/l

0.39

166

1150

Central retinal artery occlusion

330

1.99

5.82

1.8

2.79

1.76

ug/l

0.37

277

Other congenital malformations of upper alimentary tract

3.23

5.82

3.3

1.9

1.56

4.83

ug/l

0.44

Other and unspecified injuries of ankle and foot

363

1.91

5.80

2.0

1.9

1.13

1.89

ug/l

0.41

325

Vascular dementia (undefined)

497

1.77

5.80

1.9

1.7

2.80

2.83

ug/l

0.01

404

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

227

2.19

5.80

1.9

1.8

2.02

1.75

ug/l

0.12

200

Disturbance of activity and attention

507

1.75

5.80

1.7

1.9

1.79

1.55

ug/l

0.10

454

Peritonsillar abscess

322

2428

1.34

5.80

1.9

2.0

2.46

2.17

ug/l

0.14

291

2177

Congenital malformations and deformations of the musculoskeletal system

113

693

1.64

5.80

2.9

2.1

1.78

2.18

ug/l

0.22

103

616

Carcinoma in situ of skin, other sites/unspecified

139

2.58

5.79

1.9

1.6

0.82

2.43

ug/l

0.89

115

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

193

1337

1.46

5.79

2.1

1.9

1.80

1.62

ug/l

0.14

163

1178

Simple and mucopurulent chronic bronchitis

571

1.72

5.75

2.1

1.9

1.83

3.40

ug/l

0.72

501

Tuberculosis of other organs, strict

345

1.95

5.74

1.8

1.9

7.96

2.34

ug/l

0.45

291

Injuries involving multiple body regions

372

1.90

5.74

2.8

2.0

3.08

2.14

ug/l

0.24

326

Allergic conjunctivitis

607

7292

0.82

5.73

2.0

1.47

2.32

ug/l

1.12

528

6445

Carcinoma in situ, bladder

432

1.84

5.72

2.0

1.7

1.22

1.98

ug/l

0.54

379

Benign neoplasm: Skin of eyelid, including canthus

247

1795

1.39

5.71

2.1

1.8

2.31

1.86

ug/l

0.28

211

1539

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

149

985

1.54

5.70

2.2

1.8

2.46

2.37

ug/l

0.03

128

864

Essential (haemorrhagic) thrombocythaemia

395

1.87

5.69

1.7

0.93

1.81

ug/l

1.27

346

Anoxic brain damage

178

2.36

5.66

2.6

2.0

0.91

1.72

ug/l

0.70

154

Benign neoplasm of ovary

226

1620

1.41

5.64

1.9

1.8

2.38

2.36

ug/l

0.01

200

1391

Other and unspecified visual disturbances

170

1159

1.49

5.63

2.0

1.50

2.26

ug/l

0.45

140

1031

Salpingitis and oophoritis

255

1866

1.38

5.62

1.8

2.0

2.56

1.78

ug/l

0.52

222

1676

FESS (DNB20)

217

1548

1.42

5.61

1.9

2.0

2.30

2.26

ug/l

0.01

184

1408

Benign neoplasm of male genital organs

237

2.14

5.61

1.9

1.7

1.23

1.95

ug/l

0.52

209

Symptoms and signs involving emotional state

263

2.06

5.61

1.8

1.9

2.47

1.53

ug/l

0.40

236

Other/unspecified enthesopathies, not elsewhere classified

168

1144

1.49

5.60

2.0

1.15

2.70

ug/l

2.00

146

1005

Mixed disorders of conduct and emotions

2.84

5.60

2.7

1.7

4.34

4.50

ug/l

0.01

Malignant neoplasm, without specification of site

472

1.79

5.59

2.1

1.8

1.72

2.22

ug/l

0.22

395

Basal cell carcinoma

1251

8668

1.16

5.58

1.9

2.50

2.18

ug/l

0.36

1053

7566

Bullous disorders

122

779

1.60

5.54

2.4

1.9

2.45

2.19

ug/l

0.10

106

677

911

7297

1.18

5.50

1.9

2.43

2.22

ug/l

0.15

799

6313

Other and unspecified abdominal hernia

549

1.72

5.49

2.2

1.9

1.00

2.01

ug/l

0.94

488

Superficial injury of wrist and hand

287

2147

1.35

5.49

1.9

2.0

2.04

2.13

ug/l

0.05

244

1912

Other strabismus

323

2451

1.32

5.48

2.9

2.0

2.39

2.44

ug/l

0.02

277

2175

Chondropathies

248

1816

1.38

5.47

1.7

2.0

2.32

1.85

ug/l

0.27

219

1639

Acute nephritic syndrome

246

2.10

5.47

2.7

1.8

5.86

2.50

ug/l

0.63

220

Early lumbar disc prolapse, operated

115

723

1.61

5.46

2.2

1.58

2.16

ug/l

0.29

102

670

Viral meningitis

314

1.95

5.46

1.8

2.1

1.09

2.16

ug/l

0.55

287

Glaucoma suspect

717

5990

1.21

5.42

2.0

2.19

2.29

ug/l

0.09

636

5256

Lesion of radial nerve

439

1.80

5.39

2.0

1.9

2.20

2.01

ug/l

0.06

387

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

194

1367

1.43

5.38

2.1

1.8

2.97

1.49

ug/l

0.54

173

1196

Nonpyogenic thrombosis of intracranial venous system

2.97

5.37

1.9

2.2

1.30

4.24

ug/l

0.44

Cluster headache, wide

345

1.89

5.34

2.2

1.9

2.93

1.64

ug/l

0.45

309

Adenocarcinoma of pancreas

391

1.85

5.32

1.7

1.9

3.29

2.02

ug/l

0.27

340

Other noninflammatory disorders of vagina

118

753

1.59

5.31

2.0

1.9

4.17

1.95

ug/l

0.40

672

1299

0.58

5.29

2.4

1.9

3.13

2.45

ug/l

0.30

1149

Inflammatory diseases of prostate (prostatitis)

276

2071

1.35

5.27

2.0

2.1

1.41

2.35

ug/l

1.38

236

1851

Migraine without aura and triptan purchases

175

1213

1.45

5.27

1.9

2.0

1.70

1.90

ug/l

0.10

152

1083

Fall on and from stairs and steps

458

3666

1.26

5.27

2.2

1.9

1.87

2.19

ug/l

0.27

387

3221

Hydrocele

259

1926

1.36

5.25

2.1

2.0

4.28

2.49

ug/l

0.55

225

1705

Toxic liver disease

158

2.37

5.24

1.7

1.8

1.64

3.66

ug/l

0.51

144

Glaucoma secondary to other eye disorders

557

1.69

5.22

2.1

1.9

2.37

1.66

ug/l

0.25

482

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

3.71

5.20

2.1

1.6

1.03

1.46

ug/l

0.28

Other and unspecified follicular disorders

429

1.79

5.20

2.6

2.0

0.48

2.12

ug/l

1.65

382

Pemphigoid

372

1.86

5.20

2.3

1.7

0.78

3.46

ug/l

1.29

318

Synovial cyst of popliteal space [Baker]

141

943

1.52

5.18

1.9

2.0

1.55

2.59

ug/l

0.71

127

831

Cluster headache, strict

313

1.92

5.18

2.3

1.9

3.03

1.57

ug/l

0.48

281

Cyst of kidney

148

1002

1.51

5.17

2.0

1.9

1.05

2.78

ug/l

1.90

132

888

Unspecified chronic bronchitis

482

1.74

5.17

2.8

1.9

1.49

3.15

ug/l

0.75

414

Fibroblastic disorders

470

3783

1.25

5.16

1.9

2.52

2.34

ug/l

0.09

406

3329

Other injuries of spine and trunk, level unspecified

3.05

5.15

2.0

1.03

4.48

ug/l

0.49

Acute appendicitis

1246

10286

1.15

5.15

2.1

2.0

1.98

2.30

ug/l

0.48

1133

9145

Malignant neoplasm of brain

372

1.85

5.14

2.1

1.9

0.73

2.01

ug/l

0.75

334

Unspecified event, undetermined intent

252

2.04

5.12

2.3

1.9

1.29

2.65

ug/l

0.56

226

Other peripheral vascular diseases

140

937

1.52

5.12

2.0

1.9

1.86

2.20

ug/l

0.15

128

818

Myocardial infarction, unclassifiable

548

4001

1.23

5.11

2.0

1.9

1.72

2.43

ug/l

1.32

480

3407

Allergic purpura

308

1.93

5.10

2.1

1.8

1.58

2.28

ug/l

0.22

269

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

135

2.47

5.10

1.9

1.6

1.33

1.57

ug/l

0.13

117

Other otitis externa (chronic)

120

779

1.57

5.08

2.0

2.11

2.23

ug/l

0.04

694

Other menopausal disorders

251

1945

0.74

5.07

1.8

1.9

1.98

1.96

ug/l

0.01

212

1737

Alzheimer’s disease (Atypical or mixed)

204

1467

1.41

5.06

1.6

1.7

2.51

2.36

ug/l

0.05

151

1210

Eating disorder

512

1.69

5.06

2.2

1.9

2.24

2.14

ug/l

0.03

455

Inflammatory disease of cervix uteri

105

661

1.61

5.05

1.8

2.0

2.48

1.83

ug/l

0.22

577

Basal cell carcinoma, including avohilmo

1271

8781

1.15

5.03

1.9

2.49

2.16

ug/l

0.37

1071

7672

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

289

1.96

5.03

1.9

1.8

2.12

1.47

ug/l

0.37

257

Disorder of external ear, unspecified

390

1.82

5.02

1.9

2.0

6.05

1.94

ug/l

0.52

356

Scoliosis

122

796

1.55

5.00

2.3

2.0

4.14

2.40

ug/l

0.38

102

710

Carcinoma in situ of skin of scalp and neck

299

1.94

4.94

1.9

1.7

1.35

2.00

ug/l

0.47

257

Burn and corrosion of trunk

341

1.87

4.93

1.9

2.0

3.05

2.08

ug/l

0.21

308

Malignant neoplasm of head and neck

180

1277

1.43

4.92

2.0

1.61

2.45

ug/l

0.57

157

1117

Other abnormal findings in urine

196

2.18

4.91

1.9

0.45

3.30

ug/l

1.17

168

Benign neoplasm: Endocrine pancreas

3.37

4.90

2.4

1.9

8.81

2.66

ug/l

0.53

Prepatellar bursitis

621

1.63

4.90

2.2

2.1

1.10

2.30

ug/l

1.15

561

Pain and other conditions associated with female genital organs and menstrual cycle

223

1566

1.37

4.90

2.1

1.9

7.36

1.81

ug/l

0.41

196

1412

Abnormal blood-pressure reading, without diagnosis

422

1.76

4.87

2.3

2.0

1.15

1.20

ug/l

0.03

371

Benign neoplasm: other/unspecified salivary gland

278

1.96

4.87

2.5

1.7

4.41

2.05

ug/l

0.37

247

Subjective visual disturbances

410

3273

1.26

4.86

2.2

1.9

2.81

2.22

ug/l

0.20

345

2894

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

105

667

1.60

4.86

2.5

1.9

16.68

1.77

ug/l

0.54

577

Obstructive hydrocephalus

164

2.28

4.83

2.3

1.8

0.20

3.20

ug/l

1.11

147

Fracture of neck

125

830

1.54

4.83

2.3

1.9

1.60

1.71

ug/l

0.07

114

731

Pustular psoriasis

515

1.68

4.81

2.4

2.0

1.46

1.87

ug/l

0.21

455

Effects of foreign body entering through natural orifice

418

3351

1.26

4.78

2.2

2.1

2.86

2.38

ug/l

0.21

367

2995

Benign neoplasm: Other and unspecified parts of mouth

330

1.86

4.76

2.0

1.7

1.15

1.44

ug/l

0.16

286

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

165

2.26

4.76

2.0

1.6

1.65

2.36

ug/l

0.27

139

Postmenopausal bleeding

478

2119

1.25

4.73

1.9

1.83

2.08

ug/l

0.24

406

1867

Ulcerative colitis (strict definition, all Crohn cases excluded)

229

1698

1.36

4.73

2.0

1.20

2.29

ug/l

1.54

202

1520

Dronedarone medication

346

1.84

4.73

1.9

1.7

1.55

2.74

ug/l

0.51

312

Benign neoplasm: Brain, supratentorial

127

2.44

4.73

2.7

1.6

1.73

ug/l

0.00

113

Neovascular glaucoma

557

1.65

4.72

2.1

1.9

2.43

1.72

ug/l

0.24

476

Haemorrhage in early pregnancy

317

2399

1.30

4.71

1.8

2.0

1.29

2.01

ug/l

0.90

271

2150

Other specified/unspecified soft tissue disorders

581

1.63

4.67

2.3

2.0

1.11

1.38

ug/l

0.27

485

Benign neoplasm: Liver/bile ducts

179

2.17

4.66

2.2

1.8

4.61

1.32

ug/l

0.44

160

Benign neoplasm: Ascending colon

269

2052

1.33

4.66

2.1

1.9

1.82

2.40

ug/l

0.62

240

1800

Vertigo of central origin

180

2.19

4.66

1.8

1.9

1.25

3.54

ug/l

0.71

156

Melanocytic naevi, other sites/unspecified

134

908

1.50

4.66

2.2

2.0

2.08

1.77

ug/l

0.15

129

806

Hyperfunction of pituitary gland

428

1.73

4.65

2.6

2.0

1.10

1.84

ug/l

0.42

377

Other benign neoplasms of uterus

582

1.63

4.64

1.9

1.6

3.16

1.38

ug/l

0.58

484

Benign neoplasm of other and unspecified female genital organs

348

1.81

4.60

2.1

1.8

4.05

1.57

ug/l

0.60

294

Mouth breathing

741

6303

1.18

4.57

2.1

2.0

2.46

2.12

ug/l

0.22

657

5645

Carcinoma in situ of other and unspecified digestive organs

374

1.80

4.54

2.0

1.9

1.55

2.51

ug/l

0.50

327

Benign neoplasm of brain and other parts of central nervous system

100

640

1.59

4.53

2.2

1.7

2.24

1.74

ug/l

0.36

556

Other disorders of penis

188

1364

1.40

4.52

2.2

2.1

1.22

2.74

ug/l

1.94

155

1208

Procreative management

426

2897

1.25

4.52

2.2

2.1

1.97

1.94

ug/l

0.02

378

2606

Vascular dementia (mixed)

196

2.12

4.51

2.0

1.8

4.74

2.90

ug/l

0.30

172

Benign neoplasm: Parotid gland

125

841

1.51

4.51

2.2

1.8

3.01

1.67

ug/l

0.47

109

724

Benign neoplasm: Prostate

107

2.62

4.49

1.8

2.2

1.16

2.37

ug/l

0.50

Injury of muscle and tendon at lower leg level

276

2122

1.31

4.49

2.2

2.0

2.53

2.27

ug/l

0.12

248

1925

Benign neoplasm: Rectosigmoid junction

472

1.69

4.48

2.0

1.7

1.63

1.56

ug/l

0.03

405

Brachial plexus disorders

131

890

1.49

4.48

1.7

2.0

1.64

1.93

ug/l

0.11

117

809

Sudden idiopathic hearing loss

195

1426

1.39

4.48

2.2

1.9

1.18

2.63

ug/l

1.94

157

1264

Other congenital malformations

116

768

1.53

4.48

2.3

2.1

1.66

1.68

ug/l

0.01

103

688

Pustulosis palmaris et plantaris

449

1.70

4.47

2.3

2.0

1.63

1.97

ug/l

0.15

403

Manic episode

279

1.90

4.47

1.9

2.1

2.70

2.42

ug/l

0.05

249

Urethral stricture

134

919

1.49

4.45

2.0

1.9

1.87

2.89

ug/l

0.46

113

806

Infections with a predominantly sexual mode of transmission

367

2919

1.26

4.45

2.1

2.0

2.05

1.74

ug/l

0.26

317

2607

Carcinoma in situ of skin of other and unspecified parts of face

154

1084

1.45

4.45

1.6

1.7

2.78

2.07

ug/l

0.15

132

900

Benign neoplasm: Larynx

338

1.82

4.44

1.8

1.7

3.08

1.76

ug/l

0.45

297

Benign neoplasm: Kidney

346

1.80

4.42

2.0

1.8

4.24

1.82

ug/l

0.52

300

Injury of urinary and pelvic organs

246

1.97

4.40

2.2

1.9

2.61

2.76

ug/l

0.03

217

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

2.64

4.40

2.5

1.7

0.40

1.71

ug/l

1.44

Malignant neoplasm of eye, brain and central nervous system

521

1.65

4.39

1.9

2.0

0.93

1.86

ug/l

0.63

458

Other appendicitis

148

1036

1.45

4.37

2.4

2.0

1.04

2.07

ug/l

1.45

127

933

Allergic contact dermatitis

192

1404

1.38

4.36

2.1

1.9

1.34

2.11

ug/l

1.09

172

1253

Otitis media, unspecified

136

860

1.47

4.34

2.3

2.0

1.42

1.89

ug/l

0.25

119

764

Retinal detachments and breaks

697

5935

1.18

4.34

1.9

2.0

1.32

1.98

ug/l

1.72

605

5223

Complex cardiac defects

4.04

4.32

2.0

2.7

2.04

2.23

ug/l

0.05

Golimumab

268

1.90

4.31

1.7

2.1

0.33

2.04

ug/l

1.05

249

Gestational [pregnancy-induced] hypertension

265

2030

1.31

4.30

1.9

2.0

1.36

1.96

ug/l

0.74

231

1808

Other and unspecified primary disorders of muscles

2.88

4.29

1.7

2.2

2.22

4.26

ug/l

0.22

Other benign neoplasms of connective and other soft tissue

176

1277

1.40

4.25

2.1

2.0

2.85

2.13

ug/l

0.31

159

1133

Ulcerative rectosigmoiditis

135

934

1.46

4.25

2.0

2.1

11.30

1.95

ug/l

0.46

127

837

Benign neoplasm of bone and articular cartilage

109

722

1.53

4.24

2.0

1.9

0.86

1.73

ug/l

1.74

633

Single spontaneous delivery

455

2959

0.81

4.23

1.9

1.40

2.79

ug/l

1.64

405

2569

Other inflammation of eyelid

226

1706

1.34

4.22

2.3

1.9

1.64

2.24

ug/l

0.45

196

1499

Endometriosis of rectovaginal septum and vagina

119

804

1.50

4.22

2.1

1.9

3.29

2.10

ug/l

0.29

104

719

Mixed conductive and sensorineural hearing loss

241

1839

1.33

4.19

2.1

1.9

1.22

2.67

ug/l

2.30

207

1618

Algoneurodystrophy

278

1.87

4.19

2.0

2.1

3.10

2.10

ug/l

0.17

255

Sixth [abducent] nerve palsy

451

1.68

4.19

1.7

1.8

3.31

2.05

ug/l

0.26

404

Ehlers-Danlos syndrome

3.08

4.18

2.2

1.6

1.01

1.47

ug/l

0.19

Calculus of lower urinary tract

128

884

1.48

4.15

2.1

1.9

2.79

3.15

ug/l

0.13

112

769

Open wound of shoulder and upper arm

195

2.06

4.15

1.7

1.9

2.04

1.74

ug/l

0.12

175

Nontoxic multinodular goitre

357

2864

1.26

4.15

1.9

2.30

2.48

ug/l

0.08

318

2507

Skin changes due to chronic exposure to nonionizing radiation

849

6970

1.16

4.14

1.9

2.57

2.20

ug/l

0.28

740

6017

Other diseases of gallbladder

545

1.61

4.13

2.6

1.9

7.74

1.59

ug/l

0.65

471

L02BA Anti-estrogens

246

1884

1.32

4.13

1.8

2.0

1.51

1.84

ug/l

0.28

213

1656

Generalized epilepsy, mode (most common among epilepsy diagnosis)

265

1.88

4.13

2.4

1.8

0.90

2.50

ug/l

0.78

233

Benign neoplasm of urinary organs

498

1.64

4.13

1.9

1.8

3.42

1.53

ug/l

0.52

434

Benign neoplasm: Liver

155

2.18

4.11

1.8

5.33

1.45

ug/l

0.43

140

Carcinoma in situ of skin of trunk

370

1.75

4.10

2.1

1.7

1.25

2.03

ug/l

0.57

312

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

241

1844

1.32

4.10

1.8

1.80

1.67

ug/l

0.07

205

1587

Arthropathy in ulcerative colitis

117

2.39

4.09

2.5

1.8

0.31

1.26

ug/l

1.40

106

Brain meningioma, excluding all cancers (controls excluding all cancers)

491

1.64

4.09

2.1

1.8

3.19

1.52

ug/l

0.48

420

Metatarsalgia

148

1050

1.43

4.07

2.1

2.0

2.17

2.13

ug/l

0.01

129

935

Exposure to smoke, fire and flames

282

1.86

4.05

2.1

2.70

2.68

ug/l

0.00

251

Molar incisor enamel hypoplasia

102

2.43

4.05

2.9

1.7

7.30

1.96

ug/l

0.62

Viral agents as the cause of diseases classified to other chapters

225

1.96

4.04

2.3

2.0

1.88

2.71

ug/l

0.21

205

Other disorders of eyelid

896

7553

1.15

4.04

2.1

1.9

2.57

2.14

ug/l

0.31

780

6584

Cushing syndrome

118

2.38

4.04

2.3

1.8

3.74

3.62

ug/l

0.01

108

Episcleritis

532

1.60

4.03

2.4

2.1

1.38

2.03

ug/l

0.40

475

Actinic keratosis

829

6834

1.16

4.03

1.9

2.60

2.22

ug/l

0.29

721

5897

Lyme disease

291

3681

0.78

4.03

2.0

0.92

2.25

ug/l

5.00

251

3278

Other enthesopathy of foot (+metatarsalgia)

155

1111

1.41

4.02

2.1

2.0

2.08

2.04

ug/l

0.02

135

991

Other coagulation defects

115

781

1.49

4.01

2.7

1.9

1.67

2.11

ug/l

0.22

685

Wilms' tumor, excluding all cancers (controls excluding all cancers)

3.04

4.00

2.2

1.8

3.05

2.76

ug/l

0.06

Other erythematous conditions

395

1.71

3.99

1.9

2.0

2.25

2.07

ug/l

0.05

350

Sequelae of tuberculosis

270

1.87

3.97

1.8

1.02

2.84

ug/l

0.84

219

Undefined dementia

252

1791

1.31

3.96

1.7

4.57

2.54

ug/l

0.57

205

1464

Hyperkinetic disorders

572

1.56

3.96

1.7

2.0

1.77

1.74

ug/l

0.01

517

Demyelinating diseases of the central nervous system

118

807

1.48

3.96

1.9

2.1

2.10

1.67

ug/l

0.16

727

Carcinoma in situ of skin of upper limb, including shoulder

330

1.79

3.95

2.4

1.8

4.39

2.32

ug/l

0.36

283

Ocular pain

123

849

1.47

3.95

2.1

2.0

1.99

1.67

ug/l

0.17

104

756

Congenital malformations of cardiac septa

624

1.54

3.94

2.4

2.0

2.43

1.75

ug/l

0.26

550

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

498

4155

1.21

3.94

2.2

2.0

1.26

2.22

ug/l

1.90

427

3692

Family history of malignant neoplasm

128

890

1.45

3.93

2.1

1.9

1.90

2.26

ug/l

0.20

112

798

Toxic effect of ethanol

420

1.67

3.90

2.2

2.11

1.92

ug/l

0.06

380

Other injuries of upper limb, level unspecified

101

2.47

3.90

3.6

2.1

4.15

2.10

ug/l

0.29

Tongue abnormality

112

763

1.49

3.89

1.7

2.0

1.75

ug/l

0.00

103

672

Malignant melanoma, excluding all cancers (controls excluding all cancers)

285

2247

1.28

3.87

1.8

1.70

1.73

ug/l

0.02

241

1945

Beningn neoplasm: Meninges, unspecified

153

2.16

3.86

2.2

1.8

1.74

1.35

ug/l

0.13

135

Maternal care for known or suspected fetal abnormality and damage

819

0.58

3.86

2.1

3.79

1.82

ug/l

0.23

725

Other diseases of peritoneum

547

1.58

3.85

2.1

2.0

2.16

1.74

ug/l

0.13

481

Torticollis

133

2.23

3.85

1.6

1.9

0.54

3.98

ug/l

0.96

121

Infectious mononucleosis

546

1.57

3.81

2.1

1.60

1.68

ug/l

0.04

494

Carcinoma in situ of skin of ear and external auricular canal

175

2.08

3.80

1.8

1.6

3.33

2.03

ug/l

0.33

145

Malignant neoplasm of other connective and soft tissue

311

1.79

3.80

2.3

1.8

0.93

2.31

ug/l

0.67

275

Other disorders of central nervous system

115

2.34

3.79

2.4

2.0

0.72

3.47

ug/l

0.60

104

Occupational exposure to risk-factors

456

1.64

3.78

1.7

2.0

1.69

2.42

ug/l

0.26

416

Carcinoma in situ of oral cavity, oesophagus and stomach

2.78

3.77

1.8

2.2

3.06

0.79

ug/l

1.02

Colitis due to radiation

149

2.19

3.76

2.1

3.41

4.09

ug/l

0.09

127

Dental caries 1 and operation codes, only avohilmo

464

2808

0.83

3.76

1.9

2.2

1.93

2.20

ug/l

0.16

411

2486

Respiratory tuberculosis, confirmed and not-confirmed

124

868

1.45

3.76

2.0

1.9

1.97

2.29

ug/l

0.11

107

746

Respiratory tuberculosis

124

868

1.45

3.76

2.0

1.9

1.97

2.29

ug/l

0.11

107

746

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

2.73

3.73

2.3

1.7

0.56

2.07

ug/l

1.07

Other obstetric conditions, not elsewhere classified

248

1242

1.30

3.72

1.7

2.0

0.90

1.87

ug/l

2.36

207

1106

Dementia in other diseases classified elsewhere

641

1.53

3.71

2.3

1.9

2.30

2.34

ug/l

0.01

563

Urethritis and urethral syndrome

225

1.91

3.70

2.2

2.1

0.54

1.44

ug/l

1.18

200

Cervicocranial syndrome

171

1266

1.36

3.68

2.1

1.9

1.09

2.08

ug/l

1.76

152

1138

Burn and corrosion of hip and lower limb, except ankle and foot

240

1.88

3.67

2.0

2.1

2.48

2.76

ug/l

0.05

209

Nephropathy induced by other drugs, medicaments and biological substances

6.04

3.67

2.1

1.4

0.46

1.03

ug/l

—

Carcinoma in situ of skin, other sites/unspecified

171

2.08

3.67

1.9

0.82

3.39

ug/l

0.78

145

Hypoplasia of dental enamel , including avohilmo

2.40

3.64

2.4

1.7

7.59

2.07

ug/l

0.56

Other spirochaetal diseases

299

3719

0.80

3.62

2.0

1.16

2.24

ug/l

2.84

259

3313

Other superficial mycoses

220

1.91

3.61

2.8

1.9

2.86

2.07

ug/l

0.19

204

Other rupture of muscle

2.94

3.60

2.2

1.7

0.81

2.61

ug/l

0.53

Bacterial meningitis

400

1.66

3.57

2.7

2.1

1.36

2.03

ug/l

0.34

359

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

477

1.59

3.55

2.6

2.0

2.57

1.96

ug/l

0.20

429

Benign neoplasm: Pituitary gland, craniopharyngeal duct

455

1.60

3.53

2.5

1.7

2.98

1.58

ug/l

0.64

403

Femoral hernia

616

1.52

3.52

2.2

2.0

2.57

2.45

ug/l

0.04

549

Cysts of oral region, not elsewhere classified

504

1.57

3.50

2.1

2.0

3.62

1.12

ug/l

1.14

451

Atypical facial pain

528

1.56

3.49

1.7

1.9

0.97

2.01

ug/l

0.72

467

Memory loss

1407

0.68

3.48

2.4

1.9

0.79

2.14

ug/l

2.70

1237

Malignant neoplasm of small intestine

290

1.78

3.47

2.0

1.9

3.43

2.82

ug/l

0.09

254

Unspecified/other endometriosis

640

1.50

3.46

2.2

1.9

1.39

1.83

ug/l

0.28

567

Inflammatory disorders of breast

481

1.58

3.45

2.0

1.9

1.35

2.13

ug/l

0.49

423

Squamous cell neoplasms and carcinoma of cervix, excluding all cancers (controls excluding all cancers)

3.22

3.42

2.1

1.6

4.81

1.21

ug/l

0.65

Benign neoplasm of mouth and pharynx

197

1509

1.32

3.41

2.1

2.0

1.10

2.34

ug/l

1.74

167

1337

Benign neoplasm of meninges

174

1310

1.34

3.41

2.3

1.9

2.58

1.91

ug/l

0.33

137

1147

Chondrocostal junction syndrome [Tietze]

382

1.65

3.40

1.5

2.0

2.09

2.04

ug/l

0.01

337

Impetigo

366

1.66

3.40

1.9

2.0

3.19

1.92

ug/l

0.27

327

Other and unspecified mononeuropathies of upper limb

344

1.69

3.40

2.4

2.1

6.19

2.19

ug/l

0.75

315

Dislocation, sprain and strain of joints and ligaments of knee

950

7820

1.13

3.39

1.9

2.0

1.99

2.18

ug/l

0.24

827

7027

Disorders of breast

673

5403

1.16

3.39

1.9

1.83

2.38

ug/l

0.47

580

4725

Dislocation, sprain and strain of joints and ligaments of thorax

360

1.67

3.37

2.3

2.0

1.41

2.08

ug/l

0.29

316

Temporomandibular joint disorders, including avohilmo

536

4562

1.18

3.36

2.0

1.09

2.18

ug/l

3.59

481

4060

Acute appendicitis, no complications

902

7960

1.13

3.35

2.0

1.86

2.13

ug/l

0.36

821

7097

Trigeminal neuralgia

655

1.49

3.35

1.8

2.0

2.64

1.90

ug/l

0.23

576

Dental caries 3 and operation codes, only avohilmo

521

3084

0.84

3.34

1.9

2.2

2.15

2.20

ug/l

0.03

463

2743

Benign neoplasm: Skin, unspecified

479

1.57

3.32

2.1

1.9

2.77

1.85

ug/l

0.29

427

Bullous pemphigoid

302

1.74

3.31

2.6

1.8

0.92

2.78

ug/l

1.03

258

Other benign neoplasm of uterus: Other parts/unspecified

496

1.56

3.30

1.9

1.7

3.86

1.44

ug/l

0.65

410

Alcoholic gastritis

199

1.92

3.29

2.0

2.1

5.82

1.50

ug/l

0.82

180

Malignant neoplasm of oral cavity

482

1.57

3.27

1.8

2.0

2.78

2.06

ug/l

0.20

429

Disorders of refraction and accommodation

357

2932

1.22

3.27

2.0

1.9

3.81

2.13

ug/l

0.87

310

2612

Erectile dysfunction

198

1532

1.31

3.26

2.1

1.9

2.73

2.74

ug/l

0.01

174

1334

Thyrotoxicosis

391

3255

1.21

3.25

2.2

1.9

5.05

2.16

ug/l

0.35

340

2867

Toxic effect of corrosive substances

3.48

3.24

2.1

2.0

0.49

0.82

ug/l

0.31

Otosclerosis

1053

0.65

3.22

2.1

2.0

4.91

2.37

ug/l

0.73

941

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

207

1.87

3.22

2.3

1.8

3.64

1.49

ug/l

0.37

183

Embedded teeth, including avohilmo

651

1.47

3.21

1.9

2.0

2.90

1.98

ug/l

0.32

576

Hypertrophic disorders of skin

514

1.54

3.21

1.7

2.0

3.38

1.92

ug/l

0.41

451

Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)

2.66

3.21

1.8

1.6

0.84

2.01

ug/l

0.95

Septal defects

582

1.50

3.20

2.4

2.1

2.76

1.73

ug/l

0.37

516

Contusion of ankle

357

1.65

3.20

2.4

2.0

3.13

1.93

ug/l

0.26

320

Cluster headache, wide,, including avohilmo

515

1.53

3.20

2.1

2.65

2.02

ug/l

0.22

460

Endometriosis

486

2442

1.19

3.19

2.0

1.9

2.05

1.96

ug/l

0.06

424

2150

Atopic dermatitis, strict definition

335

2696

1.22

3.18

2.0

1.38

2.12

ug/l

1.01

298

2409

Follicular cysts of skin and subcutaneous tissue

308

2512

1.24

3.18

2.0

4.00

2.12

ug/l

0.60

278

2236

Vascular dementia (other)

2.52

3.17

1.6

1.8

3.32

4.46

ug/l

0.10

Other and unspecified mononeuropathies, also in other diseases

359

1.65

3.16

2.1

1.9

1.85

2.28

ug/l

0.14

318

Cluster headache, strict, including avohilmo

477

1.55

3.14

2.1

2.70

1.99

ug/l

0.23

427

Respiratory tuberculosis, clinically confirmed

181

1.94

3.13

1.9

2.0

0.69

3.43

ug/l

0.94

152

Parkinson's disease, including avohilmo

326

2683

1.23

3.12

1.9

2.11

2.55

ug/l

0.29

272

2329

Atrophic disorders of skin

208

1625

1.29

3.12

1.9

2.98

1.83

ug/l

0.71

188

1439

Dislocation of lens

167

1.97

3.11

1.8

1.9

0.72

1.50

ug/l

0.61

139

Benign neoplasm: Lower jaw bone

3.63

3.10

1.3

1.6

0.16

1.97

ug/l

—

Delivery

476

2967

0.84

3.09

2.0

1.9

1.19

2.82

ug/l

2.34

423

2576

Lichen planus

219

1726

1.28

3.09

1.9

2.0

2.32

2.13

ug/l

0.10

184

1529

Sequelae of other accidents

182

1.92

3.08

2.1

2.0

2.10

3.11

ug/l

0.22

160

Vulvovaginal ulceration/inflammation in other diseases

384

1.60

3.07

1.9

2.0

2.17

1.53

ug/l

0.31

340

Thyroiditis

105

742

1.43

3.07

2.0

1.25

2.11

ug/l

0.88

657

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

234

1196

1.27

3.06

1.7

2.0

0.92

1.90

ug/l

2.23

195

1062

Deep endometriosis

127

927

1.38

3.06

2.2

1.9

3.15

2.10

ug/l

0.27

111

814

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

247

1.76

3.05

2.0

1.9

1.94

2.94

ug/l

0.23

219

Other disorders of the genitourinary system

212

1667

1.28

3.05

2.2

1.9

1.43

1.98

ug/l

0.49

181

1459

Benign neoplasm: Long bones of lower limb

240

1.78

3.05

2.0

1.8

1.12

1.13

ug/l

0.01

216

Calcific tendinitis of shoulder

669

1.45

3.03

2.4

2.1

1.14

2.40

ug/l

1.37

594

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

402

1.59

3.03

2.1

1.7

6.01

1.44

ug/l

0.85

351

Postpartum care and examination

122

558

1.40

3.03

2.0

2.1

1.06

1.90

ug/l

0.75

105

493

Preparation and fitting of bite rail to mouth

188

1456

1.30

3.02

2.0

4.43

2.01

ug/l

0.57

165

1322

Medullary carcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

5.14

3.01

1.9

1.8

166.90

2.95

ug/l

—

Colonic or urogenital fistula

471

4018

1.18

3.01

2.1

2.0

1.72

2.20

ug/l

0.61

408

3566

Mucinous and mucinous cystic tumor of rectum

2.61

3.00

2.1

1.9

1.03

5.20

ug/l

0.55

Other demyelinating diseases of the central nervous system

325

1.65

2.99

2.1

2.89

2.47

ug/l

0.06

298

Hordeolum and other deep inflammation of eyelid

589

1.48

2.98

1.7

2.0

2.22

1.23

ug/l

0.44

520

Persistent delusional disorders

128

941

1.38

2.98

2.1

2.0

1.34

1.80

ug/l

0.35

110

824

Wilms' tumor

2.55

2.96

2.2

1.7

3.05

5.47

ug/l

0.23

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

251

1.76

2.95

1.7

0.94

1.78

ug/l

0.68

219

Juvenile osteochondrosis

273

1.71

2.94

1.5

2.0

2.89

2.35

ug/l

0.10

250

Superficial injuries involving multiple body regions

266

1.72

2.93

2.1

1.9

4.28

2.51

ug/l

0.31

234

Dementia due to Parkinsons disease, excluding more controls

282

1.71

2.93

1.9

1.8

1.83

1.99

ug/l

0.06

245

Retinal haemorrhage

305

1.68

2.93

2.4

2.0

2.43

1.48

ug/l

0.43

270

Ménière disease

175

1352

1.31

2.92

1.9

2.0

2.43

ug/l

0.00

144

1193

Chronic iridocyclitis

576

1.48

2.91

2.6

2.0

2.99

1.80

ug/l

0.35

505

Early lumbar disc prolapse operation

117

850

1.39

2.90

2.1

2.2

1.55

1.68

ug/l

0.06

104

781

Malignant neoplasm of vulva

103

2.22

2.88

2.0

1.6

1.35

3.93

ug/l

0.45

Oral lichen ruber planus, including avohilmo

685

0.59

2.88

1.8

2.0

1.10

1.99

ug/l

0.58

606

Trigger finger

222

1768

1.26

2.88

2.0

1.9

4.13

2.43

ug/l

0.37

200

1573

Seborrhoeic keratosis

406

3438

1.19

2.87

2.0

1.9

2.25

2.30

ug/l

0.03

363

3011

Complications associated with artificial fertilization

2.32

2.86

1.6

2.4

1.11

2.06

ug/l

0.31

Special screening examination for infectious and parasitic diseases

157

1535

0.76

2.86

1.8

2.0

0.57

2.73

ug/l

4.81

135

1373

Laparoscopic right hemicolectomy

112

814

1.40

2.85

2.1

2.0

2.16

2.09

ug/l

0.03

101

723

Use of levodopa decarboxylase inhibitor

275

2249

1.24

2.85

1.9

2.31

2.41

ug/l

0.05

223

1938

Intermittent heterotropia

472

1.52

2.84

2.4

1.9

2.22

2.27

ug/l

0.01

415

UC patients in KELA-register (code 208), prior to 1994

597

1.46

2.82

2.4

2.0

6.27

2.11

ug/l

0.56

537

Other noninflammatory disorders of cervix uteri

547

1.48

2.82

1.8

2.0

2.58

1.94

ug/l

0.23

493

Filling of root of tooth

339

1.62

2.82

2.1

1.08

1.67

ug/l

0.30

310

Benign neoplasm: Brain, supratentorial

159

1.93

2.81

2.7

1.7

1.73

3.70

ug/l

0.47

138

Other specified and unspecified retinal disorders

443

1.54

2.80

2.5

2.0

2.01

1.68

ug/l

0.18

392

Primary open-angle glaucoma

668

5731

1.14

2.80

1.9

2.06

2.39

ug/l

0.32

562

4958

Drug-induced Cushing's syndrome

6.80

2.80

2.0

1.9

0.61

0.41

ug/l

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

124

2.06

2.80

2.6

1.7

0.55

3.73

ug/l

0.82

113

Embedded and impacted teeth

250

1716

1.24

2.79

1.9

2.1

1.88

1.82

ug/l

0.04

224

1526

Disorders of globe

317

1.64

2.79

2.4

1.8

2.79

2.47

ug/l

0.08

268

Nontoxic goitre/thyroid nodule

508

4390

1.16

2.78

1.9

2.17

2.20

ug/l

0.01

449

3819

Heterophoria

107

773

1.40

2.78

2.5

2.0

2.40

1.99

ug/l

0.13

687

Other diseases of blood and blood-forming organs

118

869

1.38

2.76

2.1

1.9

1.53

2.24

ug/l

0.33

102

768

Other and unspecified erythematous conditions

357

1.60

2.75

1.8

2.0

2.65

2.18

ug/l

0.14

317

Varicella [chickenpox]

428

1.54

2.74

2.4

2.1

3.97

1.45

ug/l

0.79

394

Parkinson's disease

309

2567

1.21

2.74

1.9

2.21

2.59

ug/l

0.23

255

2229

Autoimmune hyperthyroidism

550

1.47

2.74

2.2

1.9

0.50

1.56

ug/l

1.89

491

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

684

1.42

2.72

1.8

3.76

1.61

ug/l

0.63

597

Benign neoplasm: Skin of ear and external auricular canal

454

1.52

2.72

1.7

1.40

1.80

ug/l

0.33

391

Carcinoma in situ of cervix uteri

493

1.49

2.71

2.0

1.8

2.20

1.29

ug/l

0.50

425

Other and unspecified vascular occlusions

189

1493

1.28

2.69

1.9

1.20

2.39

ug/l

1.39

157

1284

Congenital malformations of the nervous system

154

1.91

2.68

2.5

2.1

0.35

3.14

ug/l

0.92

139

Dislocation, sprain and strain of joint and ligaments of hip

464

1.51

2.68

2.4

1.8

2.70

2.14

ug/l

0.16

411

Disorders of glossopharyngeal nerve

5.09

2.67

1.0

1.8

0.33

0.51

ug/l

—

Acute alcohol intoxication ICD-9

497

1.50

2.67

2.2

2.0

3.26

1.86

ug/l

0.44

442

Benign neoplasm: Cerebral meninges

151

1160

1.32

2.66

2.2

2.0

2.64

1.92

ug/l

0.31

118

1011

Thyroiditis, unspecified

148

1.94

2.65

1.6

1.9

0.90

2.85

ug/l

0.51

136

Additional codes for the location of defect, injury or illness

663

1.42

2.65

1.8

1.9

1.70

1.76

ug/l

0.03

584

Thyrotoxicosis, other and/or unspecified

293

2428

1.21

2.64

2.1

1.9

6.23

2.12

ug/l

0.39

255

2156

Benign neoplasm of breast

137

1038

1.33

2.63

1.7

1.8

2.21

1.72

ug/l

0.30

113

893

Benign neoplasm: Endocrine pancreas

2.34

2.63

2.4

2.0

8.81

5.67

ug/l

0.20

Other benign neoplasms of uterus

665

1.42

2.62

1.9

3.16

1.68

ug/l

0.44

565

Causalgia

156

1.90

2.61

1.9

0.35

2.93

ug/l

0.91

149

Benign neoplasm of thyroid gland

394

1.55

2.61

2.1

2.0

1.00

2.09

ug/l

0.71

348

Other peripheral vertigo

162

1262

1.30

2.58

1.9

2.0

1.61

2.38

ug/l

0.53

132

1115

Other drug-induced secondary parkinsonism

115

2.08

2.58

2.1

0.80

4.45

ug/l

0.87

108

Use of rotigotine

136

1.98

2.57

1.7

2.0

1.41

4.34

ug/l

0.70

121

Respiratory tuberculosis, not confirmed

635

1.42

2.56

2.1

1.9

1.08

1.96

ug/l

0.74

545

Residual foreign body in soft tissue

551

1.45

2.55

1.8

2.1

2.88

1.81

ug/l

0.36

493

Other and unspecified glaucoma

136

1038

1.33

2.54

1.9

2.84

2.45

ug/l

0.13

117

887

Malignant neoplasm of cervix uteri

122

2.01

2.54

1.9

1.5

2.89

3.53

ug/l

0.09

109

Restless leg syndrome

199

1593

1.26

2.53

2.1

2.0

0.96

2.25

ug/l

2.68

174

1406

Benign neoplasm: Choroid

627

1.42

2.53

1.8

1.7

2.75

1.63

ug/l

0.33

540

Primary open-angle glaucoma, strict

536

4680

1.15

2.53

1.9

2.27

2.37

ug/l

0.06

455

4043

Ovarian dysfunction

428

1.51

2.52

2.5

1.8

0.97

1.96

ug/l

0.68

384

Acute appendicitis, with complications

344

2912

1.19

2.49

2.4

1.9

2.32

2.26

ug/l

0.04

312

2572

Hypertrophic cardiomyopathy

572

1.44

2.48

2.0

1.9

2.00

1.93

ug/l

0.03

512

Burkitt lymphoma, excluding all cancers (controls excluding all cancers)

7.35

2.48

5.8

1.3

4.82

1.90

ug/l

—

Noninflammatory disorders of female genital tract

583

2565

1.15

2.47

1.9

2.02

1.98

ug/l

0.03

508

2256

Atrial septal defect

348

1.56

2.47

2.6

2.0

0.75

2.17

ug/l

0.95

312

Other abnormal findings of blood chemistry

514

1.46

2.46

1.8

1.9

1.49

1.94

ug/l

0.26

458

Carcinoma in situ of skin of scalp and neck

369

1.56

2.46

1.9

1.8

1.35

3.43

ug/l

0.80

308

Carcinoma in situ of other and unspecified sites

591

1.44

2.46

2.0

1.9

1.16

2.58

ug/l

0.81

522

Other contact dermatitis

121

912

1.34

2.45

2.3

2.0

1.84

1.99

ug/l

0.08

105

800

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

531

1.45

2.45

2.2

2.0

1.84

1.77

ug/l

0.04

479

Intentional self-harm by hanging, strangulation and suffocation

0.00

2.45

0.0

1.7

—

1.11

—

Disorders of copper metabolism

6.92

2.44

1.8

2.8

0.37

2.48

ug/l

—

Preterm labour and delivery

285

2377

1.20

2.42

1.9

2.0

2.59

1.86

ug/l

0.53

255

2133

Muscle strain

313

1.59

2.41

1.8

2.0

0.68

1.54

ug/l

0.85

274

Mixed specific developmental disorders

2.25

2.40

2.2

2.6

4.73

3.32

ug/l

0.13

Supervision of normal pregnancy

125

941

0.76

2.40

1.6

2.1

1.72

1.86

ug/l

0.06

115

845

MS-disease / Multiple Sclerosis

650

1.40

2.39

1.8

2.1

1.28

1.79

ug/l

0.33

580

Other neurotic disorders

618

1.41

2.38

2.1

2.0

1.36

1.71

ug/l

0.21

549

Persons encountering health services in circumstances related to reproduction

669

5096

0.89

2.37

2.2

2.29

2.46

ug/l

0.13

598

4622

Benign neoplasm of male genital organs

316

1.59

2.36

1.9

2.0

1.23

1.32

ug/l

0.06

278

Dermatographic urticaria

618

1.40

2.36

2.0

3.51

1.73

ug/l

0.31

553

Injury of eye and orbit

207

1679

1.24

2.35

2.1

2.0

1.85

2.50

ug/l

0.52

174

1507

Carcinoma in situ, bladder

546

1.44

2.35

2.0

1.9

1.22

2.74

ug/l

0.80

485

Disorders of synovium and tendon in diseases classified elsewhere

253

1.66

2.35

2.6

2.1

5.46

1.29

ug/l

0.75

222

501

0.58

2.34

1.6

1.9

0.28

1.46

ug/l

2.83

442

Sequelae of injuries of lower limb

145

1129

1.30

2.34

2.1

2.0

1.81

2.01

ug/l

0.14

133

1009

Autoimmune polyglandular failure

5.06

2.34

1.8

1.2

1.47

0.24

ug/l

—

Kaposi sarcoma, excluding all cancers (controls excluding all cancers)

4.99

2.33

5.7

1.7

0.51

0.69

ug/l

—

Sequelae of infectious and parasitic diseases

127

973

1.32

2.32

2.1

2.0

1.72

1.68

ug/l

0.02

111

850

Benign neoplasm: Tongue

277

1.62

2.32

2.2

1.7

1.84

1.41

ug/l

0.15

245

Parkinson's disease, strict definition

284

2385

1.20

2.31

1.9

2.10

2.67

ug/l

0.36

233

2065

Anxious personality disorder

141

1.87

2.30

3.3

2.0

4.49

3.21

ug/l

0.16

130

Palmar fascial fibromatosis [Dupuytren]

315

2670

1.19

2.29

1.8

2.0

3.16

2.57

ug/l

0.21

263

2320

Infections of genitourinary tract in pregnancy

103

766

1.35

2.29

2.0

1.18

2.19

ug/l

0.90

687

Dislocation, sprain and strain of joints and ligaments of elbow

605

1.40

2.29

2.0

2.1

1.08

1.81

ug/l

0.58

536

Otalgia

108

810

1.35

2.29

2.1

2.0

1.21

2.34

ug/l

0.88

720

Personality and behavioural disorders due to brain disease, damage and dysfunction

186

1.76

2.29

1.9

2.0

3.09

1.89

ug/l

0.26

169

Medial epicondylitis

390

1.51

2.28

1.7

2.2

0.41

1.70

ug/l

2.27

351

Anorexia (incl.atypical)

463

1.46

2.28

1.8

1.9

2.29

2.12

ug/l

0.04

412

Tooth eruption problems

122

921

1.32

2.27

2.0

3.77

1.91

ug/l

0.76

818

Scabies

456

1.46

2.27

2.4

2.1

1.67

2.01

ug/l

0.15

417

Ulcerative proctitis

649

1.39

2.26

1.8

2.1

21.11

1.68

ug/l

0.58

581

Use of rivastigmine

199

2431

0.81

2.26

1.6

1.8

1.62

2.64

ug/l

1.24

155

2015

Benign neoplasm: Skin of trunk

375

1.51

2.25

2.1

1.8

0.73

1.68

ug/l

1.38

330

Hypertrophic scar

465

1.45

2.25

1.8

2.0

3.81

2.04

ug/l

0.43

410

Other and unspecified rosacea

128

987

1.31

2.25

1.9

2.0

1.77

2.09

ug/l

0.15

113

882

Contusion of other and unspecified parts of foot

424

1.48

2.24

1.7

2.0

1.98

1.90

ug/l

0.02

386

Other lesions of median nerve

352

1.53

2.24

1.7

1.9

1.43

2.27

ug/l

0.36

304

Nezelof syndrome

2.75

2.24

2.7

2.1

0.38

7.54

ug/l

0.55

Benign neoplasm of eye and adnexa

138

1076

1.29

2.22

1.8

3.03

1.52

ug/l

0.63

111

920

Use of ropinirole

535

1.43

2.22

2.0

1.9

1.02

1.88

ug/l

0.71

476

Certain conditions originating in the perinatal period

426

1.44

2.22

2.4

2.0

2.86

2.61

ug/l

0.06

383

Impacted teeth

161

1188

1.27

2.21

1.9

2.0

1.52

2.10

ug/l

0.38

149

1059

Anankastic personality disorder

321

1.54

2.18

1.8

2.1

2.11

1.79

ug/l

0.07

290

Carcinoma in situ of skin

132

1028

1.30

2.17

1.9

1.7

1.86

1.66

ug/l

0.08

115

871

Other benign neoplasm of uterus: Other parts/unspecified

545

1.42

2.17

1.9

1.7

3.86

1.77

ug/l

0.51

453

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

103

774

1.34

2.17

2.0

1.8

1.15

1.62

ug/l

0.43

680

Burkitt lymphoma

5.85

2.17

5.8

2.1

4.82

1.56

ug/l

—

Burkitt lymphoma, helper endpoint

5.85

2.17

5.8

2.1

4.82

1.56

ug/l

—

Disorders of adrenal gland, other and/or unspecified

2.56

2.15

2.0

1.7

0.85

6.31

ug/l

0.48

Convergent concomitant strabismus

511

1.42

2.15

3.8

2.1

3.46

2.10

ug/l

0.31

458

Single delivery by forceps and vacuum extractor

607

0.71

2.14

1.5

2.2

2.08

1.99

ug/l

0.02

541

Bitten or struck by other mammals

138

1082

1.28

2.13

2.3

2.0

1.25

1.75

ug/l

0.45

119

973

Use of memantine

536

4133

1.14

2.13

1.6

1.8

3.57

2.31

ug/l

0.64

397

3493

Use of other anti-dementia drugs

536

4133

1.14

2.13

1.6

1.8

3.57

2.31

ug/l

0.64

397

3493

Lesion of sciatic nerve

702

1.36

2.11

2.0

1.8

1.21

2.34

ug/l

0.67

600

Benign neoplasm: Liver/bile ducts

237

1.63

2.11

2.2

2.1

4.61

2.76

ug/l

0.20

211

Nonspecific lymphadenitis

615

1.38

2.11

2.3

2.1

5.59

2.19

ug/l

0.61

553

Pediculosis, acariasis and other infestations

624

1.38

2.10

2.3

2.1

5.68

1.84

ug/l

0.42

566

Haemorrhagic disorder due to circulating anticoagulants

154

1.81

2.10

1.9

1.7

2.16

3.76

ug/l

0.28

129

Ovarian hyperstimulation (induction)

2.10

2.08

1.4

1.9

1.09

1.89

ug/l

0.24

Benign lipomatous neoplasm of other sites/unspecified

161

1293

1.26

2.07

1.9

2.0

0.89

2.27

ug/l

2.19

141

1132

Diabetes mellitus in pregnancy

255

1381

1.20

2.06

1.7

2.0

1.35

1.61

ug/l

0.27

223

1225

Benign neoplasm: Skin of scalp and neck

223

1.64

2.05

2.3

1.9

2.29

1.86

ug/l

0.15

199

Complications predominantly related to the puerperium

265

2235

1.19

2.05

1.9

2.0

2.06

2.01

ug/l

0.02

238

1989

Migraine, single triptan purchase ok & required. ICD-code if available is included

977

7225

0.91

2.05

2.0

2.1

1.61

2.33

ug/l

1.31

876

6459

Triptan medication for migraine, single purchase ok

977

7225

0.91

2.05

2.0

2.1

1.61

2.33

ug/l

1.31

876

6459

Melanocytic naevi

437

3833

1.14

2.04

2.2

1.9

2.35

2.11

ug/l

0.14

392

3377

Maternal care for other conditions predominantly related to pregnancy

172

1372

1.24

2.04

2.1

1.10

1.87

ug/l

1.41

157

1221

Deviated nasal septum

611

5469

1.12

2.04

2.0

1.62

2.29

ug/l

1.21

517

4883

Benign neoplasm of middle ear and respiratory system

144

1145

1.27

2.03

1.9

2.0

4.26

2.43

ug/l

0.60

130

1007

Puerperal sepsis

159

1277

1.25

2.03

2.0

2.71

1.97

ug/l

0.34

145

1156

Hallux rigidus

228

1902

1.21

2.02

1.9

1.87

2.09

ug/l

0.14

192

1716

Other specified/unspecified hearing loss

142

1128

1.27

2.02

2.2

1.9

1.94

2.60

ug/l

0.32

131

976

Ectropion of eyelid

648

1.36

2.01

2.0

1.8

1.83

2.89

ug/l

0.51

536

Use of levodopa decarbox-comt-inhibitor

496

1.42

1.99

1.8

1.9

1.59

1.90

ug/l

0.14

437

Cystic fibrosis, other manifestations/unspecified

4.86

1.98

4.2

1.9

0.57

0.67

ug/l

—

Carcinoma in situ of skin of ear and external auricular canal

219

1.65

1.98

1.8

3.33

3.00

ug/l

0.06

185

Other bursitis of hip

218

1.64

1.97

2.5

1.9

10.54

1.22

ug/l

0.53

188

Antenatal screening

135

963

0.79

1.97

1.9

2.1

1.55

1.83

ug/l

0.14

124

861

Benign neoplasm of other and unspecified female genital organs

437

1.44

1.97

2.1

1.9

4.05

2.26

ug/l

0.37

387

Communicating hydrocephalus

274

1.56

1.96

2.7

2.0

3.76

2.62

ug/l

0.18

244

Other and unspecified injuries of wrist and hand

379

1.47

1.96

2.2

2.0

3.57

1.88

ug/l

0.41

334

Endometriosis diagnosis and infertility diagnosis occurring together

102

778

1.32

1.96

2.2

2.0

2.80

1.67

ug/l

0.27

699

Other/unspecified disorders of vestibular function

480

1.42

1.96

1.7

1.9

0.57

1.95

ug/l

1.35

420

Radial styloid tenosynovitis [de Quervain]

496

1.40

1.95

1.7

2.1

0.87

2.21

ug/l

1.81

439

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

531

1.39

1.93

2.7

1.9

2.47

1.67

ug/l

0.38

460

Thyrotoxicosis with diffuse goitre

184

1511

1.22

1.93

2.3

1.9

1.86

1.95

ug/l

0.04

162

1334

Dystonia

618

1.36

1.91

2.5

2.0

1.28

1.71

ug/l

0.22

546

Operations for atrial fibrillation

213

1.64

1.91

2.6

2.0

0.47

2.77

ug/l

1.02

189

Pneumoconiosis due to asbestos and other mineral fibres

375

1.47

1.90

1.7

1.8

0.65

2.71

ug/l

1.14

318

Scar conditions and fibrosis of skin

374

1.46

1.89

1.9

2.1

4.09

2.00

ug/l

0.39

338

Benign neoplasm: Other/unspecified site

159

1.73

1.89

2.1

1.8

0.56

1.49

ug/l

1.38

145

Squamous cell neoplasms and carcinoma of cervix

2.27

1.88

2.1

1.6

4.81

1.41

ug/l

0.59

Pedal cyclist injured in transport accident

321

2775

1.16

1.88

2.0

1.81

2.37

ug/l

0.40

283

2469

Malignant neoplasm of breast, HER-negative

305

2627

1.17

1.86

1.9

1.19

2.25

ug/l

2.88

280

2275

Corneal scars and opacities

335

1.49

1.86

2.1

1.9

2.31

2.29

ug/l

0.01

297

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

1.97

1.84

1.2

1.7

6.49

2.05

ug/l

0.30

Benign neoplasm: Rectosigmoid junction

581

1.36

1.83

2.0

1.9

1.63

2.66

ug/l

0.46

511

Benign neoplasm: Other and unspecified parts of mouth

428

1.42

1.82

2.0

1.15

2.09

ug/l

0.46

382

Benign neoplasm: other/unspecified salivary gland

370

1.46

1.81

2.5

1.9

4.41

2.11

ug/l

0.35

331

Use of antiglaucoma preparations and miotics

156

1272

1.24

1.80

1.7

1.8

2.88

2.25

ug/l

0.23

127

1081

Haemangioma, any site

127

1012

1.27

1.79

2.1

2.0

0.89

2.37

ug/l

1.98

111

903

Eustachian salpingitis and obstruction

659

1.33

1.79

2.1

1.38

1.76

ug/l

0.26

598

Voice disturbances

425

3761

1.13

1.79

2.1

2.0

1.73

2.24

ug/l

0.63

371

3322

Beningn neoplasm: Meninges, unspecified

201

1.63

1.78

2.2

1.8

1.74

2.64

ug/l

0.21

178

Other disorders of bone density and structure

232

1.57

1.78

2.0

2.1

0.40

2.79

ug/l

1.26

212

Benign neoplasm: Thymus

2.86

1.78

1.6

1.7

2.58

0.88

ug/l

—

Melanoma in situ of scalp and neck

0.00

1.78

0.0

2.0

—

7.33

—

Erosion and ectropion of cervix uteri

297

1.50

1.77

1.9

2.0

1.79

1.95

ug/l

0.04

268

Hyperaldosteronism

347

1.46

1.77

1.8

1.9

1.35

2.32

ug/l

0.49

312

Fourth [trochlear] nerve palsy

298

1.50

1.76

2.6

1.8

5.91

2.33

ug/l

0.31

267

Benign neoplasm: Liver

209

1.60

1.76

1.8

2.1

5.33

3.06

ug/l

0.21

186

Acne conglobata

2.57

1.76

2.0

1.7

3.05

0.79

ug/l

—

Lichen sclerosus et atrophicus

138

1113

1.25

1.75

1.8

1.9

2.87

1.70

ug/l

0.68

123

979

Benign neoplasm: Larynx

432

1.41

1.74

1.8

2.0

3.08

2.02

ug/l

0.31

385

Congenital deformities of hip

110

1.84

1.74

3.4

1.7

0.60

3.86

ug/l

0.74

102

Polycystic ovarian syndrome

265

1.52

1.74

2.6

1.7

1.44

1.77

ug/l

0.18

234

Propionic acid derivatives

619

2803

1.11

1.74

1.9

2.0

2.26

2.33

ug/l

0.03

530

2495

Type 1 diabetes, strict definition, subgroup 1

421

1.40

1.73

2.0

1.9

5.51

1.21

ug/l

1.31

373

Amblyopia ex anopsia

381

1.43

1.73

2.9

1.9

5.35

2.20

ug/l

0.65

336

Other specified/unspecified nutritional deficiencies

2.06

1.73

1.4

1.7

20.77

4.67

ug/l

0.55

Carcinoma in situ of skin of trunk

459

1.40

1.72

2.1

1.8

1.25

2.91

ug/l

0.76

397

Spinal enthesopathy

398

1.42

1.72

1.7

1.8

0.44

2.66

ug/l

2.02

328

Medical abortion

891

4445

1.09

1.72

1.9

2.38

2.39

ug/l

0.01

759

3893

Other and unspecified mononeuropathies of lower limb

316

1.48

1.71

2.5

2.0

1.64

2.14

ug/l

0.17

279

Entropion and trichiasis of eyelid

165

1362

1.22

1.71

2.4

1.9

1.58

2.29

ug/l

0.47

139

1159

Secondary polycythaemia

284

1.50

1.70

1.9

0.77

2.44

ug/l

0.92

247

Haemangioma and lymphangioma, any site

134

1082

1.25

1.70

2.1

2.0

0.85

2.28

ug/l

2.08

117

966

Type 1 diabetes, definitions combined

724

1.30

1.69

2.0

4.85

1.92

ug/l

1.26

649

Benign lipomatous neoplasm

503

4515

1.12

1.68

2.0

2.52

2.09

ug/l

0.27

445

3996

Other disorders of eye and adnexa

190

1590

1.20

1.68

2.1

2.0

1.62

1.89

ug/l

0.23

161

1412

Other bursitis, not elsewhere classified

112

1.83

1.68

2.1

2.0

5.75

1.01

ug/l

0.43

Postmenopausal atrophic vaginitis

293

2036

0.86

1.67

1.7

1.9

2.24

2.07

ug/l

0.11

265

1807

Retained placenta and membranes, without haemorrhage

136

1101

1.24

1.67

1.9

1.84

1.81

ug/l

0.02

121

975

Other congenital malformations of circulatory system

285

1.50

1.67

2.1

1.9

3.40

2.28

ug/l

0.21

261

Benign neoplasm: Vulva

181

1.63

1.65

1.8

1.7

6.89

1.38

ug/l

0.68

157

Anti-inflammatory and antirheumatic products, non-steroids

617

2803

1.11

1.65

1.8

2.0

2.61

2.33

ug/l

0.14

535

2495

Other disorders of binocular movement

197

1.59

1.64

2.9

2.0

0.77

3.29

ug/l

1.04

178

Other degenerative diseases of the basal ganglia

222

1.57

1.64

2.0

1.9

1.35

2.89

ug/l

0.52

195

Malignant neoplasm of endocrine gland

105

828

1.28

1.64

2.6

2.0

16.61

2.02

ug/l

0.52

736

Myopia

141

1150

1.23

1.63

2.0

3.15

1.79

ug/l

0.56

129

1027

Torsion of ovary, ovarian pedicle and fallopian tube

160

1.64

1.57

1.8

2.1

4.71

2.28

ug/l

0.24

139

Melanocytic naevi of other and unspecified parts of face

474

1.36

1.57

1.9

1.8

1.00

1.72

ug/l

0.74

408

Prolonged pregnancy

802

0.75

1.56

1.9

2.1

0.78

1.76

ug/l

1.81

711

Excessive attrition of teeth

627

3091

1.10

1.56

2.0

1.78

1.92

ug/l

0.15

546

2737

Exposure to other and unspecified inanimate mechanical forces

764

1.28

1.55

2.2

2.1

2.02

1.90

ug/l

0.04

684

Liposarcoma, excluding all cancers (controls excluding all cancers)

1.87

1.54

2.1

1.7

0.21

1.80

ug/l

1.68

Benign neoplasm: Kidney

451

1.37

1.54

2.0

4.24

1.85

ug/l

0.50

399

Endometriosis ASRM stages 3,4

279

2429

1.15

1.54

2.1

1.9

2.06

1.87

ug/l

0.09

247

2133

Congenital malformations of genital organs

680

1.29

1.54

2.5

2.1

2.11

2.30

ug/l

0.06

609

Benign neoplasm of major salivary glands

170

1425

1.20

1.53

2.4

1.9

2.65

2.29

ug/l

0.13

150

1254

Other vitreous opacities

512

1.34

1.53

2.0

1.9

1.28

2.12

ug/l

0.44

446

Chronic diseases of tonsils and adenoids

1159

7849

0.93

1.52

1.9

2.0

1.83

2.46

ug/l

1.07

1030

6988

Conductive hearing loss, unspecified

126

1026

1.24

1.51

2.1

2.0

1.93

2.16

ug/l

0.10

108

910

Whooping cough

2.90

1.51

2.3

1.4

0.91

0.86

ug/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

437

3828

0.90

1.51

2.1

2.0

2.95

1.86

ug/l

0.91

377

3384

Astigmatism

617

1.31

1.49

1.7

1.9

4.49

1.95

ug/l

0.41

552

Femoral hernia, unilateral

343

1.42

1.49

2.6

1.8

2.82

2.60

ug/l

0.05

301

Inguinal hernia, unilateral

343

1.42

1.49

2.6

1.8

2.82

2.60

ug/l

0.05

301

Inguinal of femoral hernia, unilateral

343

1.42

1.49

2.6

1.8

2.82

2.60

ug/l

0.05

301

Lateral epicondylitis

185

1565

1.19

1.49

1.9

2.0

1.51

2.42

ug/l

0.80

158

1418

Senile degeneration of the brain, not elsewhere classified

2.20

1.48

2.3

9.18

6.91

ug/l

0.08

Delivery, wide proxy

424

2521

0.89

1.47

1.9

1.08

2.91

ug/l

2.24

373

2160

Embolic stroke

726

1.28

1.47

2.2

1.8

2.11

2.52

ug/l

0.12

636

Disorders of iron metabolism

156

1.63

1.46

2.3

1.9

2.20

3.32

ug/l

0.22

139

Other predominantly sexually transmitted diseases, not elsewhere classified

178

1503

1.19

1.46

2.2

2.0

1.98

1.79

ug/l

0.11

157

1345

Type 1 diabetes, strict (exclude DM2)

732

1.27

1.46

2.0

2.1

4.90

1.90

ug/l

1.29

657

Benign neoplasm: Skin of lower limb, including hip

253

1.48

1.45

2.0

1.7

2.64

1.84

ug/l

0.18

221

Benign mammary dysplasia

203

1737

1.17

1.44

2.0

1.9

1.19

2.10

ug/l

0.97

168

1517

Motorcycle rider injured in other and unspecified transport accidents

560

1.31

1.44

2.4

2.1

2.63

1.51

ug/l

0.38

510

Other specified disorders of external ear

553

1.32

1.44

2.5

1.9

2.06

2.85

ug/l

0.32

502

Varicose veins of other sites

103

827

1.26

1.43

2.1

2.0

2.52

2.08

ug/l

0.14

741

Pedal cyclist injured in other and unspecified transport accidents

158

1325

1.20

1.42

1.9

2.0

1.64

2.11

ug/l

0.30

139

1180

Other obstructed labour

606

1.29

1.40

1.9

2.93

1.94

ug/l

0.30

542

Pre-eclampsia superimposed on chronic hypertension

2.46

1.40

1.7

1.3

0.53

1.66

ug/l

—

Other infective (teno)synovitis

2.27

1.39

2.0

2.4

0.75

1.95

ug/l

—

Benign neoplasm: Cranial nerves

281

1.44

1.38

1.9

1.8

2.25

1.81

ug/l

0.17

247

Failed induction of labour

272

1.44

1.37

1.5

1.8

0.36

1.31

ug/l

1.72

231

Carcinoma in situ of breast, intraductal

688

1.27

1.37

2.0

1.8

3.20

1.62

ug/l

0.68

590

Female genital prolapse

436

2264

1.11

1.36

1.8

1.9

1.81

2.04

ug/l

0.22

358

1991

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

742

1.26

1.36

1.9

2.0

0.68

1.71

ug/l

2.74

672

Carcinoma in situ of skin of other and unspecified parts of face

154

1298

1.20

1.35

1.6

1.8

2.78

2.48

ug/l

0.06

132

1095

Chronic rhinitis, nasopharyngitis and pharyngitis

462

4187

1.11

1.35

2.2

2.0

1.25

2.18

ug/l

1.73

411

3724

Divergent concomitant strabismus

103

833

1.24

1.35

2.8

2.0

1.46

1.96

ug/l

0.36

751

Endometriosis of fallopian tube

2.01

1.35

2.2

2.6

0.63

2.00

ug/l

0.87

Maternal care related to the fetus and amniotic cavity and possible delivery problems

362

2386

0.89

1.34

2.0

1.74

2.00

ug/l

0.21

334

2136

Exophthalmic conditions

121

1.69

1.33

1.8

0.32

1.47

ug/l

1.82

109

Amputation of ankle

3.00

1.32

1.2

1.7

0.95

14.41

ug/l

—

Cyst of spleen

2.91

1.31

2.2

1.3

9.64

14.53

ug/l

—

Pedestrian injured in collision with car, pick-up truck or van

276

1.43

1.30

1.7

1.9

2.73

2.20

ug/l

0.08

244

Rosacea

157

1329

1.19

1.30

2.0

2.50

2.17

ug/l

0.10

139

1180

Inflammation of lacrimal passages (acute and unspecified)

194

1.52

1.29

2.3

1.9

1.60

1.27

ug/l

0.19

170

Polyp of the female genital tract

443

2330

1.11

1.29

2.0

1.9

1.84

1.99

ug/l

0.08

391

2054

Acute poliomyelitis

170

1.56

1.29

1.5

1.8

1.74

2.77

ug/l

0.23

149

Benign neoplasm: Other/unspecified site

178

1.54

1.28

2.1

2.0

0.56

3.37

ug/l

1.08

162

Crowding of teeth, including avohilmo

418

1.31

1.28

2.2

1.9

3.00

1.94

ug/l

0.31

375

Benign neoplasm of urinary organs

634

1.27

1.9

2.0

3.42

2.48

ug/l

0.20

560

Aphakia

170

1.55

1.27

1.5

1.9

1.89

1.94

ug/l

0.01

146

Lichen planus, including avohilmo

291

2583

1.13

1.27

2.0

1.9

2.24

2.13

ug/l

0.07

246

2286

Other primary thrombocytopenia

2.30

1.26

1.1

1.7

0.56

1.50

ug/l

—

Non-allergic asthma

141

1188

1.19

1.25

2.0

4.46

2.40

ug/l

0.37

130

1054

Other sexually transmitted chlamydial diseases

375

0.66

1.24

1.5

2.1

1.15

1.36

ug/l

0.09

334

Adenocarcinoma and Papillary adenocarcinoma of kidney

156

1.58

1.24

2.5

2.1

0.40

3.31

ug/l

0.91

136

Oral leukoplakia

238

1.45

1.23

2.0

2.1

0.75

2.70

ug/l

0.89

215

Malignant neoplasm of thyroid gland

763

1.24

1.22

2.6

2.0

18.41

2.05

ug/l

0.53

677

Female infertility

320

1761

1.12

1.22

1.9

2.0

2.36

1.79

ug/l

0.36

291

1580

Endometriosis of ovary

199

1723

1.16

1.21

2.1

1.9

1.10

1.98

ug/l

1.57

177

1537

Other and unspecified coagulation defects

470

1.31

1.21

3.2

1.9

1.06

1.87

ug/l

0.58

422

Oral lichen ruber planus wide, hypothyreosis or thyroxin

621

1.27

1.21

2.2

2.0

2.60

2.14

ug/l

0.11

542

Postpartum haemorrhage

151

1544

0.85

1.21

2.1

2.0

1.07

1.51

ug/l

0.40

139

1368

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

791

1.23

1.20

1.9

2.0

2.55

2.08

ug/l

0.20

709

Congenital malformations of eye, ear, face and neck

585

1.27

1.20

1.9

2.0

1.15

1.81

ug/l

0.39

518

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

374

3379

1.11

1.20

2.1

2.0

1.62

2.17

ug/l

0.67

317

3025

N06DA Anticholinesterases

585

5129

0.92

1.20

1.7

1.8

2.97

2.36

ug/l

0.32

441

4391

Use of anticholinesterases

585

5129

0.92

1.20

1.7

1.8

2.97

2.36

ug/l

0.32

441

4391

Recurrent dislocation and subluxation of joint

630

1.26

1.19

1.8

2.0

0.76

1.73

ug/l

2.03

575

Malignant neoplasm of tongue

265

1.42

1.19

1.9

1.66

2.50

ug/l

0.27

233

Vasomotor and allergic rhinitis

497

4488

1.09

1.18

2.0

1.27

2.28

ug/l

3.04

434

3991

Melanocytic naevi of trunk

167

1435

1.17

1.18

2.1

2.0

3.35

2.19

ug/l

0.34

150

1285

Contraceptive management

444

3425

0.91

1.18

2.2

2.04

2.52

ug/l

0.35

394

3114

Other disorders of amniotic fluid and membranes

794

1.23

1.18

2.3

2.1

1.21

1.77

ug/l

0.43

705

Dementia due to Parkinson's disease

352

1.36

1.17

1.9

1.8

1.83

2.35

ug/l

0.18

296

Brain meningioma

616

1.26

1.16

2.1

2.0

3.28

1.80

ug/l

0.38

538

Other and unspecified degenerative diseases of nervous system

343

0.66

1.16

2.4

1.8

4.63

2.19

ug/l

0.29

291

Type 1 diabetes, strict definition

481

1.29

1.15

2.0

2.1

5.26

1.39

ug/l

1.21

429

Hypertrophy of breast in women and men

239

2113

1.13

1.14

2.0

1.71

2.08

ug/l

0.29

207

1880

Meralgia paraesthetica

371

1.33

1.12

2.4

2.1

3.46

2.09

ug/l

0.25

330

Tonsillectomy and adenotomy

587

4421

0.92

1.12

1.9

2.1

1.45

2.09

ug/l

1.15

519

3972

Other bursitis of elbow

104

1.68

1.12

2.2

2.1

0.74

1.11

ug/l

0.33

Other conjunctival vascular disorders and cysts

277

1.39

1.11

1.9

2.0

2.16

2.51

ug/l

0.08

247

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

277

1.39

1.11

2.3

2.0

3.64

2.61

ug/l

0.14

248

Type 1 diabetes, wide definition, subgroup 2

207

0.57

1.11

1.7

1.9

0.56

2.89

ug/l

0.88

168

Disorders of male genital organs in diseases classified elsewhere

1.86

1.11

2.6

2.1

0.51

1.32

ug/l

0.47

Glaucoma, exfoliation

211

1856

1.14

1.11

1.8

1.42

2.25

ug/l

0.99

171

1564

Other and unspecified injuries of shoulder and upper arm

320

1.36

1.11

2.1

2.0

5.77

1.53

ug/l

0.73

282

Benign neoplasm of brain and other parts of central nervous system

100

828

1.22

1.10

2.2

2.0

2.24

1.73

ug/l

0.34

738

Benign neoplasm: Testis

2.00

1.10

2.4

1.8

1.84

2.44

ug/l

—

Other protozoal intestinal diseases

136

1.57

1.10

1.5

1.8

0.80

3.39

ug/l

0.68

123

Benign neoplasm: salivary glands, exclude unknown (D119)

142

1217

1.17

1.07

2.2

2.0

2.76

2.36

ug/l

0.12

126

1075

Benign leiomyoma with endometriosis

176

1533

1.15

1.06

1.8

0.80

2.16

ug/l

3.84

147

1319

Acute disseminated encephalitis/encephalomyelitis

2.37

1.05

1.4

1.9

0.16

12.09

ug/l

—

Complications following abortion and ectopic and molar pregnancy

367

1.32

1.04

2.2

1.9

0.61

2.69

ug/l

1.71

328

Postpartum hemorraghe, all women as controls

151

1739

0.86

1.04

2.1

2.0

1.07

1.97

ug/l

1.05

139

1534

Torsion of testis

130

1.55

1.03

1.6

2.1

0.78

1.26

ug/l

0.45

118

Benign neoplasm: Anus and anal canal

307

1.35

1.03

2.0

1.8

0.46

1.83

ug/l

2.31

262

Foreign body on external eye

221

1961

1.13

1.03

2.2

2.1

4.00

2.28

ug/l

0.47

196

1778

Benign neoplasm: Skin of ear and external auricular canal

546

1.26

1.02

1.7

1.8

1.40

2.75

ug/l

0.74

471

Shoulder region

147

1.52

1.02

1.6

1.9

1.60

2.95

ug/l

0.29

135

Other osteochondropathies

818

1.20

1.01

1.8

2.1

3.04

1.63

ug/l

0.45

748

Other acquired deformities of musculoskeletal system and connective tissue

565

1.25

1.01

1.7

2.1

0.87

1.79

ug/l

0.89

503

Other maternal disorders predominantly related to pregnancy

636

3725

1.07

1.00

1.9

2.0

1.07

2.43

ug/l

2.60

558

3332

Intussusception

215

1.41

0.99

1.8

2.1

1.67

0.98

ug/l

0.41

191

Pigmented purpuric dermatosis

116

1.58

0.99

1.8

2.0

2.20

4.26

ug/l

0.32

109

Unspecific neurodegenerative disorder

853

5544

1.06

0.98

1.7

1.9

2.92

2.25

ug/l

0.51

654

4810

Benign neoplasm: Lip

216

1.40

0.97

2.0

1.7

0.85

1.39

ug/l

0.58

189

Benign neoplasm: Pituitary gland, craniopharyngeal duct

587

1.24

0.96

2.5

2.0

2.98

1.73

ug/l

0.51

521

Benign neoplasm: Pharynx, unspecified

1.81

0.95

1.6

0.46

2.43

ug/l

1.29

Other specified and unspecified disorders of conjunctiva

109

1.59

0.95

3.3

2.0

7.24

3.77

ug/l

0.30

101

Hypermetropia

716

1.21

0.93

2.3

2.0

6.10

1.93

ug/l

0.72

634

Oral leukoplakia and related diseases

755

1.20

0.91

2.3

2.0

0.65

1.65

ug/l

1.60

666

Motorcycle rider injured in noncollision transport accidents

279

1.34

0.91

3.4

2.2

3.73

1.30

ug/l

0.50

249

Chronic myeloid leukaemia

1.84

0.90

3.8

1.7

4.14

5.61

ug/l

—

Malignant neoplasm of gallbladder

1.84

0.90

1.6

1.17

5.39

ug/l

—

Disorders of orbit

484

1.25

0.89

2.2

1.9

0.66

1.17

ug/l

0.95

425

Injury of muscle and tendon at shoulder and upper arm level

654

6146

1.07

0.89

2.1

2.0

1.54

2.08

ug/l

1.02

584

5499

Glaucoma-related operations

826

0.82

0.89

1.7

1.9

4.20

2.28

ug/l

0.46

709

Other congenital malformations of skin

404

1.27

0.88

1.5

2.0

0.70

1.99

ug/l

0.97

362

Pedal cyclist injured in collision with motor vehicle

316

1.31

0.87

1.8

2.1

6.05

2.27

ug/l

0.37

281

Diastasis of muscle

1.75

0.87

1.9

2.1

5.41

0.35

ug/l

0.58

Atopic dermatitis

691

5548

1.06

0.87

1.9

2.0

2.04

2.25

ug/l

0.18

609

4906

Other or unspecified paralytic strabismus

1.70

0.86

1.2

2.0

0.80

1.80

ug/l

0.63

Inguinal hernia, bilateral

162

1830

0.88

0.86

1.8

1.9

3.69

2.30

ug/l

0.30

142

1630

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

1.83

0.86

2.5

1.9

0.86

7.43

ug/l

—

Postpartum hemorraghe, parous women as controls

151

1503

0.88

0.85

2.1

2.0

1.07

1.75

ug/l

0.74

139

1329

Other and unspecified trigeminal disorders

162

1.44

0.85

2.0

1.9

3.36

3.19

ug/l

0.02

151

Benign neoplasm of bone and articular cartilage

109

936

1.17

0.85

2.0

2.1

0.86

1.68

ug/l

1.22

841

Medical treatment for female infertility

147

1286

1.14

0.85

2.0

2.27

1.80

ug/l

0.15

137

1133

Contact with heat and hot substances

578

1.22

0.85

2.0

2.1

4.05

1.57

ug/l

0.54

514

Overjet

120

1.50

0.84

1.9

0.56

3.89

ug/l

0.83

109

Other, unspecified and serous retinal detachments

390

1.27

0.84

2.4

1.9

0.54

1.78

ug/l

2.28

346

Pathological resorption of teeth

310

1.30

0.83

2.3

2.0

1.31

1.40

ug/l

0.06

280

Effects of heat and light

1.64

0.83

3.5

1.6

2.29

4.29

ug/l

0.23

Benign neoplasm: Parotid gland

125

1090

1.15

0.81

2.2

2.0

3.01

2.04

ug/l

0.30

109

966

Pregnancy examination and test

118

636

1.16

0.81

2.0

0.84

2.01

ug/l

1.96

108

565

Monoamine oxidase A inhibitors

173

1542

1.13

0.80

2.2

2.0

1.24

2.09

ug/l

0.80

156

1389

Burn and corrosion of head and neck

233

1.34

0.80

1.8

2.1

3.76

2.64

ug/l

0.14

214

Other noninflammatory disorders of vulva and perineum

830

1.17

0.80

2.3

1.9

4.79

2.02

ug/l

0.44

741

Benign neoplasm: Long bones of lower limb

330

1.28

0.80

2.0

1.12

2.09

ug/l

0.47

301

Inguinal or femoral hernia, bilateral

166

1861

0.89

0.80

1.9

3.62

2.29

ug/l

0.30

145

1657

Other congenital malformations of face and neck

260

1.32

0.78

1.6

2.0

1.88

2.35

ug/l

0.10

236

Benign neoplasm: Tongue

349

1.27

0.78

2.2

1.9

1.84

2.18

ug/l

0.09

312

Ptosis of eyelid

180

1613

1.12

0.78

2.1

1.9

1.82

2.24

ug/l

0.18

160

1405

Endometriosis of pelvic peritoneum

158

1385

1.13

0.78

2.2

2.0

1.78

1.79

ug/l

0.01

142

1254

Injury of muscle and tendon at hip and thigh level

135

1189

1.14

0.77

2.0

2.1

1.63

2.06

ug/l

0.24

116

1077

Loose body in joint

288

1.30

0.76

1.9

2.0

1.40

1.63

ug/l

0.13

263

Oral leukoplakia and related diseases, including avohilmo

134

1181

1.14

0.76

2.1

2.0

0.96

1.94

ug/l

1.98

109

1054

Benign neoplasm: Vulva

218

1.34

0.76

1.8

1.9

6.89

2.33

ug/l

0.50

193

Spermatocele

142

1258

1.13

0.75

2.0

2.17

2.90

ug/l

0.35

131

1112

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

469

1.23

0.75

2.2

1.8

1.47

1.86

ug/l

0.17

396

Congenital malformations of uterus and cervix

116

1.48

0.74

3.3

1.9

0.75

0.91

ug/l

0.18

102

Glaucoma secondary to eye trauma

1.56

0.74

1.8

2.0

0.88

1.53

ug/l

—

Nontoxic single thyroid nodule

847

1.16

0.74

1.8

1.9

1.54

2.32

ug/l

0.48

760

Adenomyosis (Endometriosis of uterus)

135

1524

0.88

0.73

2.0

1.9

1.25

2.18

ug/l

1.28

118

1367

Benign neoplasm: Skin of eyelid, including canthus

247

2259

1.10

0.73

2.1

1.9

2.31

2.14

ug/l

0.09

211

1979

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

525

1.21

0.73

2.1

2.0

6.01

1.79

ug/l

0.75

465

Carcinoma in situ of cervix uteri

616

1.19

0.73

2.0

1.9

2.20

1.93

ug/l

0.10

540

Hydatidiform mole

109

0.55

0.73

1.0

1.8

0.59

3.76

ug/l

—

100

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

344

1.26

0.72

1.7

1.9

2.86

2.11

ug/l

0.21

312

Other fibroblastic disorders

1.79

0.72

1.7

2.2

0.36

0.91

ug/l

—

Maternal care for other known or suspected fetal problems

162

927

1.12

0.72

1.6

2.1

1.22

1.76

ug/l

0.34

140

825

Severe visual impairment, monocular

101

1.51

0.71

1.8

4.76

3.92

ug/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

194

1756

1.11

0.71

2.1

2.0

2.97

2.13

ug/l

0.26

173

1574

1.96

0.71

1.6

1.8

9.66

1.16

ug/l

—

Anisometropia and aniseikonia

336

1.26

0.71

1.8

1.9

0.86

2.28

ug/l

0.77

296

Histrionic personality disorder

1.58

0.71

1.8

8.06

6.85

ug/l

—

Epiphora

274

1.29

0.71

1.7

1.9

0.57

1.57

ug/l

1.60

242

Status post-ami

121

1125

0.88

0.71

2.2

1.7

4.17

3.40

ug/l

0.21

108

896

Macular hole

777

1.17

0.70

1.8

1.9

3.69

2.00

ug/l

0.57

684

Migraine with aura, drug-induced

1.52

0.70

2.4

1.9

0.21

1.62

ug/l

1.81

Benign neoplasm: Vagina

118

1.46

0.70

1.8

1.6

1.36

1.41

ug/l

0.02

100

Alcoholic cardiomyopathy

1.64

0.70

2.1

6.42

2.72

ug/l

0.38

Nontoxic diffuse goitre

355

1.25

0.70

1.6

1.8

0.73

2.10

ug/l

0.96

311

Systemic atrophies primarily affecting the central nervous system

565

1.19

0.70

2.4

2.0

0.59

2.15

ug/l

2.00

496

Benign neoplasm: Central nervous system, other parts/unspecified

1.70

0.69

2.3

1.9

0.96

7.49

ug/l

—

Open bite

319

1.26

0.69

2.7

2.0

3.04

2.06

ug/l

0.28

288

Transient global amnesia

152

1364

1.12

0.67

1.9

3.56

2.43

ug/l

0.39

130

1213

Other disorders of cornea

132

1175

1.13

0.67

1.8

2.0

1.54

1.95

ug/l

0.33

116

1038

Hyperkinetic disorders (excl. ADHD)

1.52

0.67

1.5

1.8

5.90

1.27

ug/l

0.40

Striae atrophicae

1.53

0.67

2.7

1.6

0.48

4.31

ug/l

0.66

Benign leiomyoma with endometriosis

176

1942

0.90

0.66

1.8

1.9

0.80

2.06

ug/l

4.44

147

1710

Leiomyoma of uterus

885

4811

1.05

0.66

2.0

1.9

1.81

2.14

ug/l

0.58

749

4217

Subacute thyroiditis

359

1.23

0.64

2.1

1.9

1.47

1.95

ug/l

0.21

315

Alzheimer’s disease (Early onset)

655

0.83

0.64

2.2

1.8

1.27

2.53

ug/l

0.63

543

Stenosis and insufficiency of lacrimal passages

137

1227

1.12

0.64

1.7

1.9

1.38

1.92

ug/l

0.32

122

1070

Exposure to other and unspecified animate mechanical forces

234

1.29

0.63

2.1

0.38

2.16

ug/l

0.88

212

Hypertrophy of breast

180

1637

1.10

0.62

2.0

1.27

2.02

ug/l

0.82

153

1455

Other and unspecified iridocyclitis

489

1.19

0.62

1.8

2.0

0.48

1.97

ug/l

1.70

432

Other and specified injuries of hip and thigh

271

1.27

0.62

2.0

1.9

6.50

2.49

ug/l

0.43

237

Delayed puberty

1.68

0.61

3.8

1.8

0.15

1.57

ug/l

—

Maternal care for known or suspected abnormality of pelvic organs

162

1235

0.90

0.61

1.7

2.0

1.55

1.95

ug/l

0.22

141

1102

Noise effects on inner ear

601

1.17

0.61

1.8

2.0

2.06

1.97

ug/l

0.02

544

Ganglion

267

2477

1.08

0.60

2.0

1.9

1.44

2.31

ug/l

1.00

244

2207

Gonococcal infection

308

1.24

0.60

2.1

2.0

0.57

1.94

ug/l

0.90

283

Generalized epilepsy, strict definition

183

1.32

0.60

3.5

1.9

0.74

2.57

ug/l

0.63

163

Long labour

160

1540

0.91

0.60

2.0

1.67

1.62

ug/l

0.04

137

1365

Disorders in reading

1.54

0.59

3.0

2.0

0.99

5.01

ug/l

0.55

Desensitization to allergens

355

0.79

0.59

1.8

2.0

2.53

2.44

ug/l

0.02

319

Benign neoplasm: Skin of scalp and neck

291

1.25

0.59

2.3

1.9

2.29

2.61

ug/l

0.09

256

Routine general health check-up of defined subpopulation

112

0.62

0.58

2.6

2.0

0.56

1.88

ug/l

—

Multifocal fibrosclerosis

1.51

0.58

2.5

1.9

1.12

4.79

ug/l

0.50

Poor fetal growth

706

1.15

0.58

1.7

2.0

2.77

1.17

ug/l

0.51

631

Other congenital malformations of tongue, mouth and pharynx

1.56

0.58

2.2

1.8

0.36

1.52

ug/l

—

Vestibular neuronitis

132

1189

1.11

0.57

2.2

2.0

2.35

2.31

ug/l

0.02

106

1063

Use of rasagiline

356

1.22

0.57

1.7

1.9

1.55

2.14

ug/l

0.25

317

Benign neoplasm of ovary

226

2089

1.08

0.57

1.9

2.38

1.98

ug/l

0.15

200

1841

Benign neoplasm: Scapula and long bones of upper limb

1.52

0.57

2.6

1.6

1.66

2.14

ug/l

0.13

Benign neoplasm: Brain, unspecified

1.47

0.56

5.0

1.7

4.47

2.32

ug/l

—

Use of selegiline

719

1.15

0.56

1.9

1.17

1.88

ug/l

0.64

624

Other/unspecified enthesopathies of lower limb, excluding foot

747

1.14

0.55

2.1

1.23

2.39

ug/l

1.07

681

Alzheimer disease

607

4366

1.05

0.55

1.8

3.23

2.31

ug/l

0.50

452

3720

Diseases of thymus

1.62

0.55

1.3

1.6

7.48

8.81

ug/l

—

Glaucoma secondary to eye inflammation

1.43

0.55

1.7

2.1

0.21

5.01

ug/l

0.98

Degenerative diseases of the nervous system

686

4944

1.05

0.54

1.8

3.29

2.35

ug/l

0.59

524

4253

Use of galantamine

101

1131

0.89

0.54

1.5

1.8

2.90

2.72

ug/l

0.06

943

Hereditary sideroblastic anaemia

1.56

0.53

2.0

1.5

0.20

1.40

ug/l

—

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

1.56

0.53

1.8

1.4

5.69

2.05

ug/l

—

Benign neoplasm: Conjunctiva

382

0.81

0.53

1.7

1.9

2.07

2.25

ug/l

0.04

336

All dysplastic lesions of the vulva

377

1.20

0.53

2.3

2.0

1.03

2.10

ug/l

0.66

333

Liposarcoma

0.62

0.53

2.0

0.23

5.60

ug/l

—

Unspecified privation

155

1416

1.10

0.53

2.2

2.0

2.17

2.18

ug/l

0.00

137

1245

Deep bite

887

0.89

0.52

2.0

2.1

1.86

2.11

ug/l

0.10

799

Osteomalacia

1.46

0.52

1.6

1.8

3.13

4.80

ug/l

0.16

Delayed milestone in childhood

1.43

0.52

3.2

2.9

0.94

1.96

ug/l

—

Chronic thyroiditis

1.52

0.52

2.0

1.6

2.36

9.33

ug/l

—

Ankyloglossia

1.52

0.52

2.4

2.2

0.33

1.63

ug/l

—

Normal-pressure hydrocephalus

791

1.13

0.51

1.8

1.9

1.04

2.87

ug/l

1.51

665

Chronic mastoiditis

361

1.20

0.51

1.8

1.05

2.26

ug/l

0.71

319

Macular cyst

362

1.20

0.50

1.7

1.9

3.08

1.75

ug/l

0.23

322

Unattended death

106

0.65

0.49

2.0

1.21

5.31

ug/l

—

Paget disease

1.50

0.48

1.9

1.7

0.19

4.98

ug/l

—

Disorders of conjunctiva

1308

10644

1.03

0.47

2.0

1.71

2.30

ug/l

1.05

1159

9372

Pedestrian injured in transport accident

824

1.12

0.47

1.6

2.0

2.05

1.69

ug/l

0.13

732

Oral leukoplakia, including avohilmo

346

1.19

0.47

2.1

0.67

2.12

ug/l

0.97

313

Use of donepezil

340

3453

0.94

0.47

1.8

3.64

2.41

ug/l

0.40

252

2901

Injury of muscle and tendon at wrist and hand level

196

1822

1.08

0.46

2.0

1.08

2.40

ug/l

1.52

178

1633

Foreign body entering into or through eye or natural orifice

109

987

1.11

0.46

1.9

2.1

0.81

2.12

ug/l

1.63

896

Nasal polyp

319

3016

1.06

0.46

1.9

2.0

1.92

2.38

ug/l

0.29

272

2683

Chronic suppurative otitis media, including avohilmo

107

969

1.11

0.46

2.3

2.0

1.26

1.76

ug/l

0.32

855

Lesion of plantar nerve

723

1.12

0.45

2.1

2.0

1.11

1.97

ug/l

0.67

640

HSIL lesion of the cervix uteri

117

1283

0.91

0.44

2.4

1.9

4.85

1.67

ug/l

0.89

1130

Melanoma in situ

587

0.86

0.44

1.9

1.99

1.93

ug/l

0.02

510

Female infertility, cervigal, vaginal, other or unspecified origin

269

1693

1.06

0.44

2.0

1.98

1.78

ug/l

0.14

245

1521

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.38

0.44

2.9

1.8

1.88

3.15

ug/l

—

Fenamates

230

1656

0.93

0.44

2.0

2.08

2.36

ug/l

0.17

204

1480

Acquired stenosis of external ear canal

128

0.69

0.44

2.1

2.2

1.38

3.80

ug/l

—

115

Congenital malformations of anterior segment of eye

1.43

0.43

2.3

1.9

0.60

4.11

ug/l

0.50

Intrahepatic Cholestasis of Pregnancy (ICP)

426

0.84

0.43

2.8

2.0

1.93

1.68

ug/l

0.07

389

All dysplastic lesions of the cervix uteri

178

1910

0.93

0.43

2.3

2.0

3.47

1.88

ug/l

0.61

153

1700

Melanoma in situ of upper limb, including shoulder

1.44

0.43

1.5

1.8

2.91

2.42

ug/l

—

Malignant neoplasm of nasal cavity and middle ear

1.43

0.43

3.4

2.1

0.60

6.44

ug/l

—

Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)

1.58

0.42

2.0

1.5

0.91

1.41

ug/l

—

Chalazion

155

1435

1.08

0.42

2.2

2.0

2.98

2.18

ug/l

0.32

133

1271

Venous complications and haemorrhoids in the puerperium

0.63

0.42

2.5

1.7

9.20

1.44

ug/l

—

Pedal cyclist injured in noncollision transport accidents

139

1281

1.09

0.42

2.2

2.0

1.46

2.25

ug/l

0.67

127

1150

Abrasion of teeth

369

2850

0.95

0.42

2.1

2.0

2.07

1.93

ug/l

0.11

329

2532

Premature rupture of membranes

132

1055

0.92

0.42

2.1

2.49

2.09

ug/l

0.17

113

936

Carcinoma in situ of breast

1.53

0.41

1.2

2.1

1.04

0.47

ug/l

—

Pregnancy with abortive outcome

892

4518

1.03

0.41

1.9

1.63

2.41

ug/l

1.17

773

3950

Secondary sideroblastic anaemia

1.49

0.41

2.6

1.6

1.62

1.40

ug/l

—

Vasomotor rhinitis (mode)

891

1.10

0.40

2.1

2.0

1.73

1.62

ug/l

0.04

794

Macular pucker

257

2428

1.06

0.40

2.0

1.9

5.41

2.19

ug/l

0.82

213

2123

Dacryoadenitis

1.38

0.40

2.4

2.0

0.46

1.61

ug/l

1.18

Benign neoplasm: Choroid

796

1.11

0.40

1.8

2.0

2.75

2.12

ug/l

0.15

705

Other disorders of breast

133

1227

1.09

0.40

1.8

1.9

1.36

2.07

ug/l

0.74

115

1078

Primary angle-closure glaucoma

635

1.12

0.40

1.4

2.0

1.26

2.20

ug/l

0.54

545

Degenerative myopia

1.36

0.38

1.6

5.54

4.97

ug/l

—

Other osteochondrodysplasias

1.35

0.38

1.9

2.0

2.08

5.19

ug/l

—

Transient synovitis

1.35

0.38

1.8

2.0

0.39

0.67

ug/l

—

Other deformities of toe(s)

392

1.15

0.38

2.0

0.26

1.41

ug/l

3.77

356

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

419

0.86

0.37

2.8

2.0

1.93

1.57

ug/l

0.11

383

Progressive vascular leukoencephalopathy

487

1.14

0.37

1.8

1.7

1.01

2.60

ug/l

1.33

411

Contact with nonpowered hand tool

534

1.13

0.37

2.0

2.1

0.70

2.08

ug/l

1.65

482

Postpartum haemorrhage due to anatomy

536

0.88

0.37

2.2

2.0

0.54

1.37

ug/l

1.60

480

Sequelae of other and unspecified infectious and parasitic diseases

591

1.12

0.37

2.1

2.33

1.95

ug/l

0.14

539

Glucosamine medication

930

7626

0.97

0.36

1.9

2.57

2.21

ug/l

0.31

781

6679

LSIL lesion of the cervix uteri

798

0.90

0.36

2.0

1.9

1.41

2.10

ug/l

0.46

710

Pneumoconiosis due to dust containing silica

1.41

0.35

2.7

2.0

1.11

1.06

ug/l

—

Cholesteatoma of middle ear

775

1.10

0.35

1.9

2.0

1.33

2.65

ug/l

0.82

686

Polypectomy (DHB20)

983

0.91

0.35

1.9

2.0

1.54

1.98

ug/l

0.21

885

Contact with other hot fluids

298

0.84

0.35

1.6

1.9

0.30

2.38

ug/l

1.47

269

Lesion of femoral nerve

1.38

0.35

2.1

1.8

0.46

5.23

ug/l

—

Benign neoplasm: Pharynx, unspecified

1.36

0.34

1.6

1.9

0.46

4.85

ug/l

0.73

Tinnitus

350

3354

1.05

0.34

2.1

2.0

1.26

2.22

ug/l

1.74

302

2995

Congenital malformations of ovaries, fallopian tubes and broad ligaments

396

1.14

0.34

2.3

2.0

0.25

1.99

ug/l

1.72

360

Maternal care for known or suspected malpresentation of fetus

794

0.92

0.33

1.8

2.1

0.51

1.72

ug/l

3.49

705

Special screening examination for neoplasms

519

0.88

0.33

1.8

1.12

2.82

ug/l

1.11

457

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.28

0.32

1.5

3.0

0.56

2.11

ug/l

—

Carbimazole or st.post thyroidectomy, condition for graves disease

259

2469

1.05

0.32

2.2

1.9

1.12

2.05

ug/l

2.01

223

2186

Conjunctivitis

1063

9477

0.98

0.32

2.0

1.34

2.32

ug/l

2.63

942

8342

Endometriosis ASRM stages 1,2

166

1563

1.06

0.32

2.2

1.9

1.69

1.81

ug/l

0.06

150

1386

Bicipital tendinitis

589

1.11

0.31

1.6

2.1

0.80

2.29

ug/l

1.19

529

Benign neoplasm: Vagina

138

1.24

0.31

1.8

1.6

1.36

3.42

ug/l

0.46

122

Postdysenteric arthropathy

1.30

0.30

3.6

1.9

0.51

4.11

ug/l

0.66

Alcohol abuse counselling and surveillance

174

0.80

0.30

2.9

2.1

0.98

3.13

ug/l

0.71

161

Other congenital malformations of nervous system

1.25

0.29

3.4

1.7

0.45

6.65

ug/l

—

Chronic suppurative otitis media

832

1.08

0.29

2.2

1.9

1.43

1.69

ug/l

0.13

729

Carcinoma in situ of skin

132

1239

1.07

0.29

1.9

1.8

1.86

2.46

ug/l

0.26

115

1060

Xanthelasma of eyelid

106

0.75

0.29

2.9

1.9

5.25

1.43

ug/l

—

Benign neoplasm: Skin of trunk

506

1.11

0.29

2.1

2.0

0.73

1.77

ug/l

0.98

452

Asymmetry of jaw

106

0.75

0.29

2.4

1.8

0.16

3.77

ug/l

—

101

Crushed, pushed or stepped on by crowd or human stampede

631

1.10

0.29

2.1

7.11

2.06

ug/l

0.90

562

Caught, crushed, jammed or pinched in or between objects

507

1.11

0.28

2.1

2.0

1.74

1.96

ug/l

0.07

458

Benign neoplasm: Testis

1.31

0.28

2.4

2.3

1.84

3.07

ug/l

—

Benign neoplasm: Bones of skull and face

1.33

0.28

1.9

1.8

0.17

1.34

ug/l

—

Oral lichen ruber planus

280

0.85

0.28

1.8

2.0

1.30

2.08

ug/l

0.22

253

Benign neoplasm: Brain, unspecified

1.28

0.28

5.0

1.6

4.47

4.99

ug/l

—

Other articular cartilage disorders

290

1.14

0.27

1.7

2.1

0.63

1.48

ug/l

1.10

268

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

462

1.11

0.26

1.5

2.0

0.39

1.93

ug/l

1.70

416

Other infective otitis externa

712

1.08

0.26

2.0

2.08

1.77

ug/l

0.14

632

Benign neoplasm: Bone and articular cartilage, unspecified

0.66

0.26

1.6

1.9

1.88

4.86

ug/l

—

Carcinoma in situ of cervix uteri, endocervix

0.67

0.26

1.4

1.9

0.13

5.27

ug/l

—

Other maltreatment syndromes

273

1.14

0.25

2.3

2.1

0.82

1.55

ug/l

0.86

245

Follicular adenocarcinoma of thyroid gland

1.30

0.24

2.6

1.8

0.32

4.41

ug/l

—

Supervision of high-risk pregnancy

144

919

0.95

0.24

1.9

2.1

0.60

1.79

ug/l

3.56

133

825

Burn and corrosion of wrist and hand

379

1.11

0.24

1.8

2.0

0.89

2.12

ug/l

0.86

339

Alzheimer’s disease (Early onset), excluding more controls

466

1.10

0.24

2.2

1.8

1.27

2.92

ug/l

0.86

398

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

152

1.19

0.24

2.8

2.1

1.26

2.71

ug/l

0.36

136

Varus deformity, not elsewhere classified

106

1.23

0.23

1.4

2.1

1.20

2.28

ug/l

0.51

Unspecified lump in breast

182

1741

1.05

0.23

1.9

2.89

2.04

ug/l

0.23

159

1531

Phlebitis and thrombophlebitis of unspecified site, drug-induced

0.00

0.22

0.0

1.8

—

24.58

—

Retained (old) intraocular foreign body

0.00

0.22

0.0

2.1

—

0.41

—

Pityriasis alba

0.00

0.22

0.0

3.0

—

0.22

—

Intentional self-harm by crashing of motor vehicle

0.00

0.22

0.0

1.9

—

24.61

—

Abnormalities of forces of labour

729

1.07

0.21

2.1

2.0

1.41

1.53

ug/l

0.07

650

Gluteal tendinitis

353

1.11

0.21

2.5

2.2

0.94

2.21

ug/l

0.78

321

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

1.23

0.21

1.6

1.7

1.41

1.92

ug/l

0.22

Contact with lifting and transmission devices, not elsewhere classified

230

0.87

0.21

1.9

2.1

5.11

2.94

ug/l

0.33

210

Contaminated medical or biological substances

0.00

0.21

0.0

2.2

—

0.60

—

Benign neoplasm: Retina

1.17

0.21

2.6

1.7

16.41

1.34

ug/l

—

Vascular dementia (subcortical)

402

1.10

0.21

1.7

1.8

0.79

3.38

ug/l

1.53

333

Triptan medication for migraine, min. 3 purchases

615

4747

1.02

0.21

2.0

1.98

2.04

ug/l

0.05

544

4259

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.25

0.20

1.5

3.0

0.56

2.07

ug/l

—

Childhood allergy (age < 16)

594

1.07

0.20

2.1

2.0

1.63

2.11

ug/l

0.34

523

Unspecified parasitic disease

1.22

0.20

2.0

26.71

5.61

ug/l

0.35

Obstructed labour due to malposition and malpresentation of fetus

148

1456

0.96

0.19

1.9

2.0

2.51

1.39

ug/l

0.64

132

1291

Pterygium

447

0.91

0.19

2.0

1.20

1.84

ug/l

0.29

395

Calcaneal spur

122

0.82

0.19

2.0

1.9

1.05

1.54

ug/l

—

111

Complications of labour and delivery

706

4013

0.98

0.19

2.1

2.0

2.08

2.30

ug/l

0.16

646

3532

Fall on and from ladder

126

1203

1.05

0.19

2.0

1.9

1.07

2.62

ug/l

1.69

112

1072

Mandibular retrognathia

528

0.92

0.19

2.3

2.2

4.41

2.06

ug/l

0.47

481

Sexual dysfunction

156

1.16

0.19

1.9

2.0

0.60

1.67

ug/l

0.98

140

Melanoma in situ of other and unspecified parts of face

164

0.85

0.18

1.4

1.7

0.47

3.69

ug/l

—

141

Overexertion and strenuous or repetitive movements

122

1165

1.05

0.18

2.1

2.0

3.00

1.72

ug/l

0.54

109

1047

Disorders of pituitary gland, other and/or unspecified

1.21

0.18

4.4

1.6

1.56

5.88

ug/l

—

Hair colour and hair shaft abnormalities

1.18

0.18

2.3

2.0

2.47

3.03

ug/l

—

Plantar fascial fibromatosis

115

1098

1.05

0.17

2.0

0.46

2.36

ug/l

4.76

104

985

Lichen ruber planus, wide definition including periferal and oral lichen planus

309

3008

1.03

0.17

2.0

1.9

2.17

2.27

ug/l

0.07

261

2673

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

781

6266

1.02

0.17

2.0

2.61

2.04

ug/l

0.42

688

5542

Benign neoplasm: Cranial nerves

368

1.09

0.17

1.9

2.0

2.25

2.12

ug/l

0.04

327

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

913

1.05

0.17

1.8

2.0

3.76

2.10

ug/l

0.43

815

Chondromalacia

320

1.10

0.17

1.6

2.0

0.49

2.27

ug/l

1.24

291

Injury of nerves at wrist and hand level

407

1.08

0.17

2.1

2.47

1.78

ug/l

0.12

369

Melanoma in situ

475

1.08

0.17

1.9

1.7

1.99

1.79

ug/l

0.07

410

Failed attempted abortion

0.76

0.17

1.6

1.9

0.18

1.63

ug/l

—

Other congenital malformations of ear

0.72

0.17

2.8

1.9

0.68

5.22

ug/l

—

Tarsal tunnel syndrome

101

1.19

0.17

1.8

0.89

4.15

ug/l

0.67

Benign neoplasm: Skin of lower limb, including hip

340

1.09

0.16

2.0

1.9

2.64

1.99

ug/l

0.13

306

Tic disorders

1.18

0.16

2.1

1.8

1.39

5.62

ug/l

—

Tic and related disorders

1.16

0.16

2.1

1.8

1.39

6.28

ug/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

226

2314

0.97

0.16

2.3

2.0

2.95

1.73

ug/l

0.58

193

2049

Erosion of teeth, including avohilmo

242

2271

1.03

0.16

2.2

2.1

1.98

1.90

ug/l

0.06

219

2029

Tic and related disorders

1.10

0.15

2.1

1.8

1.39

4.93

ug/l

—

Other complications of labour and delivery, not elsewhere classified

535

0.94

0.15

1.9

0.61

1.20

ug/l

1.08

455

Malignant neoplasm of larynx

245

1.11

0.15

1.4

2.0

0.87

1.33

ug/l

0.28

212

Cutis laxa senilis

1.14

0.15

4.2

1.6

1.26

1.63

ug/l

—

Dysplasia of cervi uteri

211

1681

0.97

0.15

2.2

2.0

3.28

1.78

ug/l

0.71

184

1500

Malignant melanoma

227

2334

0.97

0.15

1.8

1.9

1.89

2.50

ug/l

0.34

191

2039

Benign neoplasm: Short bones of lower limb

1.11

0.15

2.2

1.8

0.28

2.01

ug/l

—

Benign neoplasm: Conjunctiva

284

1.09

0.15

1.7

2.07

1.54

ug/l

0.16

248

Benign neoplasm: Scapula and long bones of upper limb

1.19

0.14

2.6

1.9

1.66

1.56

ug/l

0.02

Carcinoma in situ of breast, intraductal

911

0.95

0.14

2.0

1.9

3.20

1.76

ug/l

0.58

811

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

625

1.06

0.14

2.7

2.0

1.07

1.80

ug/l

0.50

564

Antepartum haemorrhage, not elsewhere classified

499

1.06

0.14

2.1

2.0

1.68

1.47

ug/l

0.09

441

Pregnancy, childbirth and the puerperium

424

2261

0.98

0.13

1.8

1.24

3.08

ug/l

1.84

375

1919

Carcinoma in situ of skin of lower limb, including hip

228

1.10

0.13

1.7

1.6

0.46

1.93

ug/l

1.88

196

Benign neoplasm: Short bones of lower limb

108

0.83

0.13

2.2

2.1

0.28

3.61

ug/l

—

100

Labour and delivery complicated by fetal stress [distress]

136

938

0.97

0.13

1.7

2.0

3.95

1.56

ug/l

0.73

122

820

Melanoma in situ of other and unspecified parts of face

123

1.14

0.12

1.4

1.6

0.47

2.50

ug/l

—

107

Alzheimer’s disease, wide definition

440

3741

0.98

0.12

1.8

3.67

2.36

ug/l

0.57

323

3149

Thyrotoxicosis with toxic multinodular goitre

732

0.95

0.12

1.9

0.68

1.93

ug/l

1.62

629

Spirochaetal infections, other/unspecified

113

1093

1.04

0.11

2.2

2.0

1.15

2.38

ug/l

1.47

982

Carcinoma in situ of skin of lower limb, including hip

271

0.92

0.11

1.7

1.8

0.46

2.69

ug/l

1.30

231

Anogenital herpesviral [herpes simplex] infection

476

0.94

0.11

2.0

2.03

1.99

ug/l

0.01

427

Benign neoplasm: Anus and anal canal

386

1.06

0.11

2.0

1.9

0.46

2.07

ug/l

1.39

338

Other and unspecified disorders of vitreous body

661

6651

0.99

0.10

2.0

4.06

2.13

ug/l

0.41

580

5885

Benign neoplasm: Lip

280

1.07

0.10

2.0

1.8

0.85

2.64

ug/l

0.97

248

Other and/or unspecified nontoxic goitre

104

1007

1.03

0.10

1.8

1.9

2.97

1.95

ug/l

0.37

889

Adenocarcinomas of cervix

1.14

0.10

2.0

1.5

0.91

7.06

ug/l

—

Congenital malformations of posterior segment of eye

1.11

0.10

1.4

2.0

0.14

8.00

ug/l

—

Papillary adenocarcinoma of thyroid gland

575

1.04

0.09

2.9

2.1

2.28

2.00

ug/l

0.09

504

Graves disease, strict definition

960

0.97

0.09

2.2

2.0

0.88

2.06

ug/l

1.65

852

Anomalies of dental arch relationship, including avohilmo

188

1653

1.02

0.09

2.2

2.0

2.23

1.95

ug/l

0.17

163

1485

Pollen allergy

148

1499

0.98

0.09

1.8

2.0

1.18

1.93

ug/l

1.24

130

1346

Allergic rhinitis

325

3172

1.01

0.08

2.0

1.19

2.08

ug/l

2.41

285

2846

Other specified/unspecified diseases of inner ear

0.83

0.08

3.4

1.7

2.92

5.55

ug/l

—

Benign neoplasm: Retina

0.78

0.08

2.6

1.9

16.41

5.00

ug/l

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.03

0.08

2.9

1.9

1.88

5.20

ug/l

—

Carcinoma in situ of breast, lobular

1.03

0.08

2.3

1.5

0.29

1.46

ug/l

—

LSIL lesion of the cervix uteri, vagina or vulva

105

1077

0.97

0.07

2.0

1.9

1.09

1.93

ug/l

0.93

945

Ectopic pregnancy

167

1638

1.02

0.07

1.9

2.0

2.57

1.95

ug/l

0.22

155

1490

Androgenic alopecia

0.83

0.07

3.3

1.5

2.95

5.04

ug/l

—

False labour

213

1315

1.02

0.07

1.6

2.1

1.13

1.64

ug/l

0.47

182

1173

Disorders of puberty, all

1.04

0.07

2.8

1.8

0.40

1.55

ug/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

103

1005

1.03

0.07

2.0

2.1

1.15

1.76

ug/l

0.54

902

Contact with machinery

171

1680

1.02

0.07

1.9

2.0

1.66

2.73

ug/l

0.76

161

1499

Benign neoplasm of breast

137

1343

1.02

0.07

1.7

1.9

2.21

1.82

ug/l

0.22

113

1173

Struck by thrown, projected or falling objec

531

1.04

0.07

1.8

2.1

1.10

1.99

ug/l

0.65

485

Benign neoplasm: Bones of skull and face

1.13

0.07

1.9

1.6

0.17

4.24

ug/l

—

Malignant melanoma of skin

171

1739

0.98

0.06

1.8

1.9

2.20

2.38

ug/l

0.06

144

1520

Other abnormal products of conception

236

1595

0.99

0.06

1.9

2.1

1.74

ug/l

0.00

201

1433

Melanocytic naevi of other and unspecified parts of face

621

1.03

0.06

1.9

2.0

1.00

1.74

ug/l

0.60

542

Prolapse and hernia of ovary and fallopian tube

538

1.03

0.05

1.9

1.7

1.00

1.83

ug/l

0.94

457

Gestational diabetes (for exclusion)

254

1818

0.99

0.05

1.9

2.1

1.40

1.80

ug/l

0.50

227

1612

Alzheimer disease, including avohilmo

686

4921

1.01

0.05

1.7

1.8

3.08

2.17

ug/l

0.62

533

4215

Perineal laceration during delivery

837

0.98

0.05

2.0

0.28

1.92

ug/l

3.63

724

Benign neoplasm of eye and adnexa

138

1400

0.99

0.04

1.8

2.0

3.03

2.39

ug/l

0.20

111

1237

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

645

1.02

0.04

2.7

2.0

1.07

2.30

ug/l

0.85

581

Other puerperal infections

433

0.97

0.04

1.5

2.0

0.51

1.43

ug/l

1.68

384

Foreign body or object entering through skin

715

0.98

0.04

2.0

2.1

2.65

1.90

ug/l

0.23

647

Alzheimer’s disease (Late onset)

410

3489

1.01

0.04

1.7

1.8

3.76

2.34

ug/l

0.59

302

2922

Presbyopia

696

1.02

0.04

1.7

2.1

4.31

1.82

ug/l

0.36

634

Foreign body in respiratory tract

577

1.02

0.03

2.0

2.07

1.87

ug/l

0.07

515

Vertical strabismus

369

1.03

0.03

2.0

1.8

2.64

2.03

ug/l

0.10

330

Blepharochalasis

480

4779

1.00

0.02

2.1

1.9

2.99

2.19

ug/l

0.35

420

4185

Uterine polyps

101

998

1.01

0.02

1.7

2.0

0.66

1.91

ug/l

3.52

902

HSIL lesion of the cervix uteri, vagina or vulva

149

1477

1.01

0.02

2.4

1.9

4.10

1.85

ug/l

0.78

128

1298

Retinal breaks without detachment

233

2316

1.01

0.02

1.8

2.0

1.52

1.95

ug/l

0.31

192

2058

Other inflammation of vagina/vulva

238

0.97

0.02

2.0

1.9

0.34

1.38

ug/l

1.55

214

Disturbances of smell and taste

492

1.02

0.01

1.8

2.0

4.97

1.27

ug/l

0.61

436

Single delivery by caesarean section

139

798

1.01

0.01

1.9

2.2

1.35

2.23

ug/l

0.58

126

709

Biomechanical lesions, not elsewhere classified

592

1.01

0.01

2.9

2.0

0.97

1.85

ug/l

0.75

520

Vascular dementia (multiple infarctions)

173

1.04

0.01

2.1

1.7

0.56

2.77

ug/l

0.70

144

Spontaneous abortion

487

3320

1.00

0.01

2.0

1.66

2.31

ug/l

0.55

430

2964

Obstructed labour due to maternal pelvic abnormality

151

1516

1.00

0.00

2.4

2.0

2.81

1.80

ug/l

0.40

135

1356

Retinal detachment with retinal break

204

2042

1.00

0.00

1.8

1.9

1.06

2.12

ug/l

1.89

183

1794

Normotensive glaucoma

127

1271

1.00

0.00

1.8

1.9

4.21

2.24

ug/l

0.51

117

1086

Malignant neoplasm of parotid gland

1.01

0.00

1.6

1.8

1.21

3.92

ug/l

—

Crossbite

458

0.99

0.00

2.5

2.0

4.28

2.28

ug/l

0.44

415

Distal bite

216

1.01

0.00

2.1

7.18

1.34

ug/l

0.56

198

Carcinoma in situ, thyroid and other endocrine glands

0.00

0.0

1.8

—

0.33

—

Other drug-induced osteomalacia in adults

0.00

0.0

2.2

—

0.37

—

Crushing injury of neck

0.00

0.0

1.5

—

0.44

—

Blindness (ICD-9)

0.00

0.0

2.6

—

0.34

—

Haemorrhagic and haematological disorders of fetus and newborn

0.92

0.00

5.5

2.4

3.00

1.61

ug/l

—

Benign neoplasm: Bone and articular cartilage, unspecified

1.02

0.00

1.6

1.88

1.95

ug/l

—

Enophthalmos

0.00

0.0

2.7

—

0.27

—

Disorders of puberty

0.92

0.00

3.3

1.7

0.47

1.01

ug/l

—

Acute thyroiditis

0.96

0.00

1.6

1.7

0.56

1.75

ug/l

—

Other disorders of bone development and growth

0.00

0.0

1.3

—

0.27

—

Defect, injury or illness of skull

0.00

0.0

2.6

—

3.31

—

Discharge of firework

0.00

0.0

1.3

—

0.43

—

Other specified disorders of skin and subcutaneous tissue in diseases classified elsewhere

0.00

0.0

2.0

—

0.30

—

Benign neoplasm of mesothelial tissue

0.00

0.0

1.7

—

0.25

—

Other specified air transport accidents

0.00

0.0

2.2

—

2.86

—

Fracture of lower limb, level unspecified

0.00

0.0

3.0

—

1.18

—

Contact with other specified venomous plants

0.00

0.0

1.4

—

27.27

—

Melanoma in situ of upper limb, including shoulder

1.01

0.00

1.5

1.9

2.91

4.94

ug/l

—

Toxic effect of other inorganic substances

0.00

0.0

1.3

—

0.54

—

Mosquito-borne viral encephalitis

0.00

0.0

1.6

—

0.28

—

Familial dysautonomia

0.00

0.0

2.3

—

0.56

—

Other operation for atrial fibrillation

0.93

0.00

1.6

2.1

0.49

5.56

ug/l

—

Bacterial vaccines

0.00

0.0

1.4

—

0.46

—

Niacin deficiency [pellagra]

0.00

0.0

1.4

—

0.26

—

Chondrolysis

0.00

0.0

2.4

—

0.60

—

Carcinoma in situ of respiratory system, other/unspecified

0.00

0.0

1.8

—

0.47

—

Villonodular synovitis (pigmented)

0.98

0.00

3.0

1.7

5.41

2.45

ug/l

—

Conditions involving the integument and temperature regulation of fetus and newborn

0.00

0.0

1.2

—

0.33

—

Other congenital malformations of posterior segment of eye (coloboma)

0.00

0.0

1.8

—

0.54

—

Increased muscle tone

0.88

0.00

2.5

1.9

0.89

5.12

ug/l

—

Miliaria, unspecified

0.00

0.0

1.6

—

0.36

—

Noonan syndrome

0.00

0.0

1.8

—

2.88

—

Megavitamin-B6 syndrome

0.00

0.0

2.6

—

35.23

—

Anhidrosis

0.00

0.0

2.2

—

0.30

—

Hereditary choroidal dystrophy

0.00

0.0

2.1

—

0.48

—

Pseudofolliculitis barbae

0.00

0.0

3.2

—

1.07

—

Disorders of glycoprotein metabolism, other/unspecified

0.00

0.0

1.4

—

0.42

—

Other respiratory conditions originating in the perinatal period

0.00

0.0

2.2

—

5.72

—

Total (external) ophthalmoplegia

0.00

0.0

1.2

—

0.42

—

Café au lait spots

0.00

0.0

5.0

—

29.80

—

Other conditions originating in the perinatal period

0.00

0.0

3.4

—

2.60

—

Plague

0.00

0.0

1.2

—

2.35

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

0.0

2.3

—

30.71

—

Nonscarring hair loss, unspecified, drug-induced

0.00

0.0

1.4

—

0.40

—

!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced

0.00

0.0

1.4

—

0.41

—

Carcinoma in situ of cervix uteri, endocervix

0.88

0.00

1.4

2.0

0.13

1.33

ug/l

—

Exposure to excessive cold of man-made origin

0.00

0.0

2.0

—

1.74

—

Moyamoya

0.00

0.0

1.2

—

2.68

—

Exposure to excessive heat of man-made origin

0.96

0.00

1.8

1.7

0.35

4.61

ug/l

—

Chlamydial lymphogranuloma (venereum)

0.00

0.0

2.4

—

0.39

—

Other degenerative disorders of globe

0.00

0.0

1.4

—

48.80

—

Other and unspecified parapsoriasis

0.95

0.00

5.7

1.9

1.85

5.70

ug/l

—

Exposure to high-pressure jet

0.00

0.0

2.2

—

0.51

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Procalcitonin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS